Target Information

General Information of This Target

Target ID	PATR0CXRBX
Target Name	Microtubule (MT)
Function	Microtubules are polymers of tubulin that form part of the cytoskeleton and provide structure and shape to eukaryotic cells. Microtubules play an important role in a number of cellular processes. They are involved in maintaining the structure of the cell and, together with microfilaments and intermediate filaments, they form the cytoskeleton. They also make up the internal structure of cilia and flagella. They provide platforms for intracellular transport and are involved in a variety of cellular processes, including the movement of secretory vesicles, organelles, and intracellular macromolecular assemblies. Click to Show/Hide

Full List of The ADC Related to This Target

Approved in 2025

Click To Hide/Show 10 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	Becotatug vedotin	Becotatug	EGFR	MMAE	Mc-Val-Cit-PABC
ADC Info	Disitamab vedotin	Hertuzumab	HER2	MMAE	Mc-Val-Cit-PABC
ADC Info	Tisotumab vedotin	Tisotumab	tissue factor	MMAE	Mc-Val-Cit-PABC	[4]
ADC Info	Belantamab mafodotin	Belantamab	BCMA	MMAF	Maleimido-caproyl	[5]
ADC Info	Telisotuzumab vedotin	Telisotuzumab	c-Met	MMAE	Mc-Val-Cit-PABC
ADC Info	Enfortumab vedotin	Enfortumab	nectin-4	MMAE	Mc-Val-Cit-PABC	[6]
ADC Info	Mirvetuximab soravtansine	Mirvetuximab	FRα	DM4	Sulfo-SPDB	[7]
ADC Info	Polatuzumab vedotin	Polatuzumab	CD79b	MMAE	Mc-Val-Cit-PABC	[8]
ADC Info	Brentuximab vedotin	Brentuximab	CD30	MMAE	Mc-Val-Cit-PABC
ADC Info	Trastuzumab emtansine	Trastuzumab	HER2	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[9]

Phase 3 (discontinued)

Click To Hide/Show 7 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker
ADC Info	Tusamitamab ravtansine	Tusamitamab	CEACAM5	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	Trastuzumab envedotin	Trastuzumab	HER2	MMAE	NH2-PEG3-Val-Cit-PABC
ADC Info	Upifitamab rilsodotin	Upifitamab	NaPi-2b	AF-HPA	Dolaflexin polymer
ADC Info	Tecotabart vedotin	Tecotabart	CLDN18.2	MMAE	Mc-Val-Cit-PABC
ADC Info	Sonesitatug vedotin	Sonesitatug	CLDN18.2	MMAE	Mc-Val-Cit-PABC
ADC Info	Fetrastobart vedotin	Anti-PD-L1 SGN-PDL1V mAb	PDL1	MMAE	Mc-Val-Cit-PABC
ADC Info	Sigvotatug vedotin	Sigvotatug	ITGB6	MMAE	Mc-Val-Cit-PABC

Phase 3 (discontinued)

Click To Hide/Show 1 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	BAT8001	BAT0606	HER2	Batansine	Maleimido-caproyl

Phase 2/3 (discontinued)

Click To Hide/Show 1 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	Luveltamab tazevibulin	Luveltamab	FRα	SC209	DBCO-Val-Cit-PABA

Phase 2

Click To Hide/Show 11 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker
ADC Info	BB-1701	Anti-HER2 antibody	HER2	Eribulin	Mal-PEG2-Val-Cit-PABC
ADC Info	Ozuriftamab vedotin	Ozuriftamab	ROR2	MMAE	Mc-Val-Cit-PABC
ADC Info	Praluzatamab ravtansine	Praluzatamab	ALCAM	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	Ladiratuzumab vedotin	Ladiratuzumab	LIV-1	MMAE	Mc-Val-Cit-PABC
ADC Info	Anvatabart opadotin	Anvatabart	HER2	Amberstatin 269 (AS269)	Hydroxylamine-PEG4
ADC Info	Zilovertamab vedotin	Zilovertamab	ROR1	MMAE	Mc-Val-Cit-PABC
ADC Info	RC108	Anti-c-Met antibody	c-Met	MMAE	Mc-Val-Cit-PABC
ADC Info	DX126-262	DX-CHO9	HER2	Tub114	Mal-PEG10 based linker
ADC Info	FOR46	YS5	CD46	MMAE	A cleavable linker
ADC Info	MRG001	Chimeric anti-CD20 mAb	CD20	MMAE	Mc-Val-Cit-PABC
ADC Info	SHR-4602	Pertuzumab	HER2	ER300	Stable enzyme-cleavable linker

Phase 2 (discontinued)

Click To Hide/Show 11 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker
ADC Info	AGS-16C3F	Anti-ENPP3 AGS-16C3F mAb	ENPP3	MMAF	Maleimido-caproyl
ADC Info	Naratuximab emtansine	Naratuximab	CD37	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	Lifastuzumab vedotin	Lifastuzumab	NaPi-2b	MMAE	Mc-Val-Cit-PABC
ADC Info	Anetumab ravtansine	Anetumab	MSLN	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	Indusatumab vedotin	Indusatumab	GC-C	MMAE	Mc-Val-Cit-PABC
ADC Info	Lorvotuzumab mertansine	Lorvotuzumab	CD56	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
ADC Info	Coltuximab ravtansine	Coltuximab	CD19	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	Glembatumumab vedotin	Glembatumumab	GPNMB	MMAE	Mc-Val-Cit-PABC
ADC Info	Cantuzumab ravtansine	Cantuzumab	Muc1	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	PSMA ADC	Fully human anti-PSMA IgG1 mAb	PSMA	MMAE	Mc-Val-Cit-PABC
ADC Info	SAR566658	huDS6	Carbonic anhydrase 6 (CA6)	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)

Phase 2

Click To Hide/Show 15 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker
ADC Info	Mecbotamab vedotin	Mecbotamab	Axl	MMAE	Mc-Val-Cit-PABC
ADC Info	CX-2029	Anti-CD71 CX-151 probody	TfR1	MMAE	Mc-Val-Cit-PABC
ADC Info	Farletuzumab ecteribulin	Farletuzumab	FRα	Eribulin	Mal-PEG2-Val-Cit-PABC
ADC Info	Bulumtatug fuvedotin	Bulumtatug	nectin-4	MMAE	IDM-Val-Cit-PBCA
ADC Info	BB-1705	Anti-EGFR antibody	EGFR	Eribulin	Mal-PEG2-Val-Cit-PABC
ADC Info	BIO-106	Anti-TROP2 antibody	TROP2	TAMTM	A non-cleavable linker
ADC Info	Vemzatatug vedotin	Anti-GPRC5D antibody	GPRC5D	MMAE	Mc-Val-Cit-PABC
ADC Info	Ciletatug vedotin	Ciletatug	CLDN18.2	MMAE	Mc-Val-Cit-PABC
ADC Info	Misitatug blivedotin	Misitatug	MSLN	MMAE	PY-MAA-Val-Cit-PABC
ADC Info	REGN5093-M114	REGN5093	c-Met	Maytansine derivative M24	SC-Val-Cit-PABC
ADC Info	SYS6002	Anti-Nectin-4 antibody	nectin-4	MMAE	NH2-PEG3-Val-Cit-PABC
ADC Info	JK06	Anti-5T4 antibody	5T4	MMAE	Mc-Val-Cit-PABC
ADC Info	ILB-3101	Anti-B7H3 antibody	B7-H3	Eribulin	A cleavable linker
ADC Info	LCB84	Hu2G10	TROP2	MMAE	β-glucuronide linker
ADC Info	PRO1107	Anti-PTK7 antibody	PTK7	MMAE	A cleavable linker

Phase 1/2 (discontinued)

Click To Hide/Show 10 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker
ADC Info	OBI-999	OBI-888	Globo H	MMAE	ThioBridge-PEG24-Val-Cit-PABC
ADC Info	Bezetabart debotansine	Bezetabart	CD74	SC347	Cys-12 ADC linker
ADC Info	Enapotamab vedotin	Enapotamab	Axl	MMAE	Mc-Val-Cit-PABC
ADC Info	Depatuxizumab mafodotin	Depatuxizumab	EGFR	MMAF	Maleimido-caproyl
ADC Info	BMS-986148	BMS-986021	MSLN	Tubulysin	Mc-Val-Cit
ADC Info	Lonigutamab ugodotin	Lonigutamab	IGF-1R	F554443	Maleimido-caproyl
ADC Info	STI-6129	STI-5171	CD38	Duostatin 5.2	Non-polyethylene glycol linker
ADC Info	MEDI4276	MEDI-4276	HER2	AZ13599185	Maleimido-caproyl based linker
ADC Info	MLN2704	MLN591	PSMA	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
ADC Info	BMS-986183	Anti-GPC3 antibody	GPC3	Tubulysin	Val-Cit dipeptide linker

Phase 1/2

Click To Hide/Show 36 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	GQ1001	Trastuzumab variant	HER2	DM1	K'-MCC'
ADC Info	AMT-151	Ab-151	FRα	Duostatin 5	Pip-Val-Cit linker
ADC Info	AGX101	Anti-TM4SF1 antibody	TM4SF1	Maytansine derivative	A non-cleavable linker
ADC Info	ASN004	Anti-5T4 scFv-Fc mAb	5T4	AF-HPA	Fleximer polymer
ADC Info	ATG-022	Anti-CLDN18.2 antibody	CLDN18.2	MMAE	Mc-Val-Cit-PABC
ADC Info	BB-1709	Anti-CD73 antibody	CD73	MMAE	Undisclosed
ADC Info	BC3195	Anti-CDH3 antibody	CDH3	MMAE	Val-Cit dipeptide linker
ADC Info	DXC009	Humanized anti-BCMA mAb	BCMA	Undisclosed	Undisclosed
ADC Info	JS107	Anti-CLDN18.2 mAb	CLDN18.2	MMAE	Maleimide linker of vc PAB
ADC Info	M1231	An antibody scaffold targeting MUC1 and EGFR	EGFR; Muc1	SC209	DBCO-Val-Cit-PABA	[10]
ADC Info	MYTX-011	Anti-c-MET pH-dependent mAb	c-Met	MMAE	Mc-Val-Cit-PABC
ADC Info	NBT508	Anti-CD79b antibody	CD79b	MMAE	TetraM-Val-Cit-PABC
ADC Info	PR301	Anti-CLDN18.2 antibody	CLDN18.2	Duostatin 5	A cleavable linker
ADC Info	Micvotabart pelidotin	Micvotabart	EDB-FN	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC
ADC Info	KM501	Trastuzumab/Pertuzumab biparatopic bsAb	HER2	MMAE	Undisclosed
ADC Info	DXC005	Anti-Muc1 antibody	Muc1	Tub201	Undisclosed
ADC Info	Felmetatug vedotin	Felmetatug	B7-H4	MMAE	Mc-Val-Cit-PABC
ADC Info	Ixotatug vedotin	Ixotatug	CLDN6	MMAE	Mc-Val-Cit-PABC
ADC Info	TRS005	Anti-CD20 antibody	CD20	MMAE	Mc-Val-Cit-PABC
ADC Info	Emiltatug ledadotin	Emiltatug	B7-H4	AF-HPA	A cleavable ester linker
ADC Info	EBC-129	Anti N256-glycosylated CEACAM5 and CEACAM6 antibody	CEACAM5; CEACAM6	MMAE	Mc-Val-Cit-PABC
ADC Info	BA1302	Anti-CD228 antibody	CD228	MMAE	MC-β-Ala-(glucuronide)-PABC
ADC Info	XB010	Anti-5T4 antibody	5T4	MMAE	RED-601 linker
ADC Info	NN3201	NN2101	c-Kit	MMAE	Bis-sulfone-(PEG24)-Glu-Val-Cit-PAB
ADC Info	SMP-656	Anti-HER2 antibody	HER2	Eribulin	SuperHydraTM linker
ADC Info	ADRX-0706	Anti-Nectin-4 antibody	nectin-4	AP052	Adcentrx' proprietary linker
ADC Info	Opugotamig olatansine	Opugotamig	FRα	DM21-C	Stable cleavable peptide linker
ADC Info	F0002-ADC	Brentuximab	CD30	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	Zarutatug vedotin	Zarutatug	CDH17	MMAE	Mc-Val-Cit-PABC
ADC Info	roltotatug vedotin	Roltotatug	DLK1	MMAE	Mc-Val-Cit-PABC
ADC Info	BL-B16D1	Anti-EGFR/HER3 bsAb	EGFR; HER3	WA-00	Undisclosed
ADC Info	DXC007	A recombinant anti-CD33 mAb	CD33	Tub255	Undisclosed
ADC Info	BL-M17D1	Anti-HER2 antibody	HER2	WA-00	Undisclosed
ADC Info	LNCB74	Anti-B7-H4 IgG1k mAb	B7-H4	MMAE	β-glucuronide linker
ADC Info	INA03	Anti-CD71 mAb	TfR1	MMAE	APN-PEG5-Val-Cit-PABC
ADC Info	SGN-35T	Brentuximab	CD30	MMAE	Mp-D-leucine-alanine-glutamate-PABC

Phase 1 (discontinued)

Click To Hide/Show 60 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	Cantuzumab mertansine	Cantuzumab	Muc1	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
ADC Info	ALT-P7	Trastuzumab variant	HER2	MMAE	Val-Cit dipeptide linker
ADC Info	Zanidatamab zovodotin	Zanidatamab	HER2	ZD02044	Mc-PEG3-Val-Cit
ADC Info	Pinatuzumab vedotin	Pinatuzumab	CD22	MMAE	Mc-Val-Cit-PABC
ADC Info	Vorsetuzumab mafodotin	Vorsetuzumab	CD70	MMAF	Maleimido-caproyl
ADC Info	Sofituzumab vedotin	Sofituzumab	Muc16	MMAE	Mc-Val-Cit-PABC
ADC Info	Azintuxizumab vedotin	Azintuxizumab	CS1	MMAE	Mc-Val-Cit-PABC
ADC Info	AVE9633	HuMy9-6	CD33	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	BIIB015	HuB3F6	TDGF1	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	PCA062	CQY684	CDH3	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	CDX-014	CR014	TIM1	MMAE	Mc-Val-Cit-PABC
ADC Info	XMT-1592	Anti-NaPi-2b antibody	NaPi-2b	AF-HPA	Cys-13 ADC linker
ADC Info	AbGn-107	Anti-AbGn-7 antibody	AbGn-7 antigen	DM4	Val-Cit dipeptide linker
ADC Info	AGS67E	AGS67C	CD37	MMAE	Mc-Val-Cit-PABC
ADC Info	AMG 224	Anti-human BCMA IgG1 mAb	BCMA	DM1	4-[N-maleimidomethyl] cyclohexane-1-carboxylate (MCC)
ADC Info	PF-06804103	Trastuzumab-(κK183C+K290C)	HER2	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC
ADC Info	Aprutumab ixadotin	Aprutumab	FGFR2	Auristatin W	Caproyl acid
ADC Info	Cofetuzumab pelidotin	Cofetuzumab	PTK7	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC
ADC Info	DAC-002	Anti-TROP2 antibody	TROP2	Tubulysin 196	2,3-disubstituted long side-chain hydrolysis-resistant linker
ADC Info	GB251	Anti-HER2 antibody	HER2	MMAE	BiM-Val-Cit-PABC
ADC Info	Iladatuzumab vedotin	Iladatuzumab	CD79b	MMAE	Mc-Val-Cit-PABC
ADC Info	Ispectamab debotansine	Ispectamab	BCMA	SC347	Cys-12 ADC linker
ADC Info	JBH492	121G12	CCR7	DM4	A cleavable linker
ADC Info	Losatuxizumab vedotin	Losatuxizumab	EGFR	MMAE	Mc-Val-Cit-PABC
ADC Info	Lupartumab amadotin	Lupartumab	LYPD3	Auristatin W derivative	Mc-hydrazide linker
ADC Info	RG7841	MLYE4489A	Ly6E	MMAE	Mc-Val-Cit-PABC
ADC Info	Samrotamab vedotin	Samrotamab	LRRC15	MMAE	Mc-Val-Cit-PABC
ADC Info	SGN-ALPV	H12F3	PLAP; ALPPL2	MMAE	Mc-Val-Cit-PABC
ADC Info	SGN-CD228A	HL49	CD228	MMAE	Mal PEG12 based β-glucuronide linker
ADC Info	SGN-CD48A	Anti-SLAMF2 mAb	SLAMF2	MMAE	PEGylated β-glucuronide linker
ADC Info	SGN-STNV	Anti-Onco-foetal sialyl-Tn antibody	Onco-foetal sialyl-Tn	MMAE	Mc-Val-Cit-PABC
ADC Info	SHR-A1403	Anti-c-MET IgG2 mAb	c-Met	SHR152852	L2-MC
ADC Info	Sirtratumab vedotin	Sirtratumab	SLITRK6	MMAE	Mc-Val-Cit-PABC
ADC Info	SYSA1801	Anti-CLDN18.2 mAb	CLDN18.2	MMAE	PEG3-Val-Cit-PABC
ADC Info	TRPH-222	Anti-CD20 antibody	CD22	DM1	HIPS-4AP
ADC Info	Samatatug zovodotin	Samatatug	tissue factor	ZD02044	Mc-PEG3-Val-Cit
ADC Info	PF-06263507	PF-06281192	5T4	MMAF	Maleimido-caproyl
ADC Info	ASG-5ME	Anti-SLC44A4 IgG2 mAb	CTL4	MMAE	Mc-Val-Cit-PABC
ADC Info	AGS62P1	Anti-FLT3 IgG1κ mAb	Flt3	AGD-0182	Alkoxyamine linker
ADC Info	LOP628	LMJ729	c-Kit	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	BAT8003	Anti-TROP2 antibody	TROP2	Batansine	Maleimido-caproyl
ADC Info	BAY 79-4620	3ee9	Carbonic anhydrase 9 (CA9)	MMAE	Val-Cit dipeptide linker
ADC Info	Bivatuzumab mertansine	Bivatuzumab	CD44	DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
ADC Info	HKT288	Anti-CDH6 HKT-288 mAb	CDH6	DM4	Sulfo-SPDB
ADC Info	IMGN388	Intetumumab	CD51	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	Laprituximab emtansine	Laprituximab	EGFR	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	MEDI-547	Anti-EPHA2 (1C1) mAb	EphA2	MMAF	Maleimido-caproyl
ADC Info	PF-06650808	Hu28	Notch-3	Auristatin 0101 (Aur0101)	Mc-Val-Cit-PABC
ADC Info	PF-06664178	PF-06478924	TROP2	Auristatin 0101 (Aur0101)	AcLys-Val-Cit-PABC
ADC Info	RG7598	MFRF3266A	FCRL5	MMAE	Mc-Val-Cit-PABC
ADC Info	RG7636	MEDN6000A	ETB	MMAE	Mc-Val-Cit-PABC
ADC Info	RG7882	MMUC3333A	Muc16	MMAE	Mc-Val-Cit-PABC
ADC Info	Vandortuzumab vedotin	Vandortuzumab	STEAP1	MMAE	Mc-Val-Cit-PABC
ADC Info	XMT-1522	XMT-1519	HER2	AF-HPA	Fleximer polymer
ADC Info	SAR428926	Anti-LAMP-1 antibody	LAMP-1	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
ADC Info	LY3076226	IMC-D11	FGFR3	DM4	Sulfo-SPDB
ADC Info	AMG 172	Anti-CD70 mAb	CD70	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	RG7600	H7D9.v3	MSLN	MMAE	Mc-Val-Cit-PABC	[11]
ADC Info	AMG 595	Anti-EGFRvIII mAb	EGFRvIII	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	Denintuzumab mafodotin	Denintuzumab	CD19	MMAF	Maleimido-caproyl

Investigative

Click To Hide/Show 1960 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	¹¹¹In-DTPA-D2B-DAR2-MMAE	Anti-PSMA IgG1 mAb D2B	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[12]
ADC Info	¹¹¹In-DTPA-D2B-DAR4-MMAE	Anti-PSMA IgG1 mAb D2B	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[12]
ADC Info	⁸⁹Zr-DFO-T-DM1	Zr-labeled trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Undisclosed	[13]
ADC Info	AbA-vcMMAE	Anti-EGFR AbA	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[14]
ADC Info	AXL02-MMAE	Anti-AXL mAb AXL02	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[15]
ADC Info	BCG033	Undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2); Inactive tyrosine-protein kinase 7 (PTK7)	Monomethyl auristatin E	Undisclosed	[16]
ADC Info	CD46-ADC	Anti-CD46 mAb 23AG2	Membrane cofactor protein (CD46)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[17]
ADC Info	Cetux Cys-vc-MMAE	Glyco-engineered cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	Cetux Cys-vc-MMAE	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	Cetux Fc/Fab-vc-MMAE	Glyco-engineered cetuximab Fc/Fab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	Cetux Fc/Fab-vc-MMAE	Cetuximab (Fc/Fab labeled with Neu5NAz)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	F105-SPDB-DM4	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[19]
ADC Info	F105-SSNPB-DM4	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	N-sulfosuccinimidyl-4-(5-nitro-2 pyridyldithio) butyrate (SSNPB)	[19]
ADC Info	H-1-vcMMAE	Anti-HER2 mAb H-1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[20]
ADC Info	H3G10.1.91-h3G10.A58 vc0101	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.1.91-h3G10.A58 vc0101	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.1.91-h3G10.A58 vcMMAD	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.1.91-h3G10.A58 vcMMAD	h3G10.1.91-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.2.37-h3G10.A58 vc0101	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.2.37-h3G10.A58 vc0101	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.2.37-h3G10.A58 vcMMAD	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.2.37-h3G10.A58 vcMMAD	h3G10.2.37-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.A57-h3G10.A58 vc0101	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.A57-h3G10.A58 vc0101	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.A57-h3G10.A58 vcMMAD	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	H3G10.A57-h3G10.A58 vcMMAD	h3G10.A57-h3G10.A58	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	H-3-vcMMAE	Anti-HER2 mAb H-3	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[20]
ADC Info	H-4-vcMMAE	Anti-HER2 mAb H-4	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[20]
ADC Info	Mil40-12B	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleamic methyl ester-based linker 12B	[22]
ADC Info	Mil40-12B	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[22]
ADC Info	RC88-Mc-Val-Cit-PAB-MMAD	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[23]
ADC Info	RC88-Mc-Val-Cit-PAB-MMAE	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[23]
ADC Info	RC88-PY-MAA-Val-Cit-PAB-MMAD	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[23]
ADC Info	RC88-PY-MAA-Val-Cit-PAB-MMAE	Anti-MSLN mAb	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[23]
ADC Info	Cirmtuzumab vedotin	Cirmtuzumab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Lysine-linker	[24]
ADC Info	Mirvetuximab-SPP-DM1	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[25]
ADC Info	Mirvetuximab-SPDB-DM4	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[26]
ADC Info	Mirvetuximab-SMCC-DM1	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[25]
ADC Info	HuFR1-48-SMCC-DM1	Anti-FOLR1 huFR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[25]
ADC Info	HuFR1-49-SMCC-DM1	Anti-FOLR1 huFR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[25]
ADC Info	HuFR1-57-SMCC-DM1	Anti-FOLR1 huFR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[25]
ADC Info	HuFR1-65-SMCC-DM1	Anti-FOLR1 huFR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[25]
ADC Info	54E-Val-Cit-MMAE	Anit-TF mAb 54E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	43Ea-Val-Cit-MMAE	Anit-TF mAb 43Ea	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	43D7-Val-Cit-MMAE	Anit-TF mAb 43D7	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	43B1-Val-Cit-MMAE	Anit-TF mAb 43B1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	39A-Val-Cit-MMAE	Anit-TF mAb 39A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	29E-Val-Cit-MMAE	Anit-TF mAb 29E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	25G1-Val-Cit-MMAE	Anit-TF mAb 25G1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	25A3-Val-Cit-MMAE	Anit-TF mAb 25A3	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	25A-Val-Cit-MMAE	Anit-TF mAb 25A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	RcEDB-ADC	Reverse chimeric (rc) Anti-EDB-FN L19	Fibronectin (FN1)	Auristatin 0101	Mc-Val-Cit-PABC	[28]
ADC Info	PODO447-ADC	PODO447	Podocalyxin (PODXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[29]
ADC Info	Anti-PIEZO1-MMAE	Anti-PIEZO1 mAb	Piezo-type mechanosensitive ion channel component 1 (PIEZO1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[30]
ADC Info	C12G1-DM1	Anti-NECTIN2 mAb c12G1	Nectin-2 (NECTIN2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[31]
ADC Info	HzMUC1-MMAE	HzMUC1	Mucin-1 (MUC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[32]
ADC Info	LSR-ADC	Anti-LSR mAb	Lipolysis-stimulated lipoprotein receptor (LSR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[33]
ADC Info	LRG1-ADC 5	Magacizumab	Leucine-rich alpha-2-glycoprotein (LRG1)	Monomethyl auristatin E	Dipeptide-diBrPD (dibromopyridazinedione )	[34]
ADC Info	1131-MMAE	C-1131	Kita-kyushu lung cancer antigen 1 (CT83)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[35]
ADC Info	Trastuzumab-SYNtansine	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Ahx-maytansine	BCN-HydraSpace-Val-Cit-PABC	[36]
ADC Info	Tmab-SPP-DM1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[37]
ADC Info	Tmab-SSNPP-DM3	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[37]
ADC Info	Tmab-SSNPP-DM4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[37]
ADC Info	Trastuzumab-AJICAP-maytansinoid	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	AJICAP	[38]
ADC Info	ADAPT6-ABD-mcDM1	ADAPT6-ABD	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Maleimidocaproyl (Ser3-Gly)3	[39]
ADC Info	HA15-1C25F	Anti-SLITRK6 mAb Ha15-1c25	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	[40]
ADC Info	HA15-1C25E	Anti-SLITRK6 mAb Ha15-1c25	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[41]
ADC Info	HA15-1ABE16F	Anti-SLITRK6 mAb Ha15-1abe16	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	[40]
ADC Info	HA15-1ABE16E	Anti-SLITRK6 mAb Ha15-1abe16	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[41]
ADC Info	HA15-10AC14F	Anti-SLITRK6 mAb Ha15-10ac14	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	[40]
ADC Info	HA15-10AC14E	Anti-SLITRK6 mAb Ha15-10ac14	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[41]
ADC Info	GPC1-ADC-MMAE	Anti-GPC1 GPC1-ADC (MMAE) mAb	Glypican-1 (GPC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[42]
ADC Info	GPC1-ADC-MMAF	Anti-GPC1 GPC1-ADC mAb	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[43]
ADC Info	LR004-Val-Cit-MMAE	LR004	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[44]
ADC Info	EDB-ADC	Anti-EDB-FN L19	Fibronectin (FN1)	Auristatin 0101	Mc-Val-Cit-PABC	[28]
ADC Info	4C9-DM1	Anti-KIT mAb 4C9	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[31]
ADC Info	NN2101-DM1	NN2101	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[45]
ADC Info	CDH6-SPDB-DM4	Human Anti-CDH6 mAb	Cadherin-6 (CDH6)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[46]
ADC Info	1F6-Val-Cit-PABC-MMAF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Monomethyl auristatin F	Mal-Val-Cit-PABC	[47]
ADC Info	1F6-Ile-Pro-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Ile-Pro	[47]
ADC Info	1F6-Me3-Lys-Pro-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Me3Lys-Pro	[47]
ADC Info	1F6-NorVal- (D)Asp-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-NorVal-D-Asp	[47]
ADC Info	1F6-beta-Ala- (D)Asp-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-bata-Ala-D-Asp	[47]
ADC Info	1F6-PhenylGly- (D)Lys-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-PhenylGly-D-Lys	[47]
ADC Info	1F6-Met- (D)Lys-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Met-D-Lys	[47]
ADC Info	1F6-Asn- (D)Lys-AM	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin M	Mal-Asn-D-Lys	[47]
ADC Info	1F6-Met- (D)Lys-AW	Anti-CD70 mAb IF6	CD70 antigen (CD70)	L-Alanyl-L-tryptophan	Mal-Met-D-Lys	[47]
ADC Info	CAC10-Gly5-MAY	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Gly5	[48]
ADC Info	CBR96-Phe-Lys-MMAE	Anti-Lewis-Y mAb cBR96	Lewis Y	Monomethyl auristatin E	Mc-Phe-Lys-PABC	[49]
ADC Info	BT062-SPDB-DM4	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[50]
ADC Info	B-B4-DM1	Cantuzumab	Syndecan-1 (SDC1)	Mertansine DM1	Undisclosed	[51]
ADC Info	AXL02	AXL Anti-ody YW327.6S2	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[52]
ADC Info	AXL-733-MMAE	AXL-733	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-726-M101L-MMAE	AXL-726-M101L	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-613-MMAE	AXL-613	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-511-MMAE	AXL-511	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-183-N52Q-MMAE	AXL-183-N52Q	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-171-MMAE	AXL-171	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-154-M103L-MMAE	AXL-154-M103L	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	AXL-148-MMAE	AXL-148	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[53]
ADC Info	ASG-15MF	Sirtratumab	SLIT and NTRK-like protein 6 (SLITRK6)	Monomethyl auristatin F	Maleimido-caproyl	[40]
ADC Info	Anti-IL13RA2-ADC	Anti-IL13RA2 PF-06473811 mAb	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Auristatin 0101	Mc-Val-Cit-PABC	[54]
ADC Info	ADC MMAE/F 4+2	Trastuzumab N297A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E+Monomethyl auristatin F	DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC	[55]
ADC Info	ADC MMAE/F 2+4	Trastuzumab N297A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E+Monomethyl auristatin F	DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC	[55]
ADC Info	HuIgG1-SPDB-DM4	Undisclosed	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[25]
ADC Info	Brentuximab-8	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Alkyl phosphoramide-PEG24-Val-Cit-PAB	[56]
ADC Info	Brentuximab-7	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Alkyl phosphoramide-PEG12-Val-Cit-PAB	[56]
ADC Info	Trastuzumab DVD-ADC	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Hexapeptide linker ASTKGP	[57]
ADC Info	PD-L1 ADC 1	Avelumab	Programmed cell death 1 ligand 1 (CD274)	Monomethyl auristatin E	Mc-Val-Ala-PABC	[58]
ADC Info	PD-L1 ADC 2	Avelumab	Programmed cell death 1 ligand 1 (CD274)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[58]
ADC Info	PD-L1 ADC 3	Atezolizumab	Programmed cell death 1 ligand 1 (CD274)	Monomethyl auristatin E	Mc-Val-Ala-PABC	[58]
ADC Info	T-CpHK-Tet-ADC	Trastuzumab-CpHK	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Tetrazine-PEG5-Val-Ala-PABC	[59]
ADC Info	T-CpHK-Mal-ADC	Trastuzumab-CpHK	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[59]
ADC Info	Trastuzumab-Man-beta-1,4GlcNAc-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc	[60]
ADC Info	Trastuzumab-Glc-beta-1,4GlcNAc-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Glc-beta-1,4GlcNAc	[60]
ADC Info	Trastuzumab-Gal-beta-1,4GlcNAc-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Gal-beta-1,4-GlcNAc	[60]
ADC Info	Trastuzumab-MMAE conjugate DAR2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	[61]
ADC Info	Trastuzumab-MMAE conjugate DAR4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	[61]
ADC Info	Trastuzumab-MMAE conjugate DAR6	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	[61]
ADC Info	Trastuzumab-MMAE conjugate DAR8	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	[61]
ADC Info	Trastuzumab-MMAE conjugate DAR12	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Man-beta-1,4-GlcNAc-DBCO-PEG5-VC-PAB	[61]
ADC Info	Anti-HER2 DVD-IgG1-h38c2-K99C_MMAF	Anti-HER2 DVD-IgG1-H38c2-K99C	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	[62]
ADC Info	Anti-HER2 DVD-Fab-h38c2-K99C_MMAF	Anti-HER2 DVD-Fab-h38c2-K99C	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	[62]
ADC Info	Anti-HER2 DVD-IgG1_MMAF	Anti-HER2 DVD-IgG1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	[62]
ADC Info	Anti-HER2 DVD-Fab_MMAF	Anti-HER2 DVD-Fab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Dibromomaleimide-PEG4	[62]
ADC Info	Mil40-12A	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleamic methyl ester-based linker 12A	[22]
ADC Info	Mil40-12C	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleamic methyl ester-based linker 12C	[22]
ADC Info	Tras-Gly5-May	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Gly5	[48]
ADC Info	Fcab-1-MMAE	Fcab-1	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	[63]
ADC Info	Fcab-2-MMAE	Fcab-2	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	[63]
ADC Info	Fcab-3-MMAE	Fcab-3	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	[63]
ADC Info	HuFc-MMAE	Anti-EGFR huFc	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	[63]
ADC Info	C-Fab-MMAE	Cetuximab Fab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	[63]
ADC Info	C-IgG-Val-Cit-MMAE	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Gly3-Val-Cit-PABC	[63]
ADC Info	ADC MMAE/F 2+2	Trastuzumab N297A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E+Monomethyl auristatin F	DBCO-PEG3-Glu-Val-Cit-PABC; TCO-PEG3-Glu-Val-Cit-PABC	[55]
ADC Info	Septuximab vedotin	Septuximab	Frizzled-7 (FZD7)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[64]
ADC Info	PeptibodyC19-PEG4-Val-Cit-MMAE	Peptibody C19	Fibroblast growth factor receptor 1 (FGFR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[65]
ADC Info	40H3-MCVCPAB-MMAE	Anti-EGFR mAb 40H3	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[66]
ADC Info	40H3-SMCC-DM1	Anti-EGFR mAb 40H3	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[66]
ADC Info	Cet-DM1	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[67]
ADC Info	1F6-Ile-Val-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Ile-Val	[47]
ADC Info	1F6-Asp-Val-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Asp-Val	[47]
ADC Info	1F6-His-Val-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-His-Val	[47]
ADC Info	1F6-Met-Lys-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Met-Lys	[47]
ADC Info	1F6-Asn-Lys-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Asn-Lys	[47]
ADC Info	1F6-Pro- (D)Lys-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Pro-D-Lys	[47]
ADC Info	1F6-Met- (D)Lys-MMAF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Monomethyl auristatin F	Mal-Met-D-Lys	[47]
ADC Info	1F6-Asn- (D)Lys-MMAF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Monomethyl auristatin F	Mal-Asn-D-Lys	[47]
ADC Info	1F6-Met- (D)Lys-AM	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin M	Mal-Met-D-Lys	[47]
ADC Info	1F6-Asn- (D)Lys-AW	Anti-CD70 mAb IF6	CD70 antigen (CD70)	L-Alanyl-L-tryptophan	Mal-Asn-D-Lys	[47]
ADC Info	MAb-DMBA-SIL-MMAE	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	DMBA-SIL	[68]
ADC Info	Alb-DMBA-SIL-MMAE	Alb	Albumin (ALB)	Monomethyl auristatin E	DMBA-SIL	[68]
ADC Info	HB22.7-SAP	Anti-CD22 mAb HB22.7	B-cell receptor CD22 (CD22)	Saporin	Undisclosed	[69]
ADC Info	GMF-1A3-MMAE	Anti-cleaved-AREG 1A3 Anti-ody	Amphiregulin (AREG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[70]
ADC Info	OMTX705	OMTX005	FAP	TAM470	Mc-Val-Cit-PABC-PEG3	[71]
ADC Info	Izeltabart tapatansine	Izeltabart	ADAM9	DM21-C	Mc-Ala-Ala-Ala	[72]
ADC Info	SHR-A1307	Anti-EGFR mAb hR3-YTE	Epidermal growth factor receptor (EGFR)	SHR152852	L2-MC	[73]
ADC Info	CD38-077	STI-5171	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duostatin 5.2	Non-polyethylene glycol linker	[74]
ADC Info	BCMA-077	Undisclosed	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Duostatin 5.2	Proprietary Concortis linker	[75]
ADC Info	BCMA-024	Undisclosed	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Duostatin 5.2	Proprietary Concortis linker	[75]
ADC Info	1959-SSS-DM3	Undisclosed	Galectin-3-binding protein (LGALS3BP)	Maytansinoid DM3	Undisclosed	[76]
ADC Info	RN927C	Humanized Anti-Trop-2 hIgG1 Anti-ody	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	AcLys-Val-Cit-PABC	[77]
ADC Info	RN765C	EGFR Ab-L	Epidermal growth factor receptor (EGFR)	Auristatin 0101	AcLys-Val-Cit-PABC	[78]
ADC Info	Anti-N3(i)-vc0101	Anti-NOTCH3(i) mAb	Neurogenic locus notch homolog protein 3 (NOTCH3)	Auristatin 0101	Mc-Val-Cit-PABC	[79]
ADC Info	Anti-N3-vc0101	Anti-NOTCH3 mAb	Neurogenic locus notch homolog protein 3 (NOTCH3)	Auristatin 0101	Mc-Val-Cit-PABC	[79]
ADC Info	Alpha-CLDN-VC0101	Undisclosed	Claudin-18.2 (CLDN18.2)	Auristatin 0101	Mc-Val-Cit-PABC	[80]
ADC Info	MP-1959-ADC	Anti-LGALS3BP mAb 1959-sss	Galectin-3-binding protein (LGALS3BP)	Maytansinoid	Undisclosed	[81]
ADC Info	M9346A Sulfo-SPDB DM4	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[25]
ADC Info	Anti-FcRL5-SPDB-DM4	Anti-FcRL5 mAb	Fc receptor-like protein 5 (FCRL5)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[82]
ADC Info	Anti-CD22-SPDB-DM4	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[83]
ADC Info	Anti-CD22-K149C-MBT-DM4	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM4	MBT	[83]
ADC Info	HuRH105-SSPDB-DM4	Undisclosed	Endoglin (ENG)	Mertansine DM4	Sulfo-SPDB	[84]
ADC Info	IMB-102	Undisclosed	Cathepsin D (CTSD)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[85]
ADC Info	CBX-13	Undisclosed	Undisclosed	Mertansine DM4	Undisclosed	[86]
ADC Info	Oberotatug ravtansine	Oberotatug	CD205	DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[87]
ADC Info	Oba01	Zaptuzumab	DR5	MMAE	PY-MAA-Val-Cit-PABC	[88]
ADC Info	Anti-HER2 antibody-drug conjugate (Spirea)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[89]
ADC Info	TTZ-Mc-NPV-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Asn-Pro-Val-PABC	[90]
ADC Info	Adcitmer	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pyridino-caproic-Val-Cit-PABC	[91]
ADC Info	Trastuzumab-BCN-HydraSpace-Val-Cit-PABC-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	BCN-HydraSpace-Val-Cit-PABC	[36]
ADC Info	MF-TTZ-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Dibromomethyl pyridine-Val-Cit-PABC	[92]
ADC Info	FGM-TTZ-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[92]
ADC Info	NC-ADC	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Divinylpyrimidine-PEG4	[93]
ADC Info	C-ADC	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Divinylpyrimidine-PEG4-Val-Ala-PABC	[93]
ADC Info	RC68-PY-Val-Cit-PABC-MMAE	RC68	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	PY-VC-PABC	[94]
ADC Info	RC68-Mc-Val-Cit-PABC-MMAE	RC68	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[94]
ADC Info	PCM-MET01-MMAE	PCM-MET01	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[95]
ADC Info	Pab-001-MMAE	Pab-001	Mucin-1 (MUC1)	Monomethyl auristatin E	Undisclosed	[96]
ADC Info	OBI-998	OBI-898	Stage-specific embryonic antigen-4 (SSEA-4)	Monomethyl auristatin E	Maleimide and PEGylated cleavable linker	[97]
ADC Info	Anti-ICOS-MMAE	Murine Anti-ICOS Anti-ody	Inducible T-cell costimulator (ICOS)	Monomethyl auristatin E	Undisclosed	[98]
ADC Info	Magacizumab PD-MMAE ADC 5	Magacizumab	Leucine-rich alpha-2-glycoprotein (LRG1)	Monomethyl auristatin E	Mepstra-PD-PEG3-Mal-Cit-PABC	[34]
ADC Info	1F-Val-Cit-MMAE	Anit-TF mAb 1F	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[27]
ADC Info	BVD-TEM8 ADC	Anti-TEM8 mAb m825	Anthrax toxin receptor 1 (ANTXR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[99]
ADC Info	IMAB362-Val-Cit-MMAE	IMAB362	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[100]
ADC Info	IMAB027-Val-Cit-MMAE	IMAB027	Claudin-6 (CLDN6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[101]
ADC Info	SS1-Val-Cit-MMAE	Anti-MSLN IgG1-SS1	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[102]
ADC Info	CHS8-Val-Cit-MMAE	Anti-MSLN IgG1-CHS8	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[102]
ADC Info	CHS7-Val-Cit-MMAE	Anti-MSLN IgG1-CHS7	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[102]
ADC Info	CHS5-Val-Cit-MMAE	Anti-MSLN IgG1-CHS5	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[102]
ADC Info	ALA12-Val-Cit-MMAE	Anti-MSLN IgG1-ALA12	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[102]
ADC Info	Bstrongximab ADC	Bstrongximab	TRA-1-60	Monomethyl auristatin E	Mc-Val-Cit-PABC	[103]
ADC Info	T-Fc-Val-Cit-MMAE	Human Anti-FGFR1 Fc	Fibroblast growth factor receptor 1 (FGFR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[104]
ADC Info	Anti-CD7 MMAE ADC	Human Anti-CD7 mAb IgG1	T-cell antigen CD7 (CD7)	Monomethyl auristatin E	PermaLink-PEG4-Val-Cit-PAB	[105]
ADC Info	PCM5B14-MMAE	H5B14	Macrophage-stimulating protein receptor (MST1R)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[106]
ADC Info	GB7008-01-Val-Cit-MMAE	GB7008-01	Claudin-6 (CLDN6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[107]
ADC Info	F7-ADC	F7-Chimeric Ab	Frizzled-7 (FZD7)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[64]
ADC Info	Cirmtuzumab-ADC-7	Cirmtuzumab	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Undisclosed	[108]
ADC Info	CDX3379-MMAE	CDX3379	Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[109]
ADC Info	MF-BTX-MMAE	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Dibromomethyl pyridine-Val-Cit-PABC	[110]
ADC Info	ADC-AVP-04	AVP04	Tumor-associated glycoprotein 72 (TAG-72)	Monomethyl auristatin E	Maleimide-functionalized TCO	[111]
ADC Info	Atezolizumab ADC	Atezolizumab	Programmed cell death 1 ligand 1 (CD274)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[58]
ADC Info	S3F-CL-MMAE	Anti-sTn mAb S3F	Onco-foetal sialyl-Tn	Monomethyl auristatin E	Mc-Val-Cit-PABC	[112]
ADC Info	Anti-FcRL5-Mc-vcPAB-MMAE	Anti-FcRL5 mAb	Fc receptor-like protein 5 (FCRL5)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[113]
ADC Info	DAR8-alphaCD30-mDPR-Gluc-MMAE	Anti-CD30 DAR8-alphaCD30-mDPR-gluc-MMAE mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Quaternary ammonium linker Gluc	[114]
ADC Info	A7R-ADC-MMAE	Anti-IL7R mAb A7R	Interleukin-7 receptor subunit alpha (IL7R)	Monomethyl auristatin E	Mal-PEG12-Val-Cit-PABC	[115]
ADC Info	S7-E430G ADC	9G8-7D12-Fc with E430G	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[116]
ADC Info	S7 ADC	9G8-7D12-Fc	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[116]
ADC Info	7H5-Val-Cit-MMAE	Anti-TIP1 mAb 7H5	Tax1-binding protein 3 (TAX1BP3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[117]
ADC Info	N41mab-Val-Cit-MMAE	Undisclosed	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[118]
ADC Info	ST1	Undisclosed	Onco-foetal sialyl-Tn	Monomethyl auristatin E	Undisclosed	[119]
ADC Info	JY207	Undisclosed	Leukocyte surface antigen CD47 (CD47); Programmed cell death 1 ligand 1 (CD274)	Monomethyl auristatin E	Undisclosed	[120]
ADC Info	Hertuzumab vedotin	Hertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[121]
ADC Info	LCB-97	Undisclosed	AF4/FMR2 family member 4 (AFF4)	Monomethyl auristatin E	Undisclosed	[122]
ADC Info	LCB-67	Undisclosed	Protein delta homolog 1 (DLK1)	Monomethyl auristatin E	Undisclosed	[123]
ADC Info	Anti-endosialin-Mc-Val-Cit-PABC-MMAE	Undisclosed	Endosialin (CD248)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[124]
ADC Info	Anti-NaPi3b antibody-drug conjugate (Genentech/Roche)	Undisclosed	Sodium-dependent phosphate transport protein 2B (SLC34A2)	Monomethyl auristatin E	Undisclosed	[125]
ADC Info	DM003	Undisclosed	Inactive tyrosine-protein kinase 7 (PTK7); Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Undisclosed	[126]
ADC Info	MSLN ADC (Development Center for Biotechnology)	Undisclosed	Mesothelin (MSLN)	Monomethyl auristatin E	Undisclosed	[127]
ADC Info	CBX-15	Undisclosed	Poly [ADP-ribose] polymerase 1 (PARP1)	Monomethyl auristatin E	Undisclosed	[86]
ADC Info	YH-012	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2); Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[128]
ADC Info	YH-013	Undisclosed	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[129]
ADC Info	DM004	Undisclosed	Trophoblast glycoprotein (TPBG); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	[130]
ADC Info	BSA01	Undisclosed	Epidermal growth factor receptor (EGFR); Mucin-1 (MUC1)	Monomethyl auristatin E	Undisclosed	[131]
ADC Info	BCG022	Undisclosed	Receptor tyrosine-protein kinase erbB-3 (ERBB3); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	[132]
ADC Info	BA-3361	Undisclosed	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[133]
ADC Info	CD46 CAB-ADC	Undisclosed	Membrane cofactor protein (CD46)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[134]
ADC Info	ARC-02	Undisclosed	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Undisclosed	[135]
ADC Info	MSLN MMAE	Undisclosed	Mesothelin (MSLN)	Monomethyl auristatin E	Undisclosed	[136]
ADC Info	B7H3-MMAE	Undisclosed	CD276 antigen (CD276)	Monomethyl auristatin E	Undisclosed	[137]
ADC Info	Tmab-SPDP-DM1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[37]
ADC Info	REGN2878-DM1	REGN2878	Prolactin receptor (PRLR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[138]
ADC Info	BT062-SPP-DM1	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[50]
ADC Info	BT062-SMCC-DM1	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[50]
ADC Info	MD1.22-DM1	mD1.22	Envelope glycoprotein gp160 (env)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[139]
ADC Info	LR-DM1	LR004	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[140]
ADC Info	HJAA-F11 ADC	JAA-F11	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[141]
ADC Info	IIIA4-USAN	Anti-EPHA3 mAb IIIA4	Ephrin type-A receptor 3 (EPHA3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[142]
ADC Info	IgG78-DM1	Anti-CD248 mAb IgG78	Endosialin (CD248)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[143]
ADC Info	ICAM1-DM1 ADC	Anti-ICAM1 mAb	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[144]
ADC Info	DS6-DM1	Anti-MUC1 mAb DS6	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[145]
ADC Info	DL35D-DM1	DL35D	Envelope glycoprotein gp160 (env); Envelope glycoprotein gp41 (env)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[139]
ADC Info	Zt/g4-DM1	Anti-RON Zt/g4 (IgG1 kappa)	Macrophage-stimulating protein receptor (MST1R)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[146]
ADC Info	Anti-SSTR2 ADC	Anti-human and mouse SSTR2 mAb (IgG1 kappa)	Somatostatin receptor type 2 (SSTR2)	Mertansine DM1	Sulfo-SMCC	[147]
ADC Info	FMOD-ADC	Anti-FMOD mAb	Fibromodulin (FMOD)	Mertansine DM1	Sulfo-SMCC	[148]
ADC Info	Anti-EGFR-PEG4-Mal-DM1	Anti-EGFR mAb rat IgG2a	Epidermal growth factor receptor (EGFR)	Mertansine DM1	PEG4-Mal	[149]
ADC Info	Anti-EGFR-Sulfo-SMCC-DM1	Anti-EGFR mAb	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Sulfo-SMCC	[150]
ADC Info	Anti-CD47 mAb (IgG2b/kappa)-DM1	Anti-CD47 mAb (IgG2b/kappa)-	Leukocyte surface antigen CD47 (CD47)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[151]
ADC Info	Anti-CD22-K149C-MPEO-DM1	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM1	MPEO	[83]
ADC Info	Anti-CD22-K149C-DM1	Anti-CD22 Anti-ody (LC-K149C)	B-cell receptor CD22 (CD22)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[83]
ADC Info	2G4-DM1	Anti-KIT mAb 2G4	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Undisclosed	[152]
ADC Info	Zt/g4-Maytansinoid	Undisclosed	Macrophage-stimulating protein receptor (MST1R)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[146]
ADC Info	APLP2/HER2 antibody-drug conjugate	Undisclosed	Amyloid beta precursor like protein 2 (APLP2); Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Undisclosed	[153]
ADC Info	PTM-001-ADC	Undisclosed	Undisclosed	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[154]
ADC Info	HuRH105-SMCC-DM1	Undisclosed	Endoglin (ENG)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[84]
ADC Info	IMB-101	Undisclosed	Cathepsin D (CTSD)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[85]
ADC Info	CTAT-ADC	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Undisclosed	[155]
ADC Info	Humanized Anti-HER2 Mab-Maytansine Conjugate	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Undisclosed	[156]
ADC Info	ZV-0501	ZV05	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	[157]
ADC Info	CD70-MMAF-ADC	Vorsetuzumab	CD70 antigen (CD70)	Monomethyl auristatin F	Maleimido-caproyl	[158]
ADC Info	Anti-TrkB DVD-ADC	TrkB-DVD (h38C2)	BDNF/NT-3 growth factors receptor (NTRK2)	Monomethyl auristatin F	Hexapeptide linker ASTKGP	[57]
ADC Info	T-K-F (DAR 3.9)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[159]
ADC Info	T-C-F (DAR 3.7)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Maleimido-caproyl	[159]
ADC Info	SG3-Val-Cit-MMAF8	SG3	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[160]
ADC Info	SG2-Val-Cit-MMAF8	SG2	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[160]
ADC Info	SG1-Val-Cit-MMAF8	SG1	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[160]
ADC Info	LCB-ADC3	Isoprenylated trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Bridged PEG4-valine-alanine	[161]
ADC Info	LCB-ADC2	Isoprenylated trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Isoprene-PEG3,3,3-beta-Glu-PABC	[161]
ADC Info	LCB-ADC1	Isoprenylated trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Isoprene-PEG3-beta-Glu-PABC	[161]
ADC Info	DAR2-ARC-ADC	Human hCLL-1 Anti-ody genetically fused with CD38	Collectin-10 (COLEC10)	Monomethyl auristatin F	NAD-based dinucleotide linker	[162]
ADC Info	EV20/MMAF	EV20	Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Monomethyl auristatin F	Maleimido-caproyl	[163]
ADC Info	Anti-TrkB mAb 641 ADC	Anti-TrkB mAb 641	BDNF/NT-3 growth factors receptor (NTRK2)	Monomethyl auristatin F	Hexapeptide linker ASTKGP	[57]
ADC Info	MP-HER3-ADC	Undisclosed	Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Monomethyl auristatin F	Undisclosed	[164]
ADC Info	AVP10	Undisclosed	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin F	Undisclosed	[165]
ADC Info	DAR4-ARC-ADC	Undisclosed	Collectin-10 (COLEC10)	Monomethyl auristatin F	NAD-based dinucleotide linker	[162]
ADC Info	NC-6201	NCAB001	Epidermal growth factor receptor (EGFR)	E7974	Undisclosed	[166]
ADC Info	An2-anti-HER2-Doxetaxel	ANG4043	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Docetaxel	Undisclosed	[167]
ADC Info	APH-0912	Undisclosed	Undisclosed	Docetaxel	Hydrophilic linker containing sugar molecules	[168]
ADC Info	DAR8-alphaCD30-mDPR-GlucQ-AE	Anti-CD30 DAR8-alphaCD30-mDPR-glucQ-AE mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin E	Quaternary ammonium linker GlucQ	[114]
ADC Info	T-N-F (DAR 3.2)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Aldehyde-tagged MMAF	Undisclosed	[159]
ADC Info	T-N-F (DAR 1.6)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Aldehyde-tagged MMAF	Undisclosed	[159]
ADC Info	1F6-Asn- (D)Lys-AF	Anti-CD70 mAb IF6	CD70 antigen (CD70)	Auristatin F	Mal-Asn-D-Lys	[47]
ADC Info	Erbitux-MHT-71	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin F	MHT-71	[169]
ADC Info	4D5-AF (CUAAC)	Anti-HER2/neu mAb 4D5	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin F	N6-(2-azidoethoxy)carbonyl-L-lysine	[170]
ADC Info	DAN-405	Undisclosed	Glutamate carboxypeptidase 2 (FOLH1)	Cabazitaxel	Undisclosed	[171]
ADC Info	Anti-HER2 scFv-Fc (Ser396Sec)-CN29	Anti-HER2 scFv-Fc (Ser396Sec)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F derivative peptide (CN29)	Lodoacetamido-caproyl	[172]
ADC Info	Trastuzumab-deBouganin	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	DeBouganin	Undisclosed	[173]
ADC Info	DAR8-alphaCD30-mDPR-Gluc-DMTub	Anti-CD30 DAR8-alphaCD30-mDPR-gluc-DMTub mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	DMTub	Quaternary ammonium linker Gluc	[114]
ADC Info	Eribulin ADC (Jiangsu hengrui)	Undisclosed	Undisclosed	Eribulin	Undisclosed	[174]
ADC Info	MET/MET-M114	Biparatopic METxMET Anti-ody	Hepatocyte growth factor receptor (MET); Hepatocyte growth factor receptor (MET)	Maytansine derivative M24	Succinate-Val-Cit-PABC	[175]
ADC Info	CBT-3112	Undisclosed	Serine/threonine-protein kinase DCLK1 (DCLK1)	Paclitaxel	Undisclosed	[176]
ADC Info	MI-130004	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	PM050489	6-(2,5-dioxopyrrol-1-yl)-N-Propylhexanamide	[177]
ADC Info	MI-130110	Anti-CD13 TEA1/8 mAb	Aminopeptidase N (ANPEP)	PM050489	6-(2,5-dioxopyrrol-1-yl)-N-Propylhexanamide	[178]
ADC Info	Monoclonal antibody HB2-saporin conjugate	Anti-CD7 mAb HB2	T-cell antigen CD7 (CD7)	Saporin	Undisclosed	[179]
ADC Info	Anti-CD30 monoclonal antibody-saporin conjugate	Anti-CD30 mAb Ber-H2	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Saporin	Undisclosed	[180]
ADC Info	33B7-Saporin	Anti-PTGFRN mAb 33B7	Prostaglandin F2 receptor negative regulator (PTGFRN)	Saporin	Undisclosed	[181]
ADC Info	Anti-CD38 IT OKT10-SAPORIN	Undisclosed	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Saporin	Undisclosed	[182]
ADC Info	Anti-HER2 DVD-IgG1-Tiancimycin	Anti-HER2 DVD-IgG1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tiancimycin	DVD-PEG4-Triazol	[183]
ADC Info	DAR8-alphaCD30-mDPR-GlucQ-Tub	Anti-CD30 DAR8-alphaCD30-mDPR-glucQ-Tub mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin analogue 3	Quaternary ammonium linker GlucQ	[114]
ADC Info	LY3343544	Emibetuzumab	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Undisclosed	[184]
ADC Info	BB-1712	Anti-B7-H3 mAb	B7-H3	Eribulin	A cleavable linker	[185]
ADC Info	Araris ADC	Enfortumab	Nectin-4 (NECTIN4)	Monomethyl auristatin E	Cathepsin B cleavable linker	[186]
ADC Info	MP-EV-20	EV20	Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Monomethyl auristatin F	Undisclosed	[187]
ADC Info	GENA-111-AF	GENA-111	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Undisclosed	[188]
ADC Info	AG 02 saporin conjugate	Anti-CSP-1 mAb AG02	Cell surface protein 1 (CSP-1)	Saporin	Undisclosed	[189]
ADC Info	SC16.3-DL1	SC16.3	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.4-DL1	SC16.4	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.5-DL1	SC16.5	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.7-DL1	SC16.7	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.8-DL1	SC16.8	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.10-DL1	SC16.10	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.11-DL1	SC16.11	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.13-DL1	SC16.13	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.15-DL1	SC16.15	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.18-DL1	SC16.18	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.19-DL1	SC16.19	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.20-DL1	SC16.20	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.21-DL1	SC16.21	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.22-DL1	SC16.22	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.23-DL1	SC16.23	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.25-DL1	SC16.25	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.26-DL1	SC16.26	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.29-DL1	SC16.29	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.30-DL1	SC16.30	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.31-DL1	SC16.31	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.34-DL1	SC16.34	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.35-DL1	SC16.35	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.36-DL1	SC16.36	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.38-DL1	SC16.38	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.41-DL1	SC16.41	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.42-DL1	SC16.42	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.45-DL1	SC16.45	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.47-DL1	SC16.47	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.49-DL1	SC16.49	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.50-DL1	SC16.50	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.52-DL1	SC16.52	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.55-DL1	SC16.55	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.56-DL1	SC16.56	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.57-DL1	SC16.57	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.58-DL1	SC16.58	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.61-DL1	SC16.61	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.62-DL1	SC16.62	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.63-DL1	SC16.63	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.65-DL1	SC16.65	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.67-DL1	SC16.67	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.68-DL1	SC16.68	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.72-DL1	SC16.72	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.73-DL1	SC16.73	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.78-DL1	SC16.78	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.79-DL1	SC16.79	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.80-DL1	SC16.80	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.81-DL1	SC16.81	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.84-DL1	SC16.84	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.88-DL1	SC16.88	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.101-DL1	SC16.101	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.103-DL1	SC16.103	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.104-DL1	SC16.104	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.105-DL1	SC16.105	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.106-DL1	SC16.106	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.107-DL1	SC16.107	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.108-DL1	SC16.108	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.109-DL1	SC16.109	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.110-DL1	SC16.110	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.111-DL1	SC16.111	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.113-DL1	SC16.113	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.114-DL1	SC16.114	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.115-DL1	SC16.115	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.116-DL1	SC16.116	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.117-DL1	SC16.117	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.118-DL1	SC16.118	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.120-DL1	SC16.120	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.121-DL1	SC16.121	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.122-DL1	SC16.122	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.123-DL1	SC16.123	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.124-DL1	SC16.124	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.125-DL1	SC16.125	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.126-DL1	SC16.126	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.129-DL1	SC16.129	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.130-DL1	SC16.130	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.131-DL1	SC16.131	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.132-DL1	SC16.132	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.133-DL1	SC16.133	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.134-DL1	SC16.134	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.135-DL1	SC16.135	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.136-DL1	SC16.136	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.137-DL1	SC16.137	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.138-DL1	SC16.138	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.139-DL1	SC16.139	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.140-DL1	SC16.140	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.141-DL1	SC16.141	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.142-DL1	SC16.142	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.143-DL1	SC16.143	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.144-DL1	SC16.144	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.147-DL1	SC16.147	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.148-DL1	SC16.148	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.149-DL1	SC16.149	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	SC16.150-DL1	SC16.150	Delta-like protein 3 (DLL3)	SG2000 derivative PBD 1	Mal-PEG8-Val-Ala	[190]
ADC Info	HuM25-vcMMAE-E2	HuM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[191]
ADC Info	HuM25-vcMMAE-DAR4	HuM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[191]
ADC Info	HuAD208.4.1-vcMMAE-DAR4	huAD208.4.1	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[191]
ADC Info	HuAD208.14.1-vcMMAE-DAR4	huAD208.14.1	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[191]
ADC Info	HuM25-mcMMAF-E2	HuM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin F	Maleimido-caproyl	[191]
ADC Info	NS Cys-vc-MMAE	Undisclosed	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	Glyco-cetuximab Fab-vc-MMAE	Glyco-engineered cetuximab Fab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	IC1-MMAE	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[192]
ADC Info	IC1-MMAF	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	Maleimido-caproyl	[192]
ADC Info	IC1-DM4	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM4	Mal-EBE-Mal	[192]
ADC Info	IC1-DM1	Chimeric ICAM1 Anti-ody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM1)	Mertansine DM1	Mal-EBE-Mal	[192]
ADC Info	ADC Trast-7	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[193]
ADC Info	ADC Trast-10	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Bis-BCN-modified Val-Cit-PABC linker 10	[193]
ADC Info	MMAE-IgG1 17	Anti-ENPP1 IgG1 17	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1)	Monomethyl auristatin E	Undisclosed	[194]
ADC Info	MMAE-IgG1 3G12	Anti-ENPP1 IgG1 3G12	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1)	Monomethyl auristatin E	Undisclosed	[194]
ADC Info	AB-3A4-Val-Cit-MMAE	Anti-KAAG1 mAb AB-3A4	Kidney-associated antigen 1 (KAAG1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[195]
ADC Info	IGN-786	Anti-SAIL mAb	Translocator protein (TSPO)	Monomethyl auristatin F	Maleimido-caproyl	[196]
ADC Info	AVID-300	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Undisclosed	[197]
ADC Info	1711 (scFv)-SNAP-AuriF	1711/425 scFv-SNAP	Epidermal growth factor receptor (EGFR)	Auristatin F	BG based linker	[198]
ADC Info	MMAE.VC.SA.617	Undisclosed	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Undisclosed	[199]
ADC Info	CLDN1 ADC	Anti-CLDN1 mAb 6F6	Claudin-1 (CLDN1)	Monomethyl auristatin E	Undisclosed	[200]
ADC Info	1959-sss/DM4	Undisclosed	Galectin-3-binding protein (LGALS3BP)	Mertansine DM4	Undisclosed	[201]
ADC Info	ZHER2-ABD-mcMMAF	ZHER2-ABD	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Maleimido-caproyl	[202]
ADC Info	ZHER2-ABD-mcMMAE	ZHER2-ABD	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleimido-caproyl	[202]
ADC Info	ITcetuximab	Cetuximab	Epidermal growth factor receptor (EGFR)	Saporin	Undisclosed	[203]
ADC Info	Bevacizumab vedotin	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[204]
ADC Info	Anti-DOG1-DM4-ADC	Anti-DOG1 mAb	Anoctamin-1 (ANO1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[205]
ADC Info	A5/158-vc-MMAE	A5/158	C-type mannose receptor 2 (MRC2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[206]
ADC Info	MesoADC	Anti-GSDME mAb	Gasdermin-E (GSDME)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[207]
ADC Info	3A5-mc-VC-PAB-MMAE	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[208]
ADC Info	3A5-55 ADC	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Maytansine derivative 55	Mal-EBE-Mal	[208]
ADC Info	3A5-56 ADC	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Maytansine derivative 56	Mal-EBE-Mal	[208]
ADC Info	3A5-57 ADC	Anti-MUC16 Anti-ody 3A5	Mucin-16 (MUC16)	Maytansine derivative 57	Maleimido-caproyl	[208]
ADC Info	MUC16-55 ADC	Anti-MUC16 mAb	Mucin-16 (MUC16)	Maytansine derivative 55	Mal-EBE-Mal	[208]
ADC Info	MUC16-56 ADC	Anti-MUC16 mAb	Mucin-16 (MUC16)	Maytansine derivative 56	Mal-EBE-Mal	[208]
ADC Info	Cys-linker-MMAE-based ADC 11	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Cys-11 ADC linker	[209]
ADC Info	Cys-linker-MMAE-based ADC 12	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Cys-12 ADC linker	[209]
ADC Info	Cys-linker-MMAE-based ADC 13	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Cys-13 ADC linker	[209]
ADC Info	Cys-linker-MMAE-based ADC 14	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Cys-14 ADC linker	[209]
ADC Info	Cys-linker-MMAE-based ADC 15	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-PABC	[209]
ADC Info	Cys-linker-MMAE-based ADC 16	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[209]
ADC Info	P38B-DM1	P38B	Podoplanin (PDPN)	Mertansine DM1	Azide-modified dibenzocyclooctyne(DBCO)-albumin(HAS)	[210]
ADC Info	GPC-1-ADC	Anti-GPC1 mAb clone 01a033	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[211]
ADC Info	10D7-MMAE	Anti-CDCP1 mAb 10D7	CUB domain-containing protein 1 (CDCP1)	Monomethyl auristatin E	Undisclosed	[212]
ADC Info	CD4-Val-Cit-MMAE	Anti-CD4 mAb	T-cell surface glycoprotein CD4 (CD4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[213]
ADC Info	Trastuzumab-iCME	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Membrane-impermable colchinolmethyl ether (iCME) cytotoxin	Pacific blue fluorophore-SH based linker	[214]
ADC Info	2G10 RED-106 maytansine 2	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-106	[215]
ADC Info	2G10 RED-106 maytansine 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-106	[215]
ADC Info	2G10 RED-425 maytansine 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-425	[215]
ADC Info	2G10 RED-432 maytansine 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Mertansine DM1	RED-432	[215]
ADC Info	2G10 RED-244 MMAE 2	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-244	[215]
ADC Info	2G10 RED-244 MMAE 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-244	[215]
ADC Info	2G10 RED-412 MMAE 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-412	[215]
ADC Info	2G10 RED-388 MMAE 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-388	[215]
ADC Info	2G10 RED-426 MMAE 4	Anti-PLAUR mAb 2G10	Urokinase plasminogen activator surface receptor (PLAUR)	Monomethyl auristatin E	RED-426	[215]
ADC Info	IgG1 (trastuzumab)-vc-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[216]
ADC Info	IgG1 (H32)-vc-MMAE	Anti-HER2 IgG1(H32)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[216]
ADC Info	IgG1 (GH2-20)-vc-MMAE	Anti-HER2 IgG1(GH2-20)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[216]
ADC Info	IgG1 (GH2-61)-vc-MMAE	Anti-HER2 IgG1(GH2-61)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[216]
ADC Info	IgG1 (GH2-75)-vc-MMAE	Anti-HER2 IgG1(GH2-75)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[216]
ADC Info	Ch735-Py-DM1	Chimeric human mAb ch735	Oncodevelopmental antigen polysialic acid (polySia)	Mertansine DM1	TCO-PEG3-Mal	[217]
ADC Info	T-Py-DM1	Trastuzumab	Oncodevelopmental antigen polysialic acid (polySia)	Mertansine DM1	TCO-PEG3-Mal	[217]
ADC Info	IgG1 (trastuzumab)-AL1-MMAE	Trastuzumab-AL1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[216]
ADC Info	IgG1 (H32)-AL1-MMAE	Anti-HER2 IgG1(H32)-AL1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[216]
ADC Info	IgG1 (GH2-20)-AL1-MMAE	Anti-HER2 IgG1(GH2-20)-AL1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[216]
ADC Info	IgG1 (GH2-61)-AL1-MMAE	Anti-HER2 IgG1(GH2-61)-AL1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[216]
ADC Info	IgG1 (GH2-75)-AL1-MMAE	Anti-HER2 IgG1(GH2-75)-AL1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[216]
ADC Info	SNS-622-DM1	SNS-622	Aspartyl/asparaginyl beta-hydroxylase (ASPH)	Mertansine DM1	Maleimido-caproyl	[218]
ADC Info	SNS-622-MMAE	SNS-622	Aspartyl/asparaginyl beta-hydroxylase (ASPH)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[218]
ADC Info	DAB4-DM1	DAB4	Lupus La protein (SSB)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[219]
ADC Info	DAB4-DM4	DAB4	Lupus La protein (SSB)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[219]
ADC Info	Sal5-DM4	Sal5	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[219]
ADC Info	DAB4-MMAE	DAB4	Lupus La protein (SSB)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[219]
ADC Info	Sal5-MMAE	Sal5	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[219]
ADC Info	DAB4-MMAF	DAB4	Lupus La protein (SSB)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[219]
ADC Info	Zt/g4-MMAE	Anti-RON Zt/g4 (IgG1 kappa)	Macrophage-stimulating protein receptor (MST1R)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[220]
ADC Info	Promiximab-MMAE	Promiximab	Neural cell adhesion molecule 1 (NCAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[221]
ADC Info	EGFRvIII-16	Anti-EGFRvIII mAb	Epidermal growth factor receptor variant III (EGFRvIII)	DM1 derivative 16	Mc-Val-Cit-PABC	[222]
ADC Info	EGFRvIII-MCC-DM1	Anti-EGFRvIII mAb	Epidermal growth factor receptor variant III (EGFRvIII)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[222]
ADC Info	PSMA-15	Anti-PSMA mAb	Glutamate carboxypeptidase 2 (FOLH1)	DM1 derivative 15	Mc-Val-Cit-PABC	[222]
ADC Info	PSMA-16	Anti-PSMA mAb	Glutamate carboxypeptidase 2 (FOLH1)	DM1 derivative 16	Mc-Val-Cit-PABC	[222]
ADC Info	PRLR-16	Anti-PRLR mAb	Prolactin receptor (PRLR)	DM1 derivative 16	Mc-Val-Cit-PABC	[222]
ADC Info	Trastuzumab/nab-paclitaxel	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Paclitaxel	Undisclosed	[223]
ADC Info	GPC-1 ADC 1	Anti-GPC1 mAb 01a033	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 2	Anti-GPC1 mAb 01a002	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 3	Anti-GPC1 mAb 02a035	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 4	Anti-GPC1 mAb 02a034	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 5	Anti-GPC1 mAb 02a014	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 6	Anti-GPC1 mAb 02a002	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 7	Anti-GPC1 mAb 02a010	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 8	Anti-GPC1 mAb 01a016	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 9	Anti-GPC1 mAb 02b006	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 10	Anti-GPC1 mAb 01a021	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 11	Anti-GPC1 mAb 02a022	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 12	Anti-GPC1 mAb 01a009	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 13	Anti-GPC1 mAb 01a030	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 14	Anti-GPC1 mAb 01a017	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 15	Anti-GPC1 mAb 01a007	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 16	Anti-GPC1 mAb 01a042	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 17	Anti-GPC1 mAb 01a026	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	GPC-1 ADC 18	Anti-GPC1 mAb 02a006	Glypican-1 (GPC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[224]
ADC Info	Docetaxel-trastuzumab	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Docetaxel	Undisclosed	[225]
ADC Info	M9346A-CX-DM1	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	triglycyl peptide linker CX	[226]
ADC Info	M9346A-4a-Cxxx-Mal-CX-DM1	Mirvetuximab (engineered cysteine LC-C205)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	[226]
ADC Info	M9346A-4b-Cxxx-Mal-CX-DM1	Mirvetuximab (engineered cysteine LC-C400)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	[226]
ADC Info	M9346A-4c-Cxxx-Mal-CX-DM1	Mirvetuximab (engineered cysteine HC-C118)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	[226]
ADC Info	M9346A-4d-Cxxx-Mal-CX-DM1	Mirvetuximab (engineered cysteine HC-C239)	Folate receptor alpha (FOLR1)	Mertansine DM1	Cxxx-Mal-CX	[226]
ADC Info	HBU12-mc-MMAF	Anti-CD19 mAb hBU12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[227]
ADC Info	CC2B-h15H3-gluc-MMAE	Anti-ITGA5 mAb CC2B-h15H3	Integrin alpha-5 (ITGA5)	Monomethyl auristatin E	Quaternary ammonium linker Gluc	[227]
ADC Info	H15H3-gluc-MMAE	Anti-ITGA5 mAb h15H3	Integrin alpha-5 (ITGA5)	Monomethyl auristatin E	Quaternary ammonium linker Gluc	[227]
ADC Info	HcHAb18-DM1	HcHAb18	Basigin (BSG)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[228]
ADC Info	ChmAb-A B7-H3-ADC	chmAb-A	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[229]
ADC Info	ChmAb-B B7-H3-ADC	chmAb-B	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[229]
ADC Info	ChmAb-C B7-H3-ADC	chmAb-C	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[229]
ADC Info	ChmAb-D B7-H3-ADC	chmAb-D	CD276 antigen (CD276)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[229]
ADC Info	QD6/B09-AZ1508	QD6/B09	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	QD6/B09-AZ1508	QD6/B09-AZ1508	[230]
ADC Info	RAA22/B09-AZ1508	RAA22/B09	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	RAA22/B09-AZ1508	RAA22/B09-AZ1508	[230]
ADC Info	MuDS6-DM1	Anti-CA6 mAb muDS6	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[231]
ADC Info	MuDS6-SSNPP-MM1-202	Anti-CA6 mAb muDS6	Mucin-1 (MUC1)	Mertansine DM1	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[231]
ADC Info	HuDS6v1.01-DM4	huDS6v1.01	Mucin-1 (MUC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[231]
ADC Info	HuDS6v1.21-DM4	huDS6v1.21	Mucin-1 (MUC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[231]
ADC Info	28E4-DM1	280000	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[231]
ADC Info	HAZcPB-DM1	HAZcPB	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[231]
ADC Info	SSaPB-DM1	SSaPB	Mucin-1 (MUC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[231]
ADC Info	CNTO95-DM1	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[19]
ADC Info	F105-DM1	F105	Integrin alpha-V (ITGAV)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[19]
ADC Info	CNTO95-SPP-DM1	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[19]
ADC Info	F105-SPP-DM1	F105	Integrin alpha-V (ITGAV)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[19]
ADC Info	CNTO95-SSNPB-DM4	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	N-sulfosuccinimidyl-4-(5-nitro-2 pyridyldithio) butyrate (SSNPB)	[19]
ADC Info	CNTO95-SSNPP-DM4	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[19]
ADC Info	F105-SSNPP-DM4	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[19]
ADC Info	CNTO95-SPP-DM4	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[19]
ADC Info	F105-SPP-DM4	F105	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[19]
ADC Info	CNTO95-SPDB-DM4	CNTO95	Integrin alpha-V (ITGAV)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[19]
ADC Info	NBT062-SMCC-DM1	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[3]
ADC Info	NBT062-SPP-DM1	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[3]
ADC Info	B-B4-SPP-DM1	Anti-CD138 mAb B-B4	Syndecan-1 (SDC1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[3]
ADC Info	B-B4-SMCC-DM1	Anti-CD138 mAb B-B4	Syndecan-1 (SDC1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[3]
ADC Info	B-B4-SPDB-DM4	Anti-CD138 mAb B-B4	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[3]
ADC Info	HuMov19-PEG4-Mal-DM1	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	FR1-21-PEG4-Mal-DM1	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	Mov19-PEG4-Mal-DM1	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	Farletuzumab-PEG4-Mal-DM1	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	FR1-48-PEG4-Mal-DM1	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	FR1-49-PEG4-Mal-DM1	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	FR1-57-PEG4-Mal-DM1	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	FR1-65-PEG4-Mal-DM1	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	HuMOV19v1.6-PEG4-Mal-DM1	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	HuMOV19v1.0-PEG4-Mal-DM1	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	HuFR1-21-PEG4-Mal-DM1	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	MuFR1-21-PEG4-Mal-DM1	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	MuFR1-9-PEG4-Mal-DM1	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	MuFR1-13-PEG4-Mal-DM1	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	MuFR1-22-PEG4-Mal-DM1	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	MuFR1-23-PEG4-Mal-DM1	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	HuFR1-23-PEG4-Mal-DM1	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	PEG4-Mal	[232]
ADC Info	HuMov19-SMCC-DM1	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	FR1-21-SMCC-DM1	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	Mov19-SMCC-DM1	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	Farletuzumab-SMCC-DM1	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	FR1-48-SMCC-DM1	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	FR1-49-SMCC-DM1	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	FR1-57-SMCC-DM1	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	FR1-65-SMCC-DM1	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	HuMOV19v1.6-SMCC-DM1	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	HuMOV19v1.0-SMCC-DM1	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	HuFR1-21-SMCC-DM1	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	MuFR1-21-SMCC-DM1	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	MuFR1-9-SMCC-DM1	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	MuFR1-13-SMCC-DM1	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	MuFR1-22-SMCC-DM1	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	MuFR1-23-SMCC-DM1	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	HuFR1-23-SMCC-DM1	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	HuMov19-SIA-DM1	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	FR1-21-SIA-DM1	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	Mov19-SIA-DM1	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	Farletuzumab-SIA-DM1	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	FR1-48-SIA-DM1	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	FR1-49-SIA-DM1	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	FR1-57-SIA-DM1	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	FR1-65-SIA-DM1	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	HuMOV19v1.6-SIA-DM1	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	HuMOV19v1.0-SIA-DM1	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	HuFR1-21-SIA-DM1	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	MuFR1-21-SIA-DM1	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	MuFR1-9-SIA-DM1	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	MuFR1-13-SIA-DM1	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	MuFR1-22-SIA-DM1	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	MuFR1-23-SIA-DM1	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	HuFR1-23-SIA-DM1	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl iodoacetate (SIA)	[232]
ADC Info	HuMov19-SPP-DM1	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	FR1-21-SPP-DM1	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	Mov19-SPP-DM1	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	Farletuzumab-SPP-DM1	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	FR1-48-SPP-DM1	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	FR1-49-SPP-DM1	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	FR1-57-SPP-DM1	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	FR1-65-SPP-DM1	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	HuMOV19v1.6-SPP-DM1	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	HuMOV19v1.0-SPP-DM1	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	HuFR1-21-SPP-DM1	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	MuFR1-21-SPP-DM1	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	MuFR1-9-SPP-DM1	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	MuFR1-13-SPP-DM1	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	MuFR1-22-SPP-DM1	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	MuFR1-23-SPP-DM1	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	HuFR1-23-SPP-DM1	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	HuMov19-sulfo-SPDB-DM4 (DAR3.8)	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	FR1-21-sulfo-SPDB-DM4	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	Mov19-sulfo-SPDB-DM4	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	Farletuzumab-sulfo-SPDB-DM4	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	FR1-48-sulfo-SPDB-DM4	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	FR1-49-sulfo-SPDB-DM4	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	FR1-57-sulfo-SPDB-DM4	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	FR1-65-sulfo-SPDB-DM4	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	HuMOV19v1.6-sulfo-SPDB-DM4	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	HuMOV19v1.0-sulfo-SPDB-DM4	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	HuFR1-21-sulfo-SPDB-DM4	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	MuFR1-21-sulfo-SPDB-DM4	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	MuFR1-9-sulfo-SPDB-DM4	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	MuFR1-13-sulfo-SPDB-DM4	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	MuFR1-22-sulfo-SPDB-DM4	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	MuFR1-23-sulfo-SPDB-DM4	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	HuFR1-23-sulfo-SPDB-DM4	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	HuMov19-SPDB-DM4	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	FR1-21-SPDB-DM4	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	Mov19-SPDB-DM4	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	Farletuzumab-SPDB-DM4	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	FR1-48-SPDB-DM4	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	FR1-49-SPDB-DM4	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	FR1-57-SPDB-DM4	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	FR1-65-SPDB-DM4	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	HuMOV19v1.6-SPDB-DM4	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	HuMOV19v1.0-SPDB-DM4	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	HuFR1-21-SPDB-DM4	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	MuFR1-21-SPDB-DM4	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	MuFR1-9-SPDB-DM4	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	MuFR1-13-SPDB-DM4	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	MuFR1-22-SPDB-DM4	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	MuFR1-23-SPDB-DM4	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	HuFR1-23-SPDB-DM4	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	HuMov19-3-sulfo-Mal-DM4 (DAR 3.7)	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	FR1-21-3-sulfo-Mal-DM4	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	Mov19-3-sulfo-Mal-DM4	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	Farletuzumab-3-sulfo-Mal-DM4	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	FR1-48-3-sulfo-Mal-DM4	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	FR1-49-3-sulfo-Mal-DM4	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	FR1-57-3-sulfo-Mal-DM4	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	FR1-65-3-sulfo-Mal-DM4	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	HuMOV19v1.6-3-sulfo-Mal-DM4	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	HuMOV19v1.0-3-sulfo-Mal-DM4	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	HuFR1-21-3-sulfo-Mal-DM4	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	MuFR1-21-3-sulfo-Mal-DM4	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	MuFR1-9-3-sulfo-Mal-DM4	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	MuFR1-13-3-sulfo-Mal-DM4	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	MuFR1-22-3-sulfo-Mal-DM4	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	MuFR1-23-3-sulfo-Mal-DM4	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	HuFR1-23-3-sulfo-Mal-DM4	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	HuMov19-PEG4-Mal-DM4	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	FR1-21-PEG4-Mal-DM4	FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	Mov19-PEG4-Mal-DM4	Mov19	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	Farletuzumab-PEG4-Mal-DM4	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	FR1-48-PEG4-Mal-DM4	FR1-48	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	FR1-49-PEG4-Mal-DM4	FR1-49	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	FR1-57-PEG4-Mal-DM4	FR1-57	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	FR1-65-PEG4-Mal-DM4	FR1-65	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	HuMOV19v1.6-PEG4-Mal-DM4	huMOV19v1.6	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	HuMOV19v1.0-PEG4-Mal-DM4	huMOV19v1.0	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	HuFR1-21-PEG4-Mal-DM4	huFR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	MuFR1-21-PEG4-Mal-DM4	mu-FR1-21	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	MuFR1-9-PEG4-Mal-DM4	mu-FR1-9	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	MuFR1-13-PEG4-Mal-DM4	mu-FR1-13	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	MuFR1-22-PEG4-Mal-DM4	mu-FR1-22	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	MuFR1-23-PEG4-Mal-DM4	mu-FR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	HuFR1-23-PEG4-Mal-DM4	huFR1-23	Folate receptor alpha (FOLR1)	Mertansine DM4	PEG4-Mal	[232]
ADC Info	HuMov19-3-sulfo-Mal-DM4 (DAR 8.23)	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	HuMov19-sulfo-SPDB-DM4 (DAR6.8)	huMov19	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[232]
ADC Info	M9346A-SMCC-DM1	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[232]
ADC Info	M9346A-SPP-DM1	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[232]
ADC Info	M9346A-sulfo-Mal-DM4	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	3-sulfo-Mal	[232]
ADC Info	M9346A-SPDB-DM4	Mirvetuximab	Folate receptor alpha (FOLR1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[232]
ADC Info	1C1-mcMMAF	Anti-EPHA2 mAb 1C1	Ephrin type-A receptor 2 (EPHA2)	Monomethyl auristatin F	Maleimido-caproyl	[233]
ADC Info	LCB14-0648	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	LCB14-0648 linker	[234]
ADC Info	LCB14-0663	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	LCB14-0663 linker	[234]
ADC Info	LCB14-0664	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	LCB14-0664 linker	[234]
ADC Info	LCB14-6e	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	LCB14-6e linker	[234]
ADC Info	Anti-CD19(LC)-G7VIM-2i	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Anti-CD19(LC)-G7VIM-2i linker	[234]
ADC Info	Blinatumomab-2i	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin F	Blinatumomab-2i linker	[234]
ADC Info	Inebilizumab-2i	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Inebilizumab-2i linker	[234]
ADC Info	Tafasitamab-2i	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Tafasitamab-2i linker	[234]
ADC Info	Obexelimab-2i	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Obexelimab-2i linker	[234]
ADC Info	MDX-1342-2i	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1342-2i linker	[234]
ADC Info	MDX-1435-2i	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1435-2i linker	[234]
ADC Info	CHD37-2i	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	cHD37-2i linker	[234]
ADC Info	AFM-11-2i	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-11-2i linker	[234]
ADC Info	AFM-12-2i	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-12-2i linker	[234]
ADC Info	GBR401-2i	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	GBR401-2i linker	[234]
ADC Info	Denintuzumab-2i	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Denintuzumab-2i linker	[234]
ADC Info	Anti-CD19(LC)-G7VIM-4i	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Anti-CD19(LC)-G7VIM-4i linker	[234]
ADC Info	Blinatumomab-4i	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin F	Blinatumomab-4i linker	[234]
ADC Info	Inebilizumab-4i	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Inebilizumab-4i linker	[234]
ADC Info	Tafasitamab-4i	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Tafasitamab-4i linker	[234]
ADC Info	Obexelimab-4i	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Obexelimab-4i linker	[234]
ADC Info	MDX-1342-4i	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1342-4i linker	[234]
ADC Info	MDX-1435-4i	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1435-4i linker	[234]
ADC Info	CHD37-4i	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	cHD37-4i linker	[234]
ADC Info	AFM-11-4i	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-11-4i linker	[234]
ADC Info	AFM-12-4i	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-12-4i linker	[234]
ADC Info	GBR401-4i	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	GBR401-4i linker	[234]
ADC Info	Denintuzumab-4i	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Denintuzumab-4i linker	[234]
ADC Info	Anti-CD19(LC)-G7VIM-3i	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Anti-CD19(LC)-G7VIM-3i linker	[234]
ADC Info	Blinatumomab-3i	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin F	Blinatumomab-3i linker	[234]
ADC Info	Inebilizumab-3i	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Inebilizumab-3i linker	[234]
ADC Info	Tafasitamab-3i	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Tafasitamab-3i linker	[234]
ADC Info	Obexelimab-3i	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Obexelimab-3i linker	[234]
ADC Info	MDX-1342-3i	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1342-3i linker	[234]
ADC Info	MDX-1435-3i	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	MDX-1435-3i linker	[234]
ADC Info	CHD37-3i	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	cHD37-3i linker	[234]
ADC Info	AFM-11-3i	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-11-3i linker	[234]
ADC Info	AFM-12-3i	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	AFM-12-3i linker	[234]
ADC Info	GBR401-3i	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	GBR401-3i linker	[234]
ADC Info	Denintuzumab-3i	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Denintuzumab-3i linker	[234]
ADC Info	Anti-CD19(LC)-G7VIM-6e	DI-B4-(LC)-GGGGGGG-CVIM	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Anti-CD19(LC)-G7VIM-6e linker	[234]
ADC Info	Blinatumomab-6e	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3D)	Monomethyl auristatin E	Blinatumomab-6e linker	[234]
ADC Info	Inebilizumab-6e	Inebilizumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Inebilizumab-6e linker	[234]
ADC Info	Tafasitamab-6e	Tafasitamab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Tafasitamab-6e linker	[234]
ADC Info	Obexelimab-6e	Obexelimab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Obexelimab-6e linker	[234]
ADC Info	MDX-1342-6e	MDX-1342	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	MDX-1342-6e linker	[234]
ADC Info	MDX-1435-6e	MDX-1435	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	MDX-1435-6e linker	[234]
ADC Info	CHD37-6e	cHD37	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	cHD37-6e linker	[234]
ADC Info	AFM-11-6e	AFM-11	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	AFM-11-6e linker	[234]
ADC Info	AFM-12-6e	AFM-12	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	AFM-12-6e linker	[234]
ADC Info	GBR401-6e	GBR401	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	GBR401-6e linker	[234]
ADC Info	Denintuzumab-6e	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Denintuzumab-6e linker	[234]
ADC Info	ADC14-0810	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	ADC14-0810 linker	[235]
ADC Info	LCB14-0645	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	LCB14-0645 linker	[235]
ADC Info	Cetuximab (LC)-2i	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC)-2i linker	[235]
ADC Info	Cetuximab (LC) G7-CVIM-3i	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC) G7-CVIM-3i linker	[235]
ADC Info	Cetuximab (LV) G7-CVIM-3i	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LV) G7-CVIM-3i linker	[235]
ADC Info	Cetuximab (LC)-3i	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC)-3i linker	[235]
ADC Info	Cetuximab (LC) G7-CVIM-4i	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC) G7-CVIM-4i linker	[235]
ADC Info	Cetuximab (LV) G7-CVIM-4i	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LV) G7-CVIM-4i linker	[235]
ADC Info	Cetuximab (LC)-4i	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Cetuximab(LC)-4i linker	[235]
ADC Info	Cetuximab (LC) G7-CVIM-6e	Cetuximab (LC) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab(LC) G7-CVIM-6e linker	[235]
ADC Info	Cetuximab (LV) G7-CVIM-6e	Cetuximab (LV) G7-CVIM	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab(LV) G7-CVIM-6e linker	[235]
ADC Info	Cetuximab (LC)-6e	Cetuximab (LC)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab(LC)-6e linker	[235]
ADC Info	MYK-3	BA03	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[236]
ADC Info	BA03-MC-MMAE	BA03	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[236]
ADC Info	BA03-MCC-MMAE	BA03	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[236]
ADC Info	TF-mAb-DM1	TF-mAb-SC1	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H29-DM1	TF-mAb-H29	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H30-DM1	TF-mAb-H30	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H31-DM1	TF-mAb-H31	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H32-DM1	TF-mAb-H32	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H33-DM1	TF-mAb-H33	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H34-DM1	TF-mAb-H34	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H35-DM1	TF-mAb-H35	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H36-DM1	TF-mAb-H36	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H37-DM1	TF-mAb-H37	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H38-DM1	TF-mAb-H38	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H39-DM1	TF-mAb-H39	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H40-DM1	TF-mAb-H40	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H41-DM1	TF-mAb-H41	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H42-DM1	TF-mAb-H42	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H43-DM1	TF-mAb-H43	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H44-DM1	TF-mAb-H44	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H45-DM1	TF-mAb-H45	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H46-DM1	TF-mAb-H46	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H47-DM1	TF-mAb-H47	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-H48-DM1	TF-mAb-H48	Tissue factor (F3)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[237]
ADC Info	TF-mAb-MMAE	TF-mAb-SC1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H29-MMAE	TF-mAb-H29	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H30-MMAE	TF-mAb-H30	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H31-MMAE	TF-mAb-H31	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H32-MMAE	TF-mAb-H32	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H33-MMAE	TF-mAb-H33	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H34-MMAE	TF-mAb-H34	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H35-MMAE	TF-mAb-H35	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H36-MMAE	TF-mAb-H36	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H37-MMAE	TF-mAb-H37	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H38-MMAE	TF-mAb-H38	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H39-MMAE	TF-mAb-H39	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H40-MMAE	TF-mAb-H40	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H41-MMAE	TF-mAb-H41	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H42-MMAE	TF-mAb-H42	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H43-MMAE	TF-mAb-H43	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H44-MMAE	TF-mAb-H44	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H45-MMAE	TF-mAb-H45	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H46-MMAE	TF-mAb-H46	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H47-MMAE	TF-mAb-H47	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	TF-mAb-H48-MMAE	TF-mAb-H48	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[237]
ADC Info	RGCLN18.2-MC-Val-Cit-PAB-MMAE	RGCLN18.2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[238]
ADC Info	RGCLN18.2-D07-Val-Cit-PAB-MMAE	RGCLN18.2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	D07-Val-Cit-PABC	[238]
ADC Info	RGCLN18.2-PY-Val-Cit-PAB-MMAE	RGCLN18.2	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	PY-VC-PABC	[238]
ADC Info	IMAB362-MC-Val-Cit-PAB-MMAE	IMAB362	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[238]
ADC Info	WO2017089895A1 ADC1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC1 linker	[239]
ADC Info	WO2017089895A1 ADC2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC2 linker	[239]
ADC Info	WO2017089895A1 ADC3	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC3 linker	[239]
ADC Info	WO2017089895A1 ADC4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC4 linker	[239]
ADC Info	WO2017089895A1 ADC5	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC5 linker	[239]
ADC Info	WO2017089895A1 ADC6	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC6 linker	[239]
ADC Info	WO2017089895A1 ADC7	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC7 linker	[239]
ADC Info	WO2017089895A1 ADC8	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC8 linker	[239]
ADC Info	WO2017089895A1 ADC9	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC9 linker	[239]
ADC Info	WO2017089895A1 ADC10	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC10 linker	[239]
ADC Info	WO2017089895A1 ADC11	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC11 linker	[239]
ADC Info	WO2017089895A1 ADC12	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC12 linker	[239]
ADC Info	WO2017089895A1 ADC13	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC13 linker	[239]
ADC Info	WO2017089895A1 ADC14	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC14 linker	[239]
ADC Info	WO2017089895A1 ADC15	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC15 linker	[239]
ADC Info	WO2017089895A1 ADC16	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC16 linker	[239]
ADC Info	WO2017089895A1 ADC17	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC17 linker	[239]
ADC Info	WO2017089895A1 ADC18	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC18 linker	[239]
ADC Info	WO2017089895A1 ADC19	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC19 linker	[239]
ADC Info	WO2017089895A1 ADC20	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC20 linker	[239]
ADC Info	WO2017089895A1 ADC86	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC86 linker	[239]
ADC Info	WO2017089895A1 ADC87	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC87 linker	[239]
ADC Info	WO2017089895A1 ADC23	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC23 linker	[239]
ADC Info	WO2017089895A1 ADC24	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC24 linker	[239]
ADC Info	WO2017089895A1 ADC25	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC25 linker	[239]
ADC Info	WO2017089895A1 ADC26	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC26 linker	[239]
ADC Info	WO2017089895A1 ADC27	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC27 linker	[239]
ADC Info	WO2017089895A1 ADC28	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC28 linker	[239]
ADC Info	WO2017089895A1 ADC29	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC29 linker	[239]
ADC Info	WO2017089895A1 ADC30	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC30 linker	[239]
ADC Info	WO2017089895A1 ADC31	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC31 linker	[239]
ADC Info	WO2017089895A1 ADC32	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC32 linker	[239]
ADC Info	WO2017089895A1 ADC33	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC33 linker	[239]
ADC Info	WO2017089895A1 ADC34	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC34 linker	[239]
ADC Info	WO2017089895A1 ADC35	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC35 linker	[239]
ADC Info	WO2017089895A1 ADC36	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC36 linker	[239]
ADC Info	WO2017089895A1 ADC37	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC37 linker	[239]
ADC Info	WO2017089895A1 ADC38	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC38 linker	[239]
ADC Info	WO2017089895A1 ADC39	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC39 linker	[239]
ADC Info	WO2017089895A1 ADC40	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC40 linker	[239]
ADC Info	WO2017089895A1 ADC41	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC41 linker	[239]
ADC Info	WO2017089895A1 ADC42	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC42 linker	[239]
ADC Info	WO2017089895A1 ADC43	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC43 linker	[239]
ADC Info	WO2017089895A1 ADC44	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC44 linker	[239]
ADC Info	WO2017089895A1 ADC45	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC45 linker	[239]
ADC Info	WO2017089895A1 ADC46	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC46 linker	[239]
ADC Info	WO2017089895A1 ADC47	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC47 linker	[239]
ADC Info	WO2017089895A1 ADC48	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC48 linker	[239]
ADC Info	WO2017089895A1 ADC49	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC49 linker	[239]
ADC Info	WO2017089895A1 ADC50	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC50 linker	[239]
ADC Info	WO2017089895A1 ADC51	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC51 linker	[239]
ADC Info	WO2017089895A1 ADC52	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC52 linker	[239]
ADC Info	WO2017089895A1 ADC53	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC53 linker	[239]
ADC Info	WO2017089895A1 ADC54	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC54 linker	[239]
ADC Info	WO2017089895A1 ADC55	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC55 linker	[239]
ADC Info	WO2017089895A1 ADC76	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC76 linker	[239]
ADC Info	WO2017089895A1 ADC88	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC88 linker	[239]
ADC Info	WO2017089895A1 ADC89	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC89 linker	[239]
ADC Info	WO2017089895A1 ADC90	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC90 linker	[239]
ADC Info	WO2017089895A1 ADC91	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC91 linker	[239]
ADC Info	WO2017089895A1 ADC60	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC60 linker	[239]
ADC Info	WO2017089895A1 ADC61	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC61 linker	[239]
ADC Info	WO2017089895A1 ADC62	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC62 linker	[239]
ADC Info	WO2017089895A1 ADC63	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089895A1_ADC63 linker	[239]
ADC Info	WO2017089895A1 ADC77	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089895A1_ADC77 linker	[239]
ADC Info	WO2017089895A1 ADC64	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089895A1_ADC64 linker	[239]
ADC Info	WO2017089895A1 ADC65	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	WO2017089895A1_ADC65 linker	[239]
ADC Info	WO2017089895A1 ADC66	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089895A1_ADC66 linker	[239]
ADC Info	WO2017089895A1 ADC67	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089895A1_ADC67 linker	[239]
ADC Info	WO2017089895A1 ADC68	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	WO2017089895A1_ADC68 linker	[239]
ADC Info	WO2017089895A1 ADC69	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089895A1_ADC69 linker	[239]
ADC Info	WO2017089895A1 ADC70	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089895A1_ADC70 linker	[239]
ADC Info	WO2017089895A1 ADC71	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	WO2017089895A1_ADC71 linker	[239]
ADC Info	WO2017089895A1 ADC72	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089895A1_ADC72 linker	[239]
ADC Info	WO2017089895A1 ADC73	Depatuxizumab	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin F	WO2017089895A1_ADC73 linker	[239]
ADC Info	WO2017089895A1 ADC74	Depatuxizumab	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	WO2017089895A1_ADC74 linker	[239]
ADC Info	WO2017089895A1 ADC75	Depatuxizumab	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin F	WO2017089895A1_ADC75 linker	[239]
ADC Info	WO2021044208A1 ADC2	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC2 linker	[240]
ADC Info	WO2021044208A1 ADC3	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC3 linker	[240]
ADC Info	WO2021044208A1 ADC4	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC4 linker	[240]
ADC Info	WO2021044208A1 ADC5	Anti-ROR1 mAb C2E3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC5 linker	[240]
ADC Info	WO2021044208A1 ADC9	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC9 linker	[240]
ADC Info	WO2021044208A1 ADC10	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC10 linker	[240]
ADC Info	WO2021044208A1 ADC 2A2-4	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC 2A2-4 linker	[240]
ADC Info	WO2021044208A1 ADC 2A2-5	Anti-ROR1 mAb 2A2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC 2A2-5 linker	[240]
ADC Info	WO2021044208A1 ADC AB4-2	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC AB4-2 linker	[240]
ADC Info	WO2021044208A1 ADC AB4-3	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC AB4-3 linker	[240]
ADC Info	WO2021044208A1 ADC AB4-4	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC AB4-4 linker	[240]
ADC Info	WO2021044208A1 ADC AB4-5	Anti-ROR1 mAb AB4	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC AB4-5 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2-2	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC A2F2-2 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2-3	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2-3 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2-4	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2-4 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2-5	Anti-ROR1 mAb A2F2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2-5 linker	[240]
ADC Info	WO2021044208A1 ADC A2F3-2	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC A2F3-2 linker	[240]
ADC Info	WO2021044208A1 ADC A2F3-3	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F3-3 linker	[240]
ADC Info	WO2021044208A1 ADC A2F3-4	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F3-4 linker	[240]
ADC Info	WO2021044208A1 ADC A2F3-5	Anti-ROR1 mAb A2F3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F3-5 linker	[240]
ADC Info	WO2021044208A1 ADC BA6-2	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC BA6-2 linker	[240]
ADC Info	WO2021044208A1 ADC BA6-3	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC BA6-3 linker	[240]
ADC Info	WO2021044208A1 ADC BA6-4	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC BA6-4 linker	[240]
ADC Info	WO2021044208A1 ADC BA6-5	Anti-ROR1 mAb BA6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC BA6-5 linker	[240]
ADC Info	WO2021044208A1 ADC CC9-2	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC CC9-2 linker	[240]
ADC Info	WO2021044208A1 ADC CC9-3	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC CC9-3 linker	[240]
ADC Info	WO2021044208A1 ADC CC9-4	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC CC9-4 linker	[240]
ADC Info	WO2021044208A1 ADC CC9-5	Anti-ROR1 mAb CC9	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC CC9-5 linker	[240]
ADC Info	WO2021044208A1 ADC DG6-2	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC DG6-2 linker	[240]
ADC Info	WO2021044208A1 ADC DG6-3	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC DG6-3 linker	[240]
ADC Info	WO2021044208A1 ADC DG6-4	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC DG6-4 linker	[240]
ADC Info	WO2021044208A1 ADC DG6-5	Anti-ROR1 mAb DG6	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC DG6-5 linker	[240]
ADC Info	WO2021044208A1 ADC D2B12-2	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC D2B12-2 linker	[240]
ADC Info	WO2021044208A1 ADC D2B12-3	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC D2B12-3 linker	[240]
ADC Info	WO2021044208A1 ADC D2B12-4	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC D2B12-4 linker	[240]
ADC Info	WO2021044208A1 ADC D2B12-5	Anti-ROR1 mAb D2B12	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC D2B12-5 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2 M1-2	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin F	WO2021044208A1_ADC A2F2 M1-2 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2 M1-3	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2 M1-3 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2 M1-4	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2 M1-4 linker	[240]
ADC Info	WO2021044208A1 ADC A2F2 M1-5	Anti-ROR1 mAb A2F2 M1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	WO2021044208A1_ADC A2F2 M1-5 linker	[240]
ADC Info	WO2007011968A2 cAC10-9a	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	WO2007011968A2_cAC10-9a linker	[241]
ADC Info	WO2007011968A2 c1F6-9a	Anti-CD70 mAb c1F6	CD70 antigen (CD70)	Monomethyl auristatin E	WO2007011968A2_c1F6-9a linker	[241]
ADC Info	WO2007011968A2 cAC10-9b	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin F	WO2007011968A2_cAC10-9b linker	[241]
ADC Info	WO2007011968A2 c1F6-9b	Anti-CD70 mAb c1F6	CD70 antigen (CD70)	Monomethyl auristatin F	WO2007011968A2_c1F6-9b linker	[241]
ADC Info	WO2015095755A1 h1F6-1.3	Anti-CD70 mAb h1F6	CD70 antigen (CD70)	Monomethyl auristatin E	WO2015095755A1_h1F6-1.3 linker	[242]
ADC Info	WO2015095755A1 cAC10-1.3	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	WO2015095755A1_cAC10-1.3 linker	[242]
ADC Info	WO2015095755A1 h1F6-2.0	Anti-CD70 mAb h1F6	CD70 antigen (CD70)	Monomethyl auristatin E	WO2015095755A1_h1F6-2.0 linker	[242]
ADC Info	WO2015095755A1 cAC10-2.0	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	WO2015095755A1_cAC10-2.0 linker	[242]
ADC Info	AAJ8D6-Mc-Val-Cit-MMAE	AAJ8D6	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[243]
ADC Info	AAJ8D6-D07-Val-Cit-PAB-MMAE	AAJ8D6	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[243]
ADC Info	AAJ8D6-PY-Val-Cit-MMAE	AAJ8D6	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	PY-VC-PABC	[243]
ADC Info	ABT-700-Mc-Val-Cit-MMAE	Telisotuzumab	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[243]
ADC Info	LgG1-Mc-Val-Cit-MMAE	Anti-MET lgG1	Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[243]
ADC Info	hBU12-mcMMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Maleimido-caproyl	[244]
ADC Info	hBU12-MC-vc-PABC-MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[244]
ADC Info	hBU12-MC-vc-PABC-MMAF DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[244]
ADC Info	hBU12-1 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Dpr-MA	[244]
ADC Info	hBU12-1 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Dpr-MA	[244]
ADC Info	hBU12-2 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MA	[244]
ADC Info	hBU12-2 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MA	[244]
ADC Info	hBU12-3 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Dpr-MA	[244]
ADC Info	hBU12-3 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Dpr-MA	[244]
ADC Info	hBU12-4 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MA	[244]
ADC Info	hBU12-4 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MA	[244]
ADC Info	hBU12-5 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-5 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-6 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-6 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-7 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Lys-MDpr	[244]
ADC Info	hBU12-7 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-Lys-MDpr	[244]
ADC Info	hBU12-8 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thiazole-Glu-Lys-MDpr	[244]
ADC Info	hBU12-9 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Glu-EDA-MDpr	[244]
ADC Info	hBU12-10 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Glu-EDA-MDpr	[244]
ADC Info	hBU12-11 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Ile-EDA-MDpr	[244]
ADC Info	hBU12-12 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Ile-EDA-MDpr	[244]
ADC Info	hBU12-13 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thiazole-Glu-EDA-MDpr	[244]
ADC Info	hBU12-14 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asp-Ala-Lys-MDpr	[244]
ADC Info	hBU12-15 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Lys-MDpr	[244]
ADC Info	hBU12-16 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	PhosphoThr-Ala-Lys-MDpr	[244]
ADC Info	hBU12-17 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asn-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-18 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-19 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asp-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-20 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-21 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	hSer-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-22 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	ValoH-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-23 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	PhosphoThr-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-24 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Pyrazole-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-25 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Triazole-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-26 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asn-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-27 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asp-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-28 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Fur-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-29 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	ValOH-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-30 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Ser-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-31 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	hSer-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-32 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-IleLeu-Dpr-MDpr	[244]
ADC Info	hBU12-33 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Ile-Leu-Dpr-MDpr	[244]
ADC Info	hBU12-34 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Phe-Leu-Dpr-MDpr	[244]
ADC Info	hBU12-35 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-LeuPhe-Dpr-MDpr	[244]
ADC Info	hBU12-36 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Leu-Phe-Dpr-MDpr	[244]
ADC Info	hBU12-37 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Phe-Phe-Dpr-MDpr	[244]
ADC Info	hBU12-38 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-LysAla-Dpr-MDpr	[244]
ADC Info	hBU12-39 MMAE	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Lys-Dpr-MDpr	[244]
ADC Info	hBU12-1 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Dpr-MA	[244]
ADC Info	hBU12-2 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Glu-Dpr-MA	[244]
ADC Info	hBU12-3 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Dpr-MA	[244]
ADC Info	hBU12-4 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-Dpr-MA	[244]
ADC Info	hBU12-5 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-6 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-7 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-Lys-MDpr	[244]
ADC Info	hBU12-8 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thiazole-Glu-Lys-MDpr	[244]
ADC Info	hBU12-9 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Glu-EDA-MDpr	[244]
ADC Info	hBU12-10 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Glu-EDA-MDpr	[244]
ADC Info	hBU12-11 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Ile-EDA-MDpr	[244]
ADC Info	hBU12-12 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Ile-EDA-MDpr	[244]
ADC Info	hBU12-13 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thiazole-Glu-EDA-MDpr	[244]
ADC Info	hBU12-14 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asp-Ala-Lys-MDpr	[244]
ADC Info	hBU12-15 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Ala-Lys-MDpr	[244]
ADC Info	hBU12-16 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	PhosphoThr-Ala-Lys-MDpr	[244]
ADC Info	hBU12-17 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asn-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-18 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-19 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asp-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-20 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-21 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	hSer-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-22 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	ValoH-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-23 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	PhosphoThr-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-24 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Pyrazole-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-25 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Triazole-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-26 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asn-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-27 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Asp-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-28 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Fur-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-29 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	ValOH-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-30 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Ser-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-31 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	hSer-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-32 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-IleLeu-Dpr-MDpr	[244]
ADC Info	hBU12-33 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Ile-Leu-Dpr-MDpr	[244]
ADC Info	hBU12-34 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Phe-Leu-Dpr-MDpr	[244]
ADC Info	hBU12-35 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-LeuPhe-Dpr-MDpr	[244]
ADC Info	hBU12-36 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Phe-Leu-Phe-Dpr-MDpr	[244]
ADC Info	hBU12-37 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Glu-Phe-Phe-Dpr-MDpr	[244]
ADC Info	hBU12-38 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-LysAla-Dpr-MDpr	[244]
ADC Info	hBU12-39 MMAF	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	Thr-Lys-Dpr-MDpr	[244]
ADC Info	hBU12-MC-vc-PABC-MMAF DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[244]
ADC Info	hBU12-13 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thiazole-Glu-EDA-MDpr	[244]
ADC Info	hBU12-12 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Thr-Ile-EDA-MDpr	[244]
ADC Info	hBU12-11 MMAE DAR8	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Phe-Ile-EDA-MDpr	[244]
ADC Info	hBU12-17 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Asn-AlaGlu-Dpr-MDpr	[244]
ADC Info	hBU12-20 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Glu-Ala-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-24 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	Pyrazole-Glu-Dpr-MDpr	[244]
ADC Info	hBU12-29 MMAE DAR4	Denintuzumab	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	ValOH-Glu-Dpr-MDpr	[244]
ADC Info	hL49-ADC	Humanized Anti-CD228 SGN-CD228A mAb	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_27D_Ala-ADC	hL49_27D_Ala	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_27D_Gln-ADC	hL49_27D_Gln	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_27D_Tyr-ADC	hL49_27D_Tyr	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_34_Ala-ADC	hL49_34_Ala	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_34_Gln-ADC	hL49_34_Gln	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_34_Tyr-ADC	hL49_34_Tyr	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_3x_Ala-ADC	hL49_3x_Ala	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_3x_Gln-ADC	hL49_3x_Gln	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	hL49_3x_Tyr-ADC	hL49_3x_Tyr	Melanotransferrin (MELTF)	Monomethyl auristatin E	mp-dLAE-PABC	[245]
ADC Info	M69-MMAE	Anti-Matriptase mAb M69	Suppressor of tumorigenicity 14 protein (ST14)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[246]
ADC Info	Zapadcine-1	Zaptuzumab	Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)	Monomethyl auristatin D	PY-VC-PABC	[247]
ADC Info	Wild type nBT062-DM4	Indatuximab	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[248]
ADC Info	Half nBT062-DM4	Indatuximab (C226S + C229S)	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[248]
ADC Info	Stable nBT062-DM4	Indatuximab (S228P + R409K)	Syndecan-1 (SDC1)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[248]
ADC Info	Bispecific nBT062-natalizumab-DM4	Bispecific nBT062-natalizumab	Syndecan-1 (SDC1); Integrin alpha-4 (ITGA4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[248]
ADC Info	ScFvF7-Fc-vcMMAE	Anti-FGFR2 scFv ECD_FGFR2	Fibroblast growth factor receptor 2 (FGFR2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[249]
ADC Info	Alpha-CD30-7	Anti-CD30 mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin 7	Glucuronide quaternary ammonium linker 7	[250]
ADC Info	Alpha-CD30-8	Anti-CD30 mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin 8	Glucuronide quaternary ammonium linker 8	[250]
ADC Info	Alpha-CD30-9	Anti-CD30 mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Tubulysin 9	Glucuronide quaternary ammonium linker 9	[250]
ADC Info	VCit ADC 3a	Anti-HER2 mAb glutamine 295 (Q295)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	DBCO-PEG-VCit-PABC	[251]
ADC Info	EVCit ADC 3c	Anti-HER2 mAb glutamine 295 (Q295)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	DBCO-PEG-EVCit-PABC	[251]
ADC Info	EGFR-MMAU ADC	Cetuximab	Epidermal growth factor receptor (EGFR)	Glucuronyl-monomethyl-auristatin E (MMAU)	Mc-Val-Cit-PABC	[252]
ADC Info	HER2-MMAU ADC	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Glucuronyl-monomethyl-auristatin E (MMAU)	Mc-Val-Cit-PABC	[252]
ADC Info	GABRP Ab-DM1 ADC	GABRP-Ab	Gamma-aminobutyric acid receptor subunit pi (GABRP)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[253]
ADC Info	Anti-alpha10-SAP	Anti-integrin alpha10 mAb	Integrin alpha-10 (ITGA10)	Saporin	Undisclosed	[254]
ADC Info	ADC Mil40-6	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Silyl ether-based linker	[255]
ADC Info	Anti-CXCR4 ADC 513	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 518	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 510	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 519	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 381	Anti-CXCR4 mAb m17	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 553	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 554	Anti-CXCR4 mAb h17-NS	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 555	Anti-CXCR4 mAb h17-NQ	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 556	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	AcLys-Val-Cit-PABC	[256]
ADC Info	Anti-CXCR4 ADC 669	Anti-CXCR4 mAb h17-NQ	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 670	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 671	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 672	Anti-CXCR4 mAb h17-NS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 711	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 712	Anti-CXCR4 mAb h17-NA	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 713	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Anti-CXCR4 ADC 714	Anti-CXCR4 mAb h17-NV.TS	C-X-C chemokine receptor type 4 (CXCR4)	Aur0131	AmPEG6C2	[256]
ADC Info	Cetux Fab-vc-MMAE	Cetuximab Fab (conjugate to glycan residues)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[18]
ADC Info	ScFvGPIIb/IIIa-MMAE	Anti-ITGA2B scFv	Integrin beta-3 (ITGB3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[257]
ADC Info	MMAE-9F7-F11 ADC	Anti-HER3 mAb 9F7-F11	Receptor tyrosine-protein kinase erbB-3 (ERBB3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[258]
ADC Info	RBGO1-mcF	Anti-RAGE mAb RBGO1	Advanced glycosylation end product-specific receptor (AGER)	Monomethyl auristatin F	Maleimido-caproyl	[259]
ADC Info	TTZ-1-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DSPh-Val-Ala-PABC	[260]
ADC Info	TTZ-2-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DSPh-Val-Cit-PABC	[260]
ADC Info	TTZ-3-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DSPh-PEG12-Val-Ala-PABC	[260]
ADC Info	TTZ-4-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DSPh-PEG12-Val-Cit-PABC	[260]
ADC Info	Trastuzumab-DVP-linker-MMAE 1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DVP-based linker 1f	[261]
ADC Info	Trastuzumab-Val-Cit linker-MMAE 2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Val-Cit linker 2e	[261]
ADC Info	Trastuzumab-DVP-linker-MMAE 3	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DVP-based linker 3	[261]
ADC Info	Trastuzumab-DVP-linker-MMAE 4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	DVP-based linker 4	[261]
ADC Info	B10v5 225-M-vc-MMAE	B10v5 225-M	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[262]
ADC Info	B10v5 225-H-vc-MMAE	B10v5 225-H	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[262]
ADC Info	B10 225-M-vc-MMAE	B10 225-M	Epidermal growth factor receptor (EGFR); Hepatocyte growth factor receptor (MET)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[262]
ADC Info	Cetuximab-vc-MMAE	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[262]
ADC Info	Mil40-15	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-PABC	[209]
ADC Info	M25ADCMMAF	Anti-ALPPL2 mAb M25	Alkaline phosphatase, germ cell type (ALPG)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[263]
ADC Info	M25ADCMMAE	Anti-ALPPL2 mAb M25	Alkaline phosphatase, germ cell type (ALPG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[263]
ADC Info	FOLR1-Mal-PEG2-Val-Cit-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2-Val-Cit-PABC	[264]
ADC Info	FOLR1-Mal-PEG8-Val-Cit-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG8-Val-Cit-PABC	[264]
ADC Info	FOLR1-Mal-Caproyl-Val-Cit-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Maleimide-Caproyl-Val-Cit-PABC	[264]
ADC Info	FOLR1-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2-Ala-Ala-Asn-PABC	[264]
ADC Info	FOLR1-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC	[264]
ADC Info	FOLR1-Mal-PEG4-tria-PEG3-Sulfo-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG4-triazole-PEG3-Sulfonamide	[264]
ADC Info	FOLR1-Mal-PEG2-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG2	[264]
ADC Info	FOLR1-Mal-PEG4-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Mal-PEG4	[264]
ADC Info	FOLR1-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG4-Val-Cit-PABC	[264]
ADC Info	FOLR1-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC	[264]
ADC Info	FOLR1-Suc/SPAAC-PEG3-Sulfonamide-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG3-Sulfonamide	[264]
ADC Info	FOLR1-Suc/SPAAC-PEG2-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG2	[264]
ADC Info	FOLR1-Suc/SPAAC-PEG4-Eribulin	Farletuzumab	Folate receptor alpha (FOLR1)	Eribulin	Succinamide-SPAAC-PEG4	[264]
ADC Info	FOLR1-Mal-PEG-Val-Cit-PABC-Cryptophycin	Farletuzumab	Folate receptor alpha (FOLR1)	Cryptophycin	Mal-PEG-Val-Cit-PABC	[264]
ADC Info	FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAE	Farletuzumab	Folate receptor alpha (FOLR1)	Monomethyl auristatin E	Maleimide-Caproyl-Val-Cit-PABC	[264]
ADC Info	FOLR1-Mal-Caproyl-Val-Cit-PABC-MMAF	Farletuzumab	Folate receptor alpha (FOLR1)	Monomethyl auristatin F	Maleimide-Caproyl-Val-Cit-PABC	[264]
ADC Info	MSLN-Mal-PEG2-Val-Cit-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG2-Val-Cit-PABC	[264]
ADC Info	MSLN-Mal-PEG8-Val-Cit-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG8-Val-Cit-PABC	[264]
ADC Info	MSLN-Mal-Caproyl-Val-Cit-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Maleimide-Caproyl-Val-Cit-PABC	[264]
ADC Info	MSLN-Mal-PEG2-Ala-Ala-Asn-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG2-Ala-Ala-Asn-PABC	[264]
ADC Info	MSLN-Mal-PEG4-tria-PEG3-Dis-dim-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG4-triazole-PEG3-Disulfidyl-dimethyl-PABC	[264]
ADC Info	MSLN-Mal-PEG4-tria-PEG3-Sulfo-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG4-triazole-PEG3-Sulfonamide	[264]
ADC Info	MSLN-Mal-PEG2-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG2	[264]
ADC Info	MSLN-Mal-PEG4-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Mal-PEG4	[264]
ADC Info	MSLN-Suc/SPAAC-PEG4-Val-Cit-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG4-Val-Cit-PABC	[264]
ADC Info	MSLN-Suc/SPAAC-PEG3-Dis-dim-PABC-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG3-Disylfidyl-dimethyl-PABC	[264]
ADC Info	MSLN-Suc/SPAAC-PEG3-Sulfonamide-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG3-Sulfonamide	[264]
ADC Info	MSLN-Suc/SPAAC-PEG2-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG2	[264]
ADC Info	MSLN-Suc/SPAAC-PEG4-Eribulin	Amatuximab	Mesothelin (MSLN)	Eribulin	Succinamide-SPAAC-PEG4	[264]
ADC Info	MSLN-Mal-PEG-Val-Cit-PABC-Cryptophycin	Amatuximab	Mesothelin (MSLN)	Cryptophycin	Mal-PEG-Val-Cit-PABC	[264]
ADC Info	MSLN-Mal-Caproyl-Val-Cit-PABC-MMAE	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Maleimide-Caproyl-Val-Cit-PABC	[264]
ADC Info	MSLN-Mal-Caproyl-Val-Cit-PABC-MMAF	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin F	Maleimide-Caproyl-Val-Cit-PABC	[264]
ADC Info	Farletuzumab-sulfo SPDB-DM4	Farletuzumab	Folate receptor alpha (FOLR1)	Mertansine DM4	Sulfo-SPDB	[264]
ADC Info	Crown Ether ADC 4a	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	6-Amino-alpha-cyclodextrin-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 4b	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	6-Amino-beta-cyclodextrin-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 4c	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	6-Amino-gama-cyclodextrin-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 4d	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	3-Amino-alpha-cyclodextrin-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 4e	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	3-Amino-beta-cyclodextrin-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 4f	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	3-Amino-gama-cyclodextrin-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 5a	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	1-Aza-24-crown-8-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 5b	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	1-Aza-42-crown-14-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 6a	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	PEG(8u)-Val-Cit-PABC	[265]
ADC Info	Crown Ether ADC 6b	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	PEG(24u)-Val-Cit-PABC	[265]
ADC Info	Ch14.18-MMAE	Anti-GD2 mAb ch14.18	Ganglioside GD2 (GD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[266]
ADC Info	Ch14.18-MMAF	Anti-GD2 mAb ch14.18	Ganglioside GD2 (GD2)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[266]
ADC Info	HER2-acetal-ADC 11	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Clravable-acetal based linker 11	[267]
ADC Info	HER2-acetal-ADC 12	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Clravable-TAMRA-acetal based linker 12	[267]
ADC Info	HER2-azide-alkyne MMAE conjugate	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Azide-alkyne based linker 10a	[268]
ADC Info	HER2-cyclopropene-tetrazine MMAE conjugate	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Cyclopropene-tetrazine based linker 10b	[268]
ADC Info	HER2-norbornene-tetrazine MMAE conjugate	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Norbornene-tetrazine based linker 10c	[268]
ADC Info	5E3-Saporin ADC	Anti-SEMA4A mAb 5E3	Semaphorin-4A (SEMA4A)	Saporin	Undisclosed	[269]
ADC Info	5E3-vedotin	Anti-SEMA4A mAb 5E3	Semaphorin-4A (SEMA4A)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[269]
ADC Info	5E3-emtansine	Anti-SEMA4A mAb 5E3	Semaphorin-4A (SEMA4A)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[269]
ADC Info	Trastuzumab biosimilar mil40 12a	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleamic methyl ester-based Val-Ala-PABC linker 12a	[270]
ADC Info	Trastuzumab biosimilar mil40 12b	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleamic methyl ester-based Val-Ala-PABC linker 12b	[270]
ADC Info	Trastuzumab biosimilar mil40 12c	Mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleamic methyl ester-based Val-Cit-PABC linker 12c	[270]
ADC Info	T-FcBP-DM1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	N-terminal norbornene group pFcBP linker	[271]
ADC Info	T-D8-1508	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	AZ-1508	Cysteine D8	[272]
ADC Info	T-D6-1508	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	AZ-1508	Cysteine D6	[272]
ADC Info	T-D4-1508	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	AZ-1508	Cysteine D4	[272]
ADC Info	T-D2-1508	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	AZ-1508	Cysteine D2	[272]
ADC Info	N-D8-1508	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)	AZ-1508	Cysteine D8	[272]
ADC Info	N-D6-1508	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)	AZ-1508	Cysteine D6	[272]
ADC Info	N-D4-1508	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)	AZ-1508	Cysteine D4	[272]
ADC Info	N-D2-1508	NIP228	Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)	AZ-1508	Cysteine D2	[272]
ADC Info	THL4-mpeoDM1	Anti-DLL4 mAb THL4 (V207C, A121C)	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	[273]
ADC Info	TH2-mpeoDM1	Anti-DLL4 mAb TH2 (A121C)	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	[273]
ADC Info	TL2-mpeoDM1	Anti-DLL4 mAb TL2 (V207C)	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	[273]
ADC Info	THL4-vcMMAE	Anti-DLL4 mAb THL4 (V207C, A121C)	Delta-like protein 4 (DLL4)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[273]
ADC Info	H3L2-mpeoDM1	Anti-DLL4 mAb H3L2	Delta-like protein 4 (DLL4)	Mertansine DM1	BIMPRO	[273]
ADC Info	CTX-MMAE	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	PD-Val-Cit-PABC	[274]
ADC Info	H32-DM1_3.0	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[275]
ADC Info	H32-DM1_3.3	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[275]
ADC Info	H32-DM1_3.7	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[275]
ADC Info	H32-DM1_3.8	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[275]
ADC Info	H32-VCMMAE_2.1	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[275]
ADC Info	H32-VCMMAE_3.2	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[275]
ADC Info	H32-VCMMAE_3.8	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[275]
ADC Info	H32-VCMMAE_6.6	Anti-HER2 mAb H32	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[275]
ADC Info	HER2 ADC-18	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Vinylsulfonamide based linker 15	[276]
ADC Info	HER2 ADC-19	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Vinylsulfonamide based linker 16	[276]
ADC Info	HER2 ADC-20	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Vinylsulfonamide based linker 17	[276]
ADC Info	EGFR ADC-21	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Vinylsulfonamide based linker 15	[276]
ADC Info	EGFR ADC-22	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Vinylsulfonamide based linker 16	[276]
ADC Info	EGFR ADC-23	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Vinylsulfonamide based linker 17	[276]
ADC Info	T-DM1-IR700	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1 plus IRDye700DX	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[277]
ADC Info	Trastuzumab I253Q-MMAE	Trastuzumab I253Q	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Dansylcadaverine-BCN based linker	[278]
ADC Info	Trastuzumab deglycosylated WT-MMAE	Trastuzumab I253Q	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Dansylcadaverine deglycosylated-BCN based linker	[278]
ADC Info	HER2-gsADC-1	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	ThioPz linker 6a	[279]
ADC Info	HER2-gsADC-2	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	2-Aminobenzamide oxime	[279]
ADC Info	HER2-gsADC-3	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Hydroxylamine derivative 6c	[279]
ADC Info	HER2-gsADC-4	CHO-S2G2F-Tras (Ab1)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6n	[279]
ADC Info	HER2-gsADC-5	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Azadibenzocylooctyne-amine derivative 6d	[279]
ADC Info	HER2-gsADC-6	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Bicyclononyne derivative 6e	[279]
ADC Info	HER2-gsADC-7	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6m	[279]
ADC Info	HER2-gsADC-8	Azido-tagged trastuzumab (Ab2)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6r	[279]
ADC Info	HER2-gsADC-9	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Linear alkyne 6f	[279]
ADC Info	HER2-gsADC-10	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6g	[279]
ADC Info	HER2-gsADC-11	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6h	[279]
ADC Info	HER2-gsADC-12	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6i	[279]
ADC Info	HER2-gsADC-13	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6j	[279]
ADC Info	HER2-gsADC-14	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6k	[279]
ADC Info	HER2-gsADC-15	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6l	[279]
ADC Info	HER2-gsADC-16	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6m	[279]
ADC Info	HER2-gsADC-17	Azido-tagged trastuzumab (Ab3)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Noncleavable linker 6t	[279]
ADC Info	HER2-gsADC-18	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	ThioPz linker 6a	[279]
ADC Info	HER2-gsADC-19	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	2-Aminobenzamide oxime	[279]
ADC Info	HER2-gsADC-20	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Hydroxylamine derivative 6c	[279]
ADC Info	HER2-gsADC-21	CHO-G2F-Tras (Ab4)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6n	[279]
ADC Info	HER2-gsADC-22	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Linear alkyne 6f	[279]
ADC Info	HER2-gsADC-23	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6g	[279]
ADC Info	HER2-gsADC-24	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6h	[279]
ADC Info	HER2-gsADC-25	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6i	[279]
ADC Info	HER2-gsADC-26	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6j	[279]
ADC Info	HER2-gsADC-27	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6k	[279]
ADC Info	HER2-gsADC-28	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6l	[279]
ADC Info	HER2-gsADC-29	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6m	[279]
ADC Info	HER2-gsADC-30	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6o	[279]
ADC Info	HER2-gsADC-31	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6p	[279]
ADC Info	HER2-gsADC-32	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6q	[279]
ADC Info	HER2-gsADC-33	Azido-tagged trastuzumab (Ab5)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Glycosyl PEGylation linker 6r	[279]
ADC Info	HER2-gsADC-34	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Linear alkyne 6f	[279]
ADC Info	HER2-gsADC-35	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6g	[279]
ADC Info	HER2-gsADC-36	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6h	[279]
ADC Info	HER2-gsADC-37	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6i	[279]
ADC Info	HER2-gsADC-38	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6j	[279]
ADC Info	HER2-gsADC-39	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6k	[279]
ADC Info	HER2-gsADC-40	Azido-tagged trastuzumab (Ab6)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6l	[279]
ADC Info	HER2-gsADC-41	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Bicyclononyne derivative 6e	[279]
ADC Info	HER2-gsADC-42	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6l	[279]
ADC Info	HER2-gsADC-43	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEGylation linker 6m	[279]
ADC Info	HER2-gsADC-44	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Noncleavable linker 6s	[279]
ADC Info	HER2-gsADC-45	Az-LacNAc-Tras Ab7	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Noncleavable linker 6t	[279]
ADC Info	HER2-gsADC-46	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	ThioPz linker 6a	[279]
ADC Info	HER2-gsADC-47	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Hydroxylamine derivative 6c	[279]
ADC Info	HER2-gsADC-48	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	2-Aminobenzamide oxime	[279]
ADC Info	HER2-gsADC-49	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Azadibenzocylooctyne-amine derivative 6d	[279]
ADC Info	HER2-gsADC-50	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	2-Aminobenzamidoxime without core-fucosylation	[279]
ADC Info	T-DM1-2.6	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[279]
ADC Info	NOV0712-DM4	Anti-CDH6 mAb NOV0712	Cadherin-6 (CDH6)	Mertansine DM4	Sulfo-SPDB	[280]
ADC Info	H01L02-DM4	Anti-CDH6 mAb H01L02	Cadherin-6 (CDH6)	Mertansine DM4	Sulfo-SPDB	[280]
ADC Info	hu4DFabv7-BMPEO-DM1	hu4DFabv7	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv7-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (A121C)-BMPEO-DM1	hu4DFabv8 (A121C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (A121C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (V110C)-BMPEO-DM1	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (V110C)-BMPEO-DM1 linker	[281]
ADC Info	Thio-Tr (A121C)-BMPEO-DM1	Thio-Tr (A121C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	Thio-Tr (A121C)-BMPEO-DM1 linker	[281]
ADC Info	2H9-A121C-BMPEO-DM1	Anti-HER2 antibody 2H9-A121C	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	2H9-A121C-BMPEO-DM1 linker	[281]
ADC Info	Thio-3A5 (A121C)-BMPEO-DM1	Thio-3A5 (A121C)	Mucin-16 (MUC16)	Maytansinoid DM1	Thio-3A5 (A121C)-BMPEO-DM1 linker	[281]
ADC Info	Anti-MUC16 antibody 3A5-BMPEO-DM1	Anti-MUC16 antibody 3A5	Mucin-16 (MUC16)	Maytansinoid DM1	Anti-MUC16 antibody 3A5-BMPEO-DM1 linker	[281]
ADC Info	Thio-Tmab-BMPEO-DM1	Thio-Tmab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	Thio-Tmab-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (V110C)-MC-MMAF	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Maleimido-caproyl	[281]
ADC Info	hu4DFabv8 (V110C)-MC-MMAE	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maleimido-caproyl	[281]
ADC Info	hu4DFabv8 (V110C)-MC-Val-Cit-PAB-MMAF	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[281]
ADC Info	hu4DFabv8 (V110C)-MC-Val-Cit-PAB-MMAE	hu4DFabv8 (V110C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[281]
ADC Info	hu4DFabv8 (L-V15C)-BMPEO-DM1	hu4DFabv8 (L-V15C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (L-V15C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (L-A43C)-BMPEO-DM1	hu4DFabv8 (L-A43C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (L-A43C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (L-A144C)-BMPEO-DM1	hu4DFabv8 (L-A144C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (L-A144C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (L-S168C)-BMPEO-DM1	hu4DFabv8 (L-S168C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (L-S168C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (H-A40C)-BMPEO-DM1	hu4DFabv8 (H-A40C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (H-A40C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (H-A88C)-BMPEO-DM1	hu4DFabv8 (H-A88C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (H-A88C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (H-S119C)-BMPEO-DM1	hu4DFabv8 (H-S119C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (H-S119C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (H-S122C)-BMPEO-DM1	hu4DFabv8 (H-S122C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (H-S122C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (H-A175C)-BMPEO-DM1	hu4DFabv8 (H-A175C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (H-A175C)-BMPEO-DM1 linker	[281]
ADC Info	hu4DFabv8 (H-S179C)-BMPEO-DM1	hu4DFabv8 (H-S179C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Maytansinoid DM1	hu4DFabv8 (H-S179C)-BMPEO-DM1 linker	[281]
ADC Info	WO2017089890A1 ADC1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC1 linker	[282]
ADC Info	WO2017089890A1 ADC2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC2 linker	[282]
ADC Info	WO2017089890A1 ADC3	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC3 linker	[282]
ADC Info	WO2017089890A1 ADC4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC4 linker	[282]
ADC Info	WO2017089890A1 ADC5	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC5 linker	[282]
ADC Info	WO2017089890A1 ADC6	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC6 linker	[282]
ADC Info	WO2017089890A1 ADC7	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC7 linker	[282]
ADC Info	WO2017089890A1 ADC8	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC8 linker	[282]
ADC Info	WO2017089890A1 ADC9	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC9 linker	[282]
ADC Info	WO2017089890A1 ADC10	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC10 linker	[282]
ADC Info	WO2017089890A1 ADC11	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC11 linker	[282]
ADC Info	WO2017089890A1 ADC12	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC12 linker	[282]
ADC Info	WO2017089890A1 ADC13	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC13 linker	[282]
ADC Info	WO2017089890A1 ADC14	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC14 linker	[282]
ADC Info	WO2017089890A1 ADC15	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC15 linker	[282]
ADC Info	WO2017089890A1 ADC16	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC16 linker	[282]
ADC Info	WO2017089890A1 ADC17	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC17 linker	[282]
ADC Info	WO2017089890A1 ADC18	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC18 linker	[282]
ADC Info	WO2017089890A1 ADC19	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC19 linker	[282]
ADC Info	WO2017089890A1 ADC20	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC20 linker	[282]
ADC Info	WO2017089890A1 ADC86	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC86 linker	[282]
ADC Info	WO2017089890A1 ADC87	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC87 linker	[282]
ADC Info	WO2017089890A1 ADC23	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC23 linker	[282]
ADC Info	WO2017089890A1 ADC24	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC24 linker	[282]
ADC Info	WO2017089890A1 ADC25	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC25 linker	[282]
ADC Info	WO2017089890A1 ADC26	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC26 linker	[282]
ADC Info	WO2017089890A1 ADC27	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC27 linker	[282]
ADC Info	WO2017089890A1 ADC28	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC28 linker	[282]
ADC Info	WO2017089890A1 ADC29	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC29 linker	[282]
ADC Info	WO2017089890A1 ADC30	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC30 linker	[282]
ADC Info	WO2017089890A1 ADC31	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC31 linker	[282]
ADC Info	WO2017089890A1 ADC32	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC32 linker	[282]
ADC Info	WO2017089890A1 ADC33	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC33 linker	[282]
ADC Info	WO2017089890A1 ADC34	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC34 linker	[282]
ADC Info	WO2017089890A1 ADC35	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC35 linker	[282]
ADC Info	WO2017089890A1 ADC36	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC36 linker	[282]
ADC Info	WO2017089890A1 ADC37	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC37 linker	[282]
ADC Info	WO2017089890A1 ADC38	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC38 linker	[282]
ADC Info	WO2017089890A1 ADC39	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC39 linker	[282]
ADC Info	WO2017089890A1 ADC40	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC40 linker	[282]
ADC Info	WO2017089890A1 ADC41	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC41 linker	[282]
ADC Info	WO2017089890A1 ADC42	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC42 linker	[282]
ADC Info	WO2017089890A1 ADC43	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC43 linker	[282]
ADC Info	WO2017089890A1 ADC44	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC44 linker	[282]
ADC Info	WO2017089890A1 ADC45	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC45 linker	[282]
ADC Info	WO2017089890A1 ADC46	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC46 linker	[282]
ADC Info	WO2017089890A1 ADC47	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC47 linker	[282]
ADC Info	WO2017089890A1 ADC48	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC48 linker	[282]
ADC Info	WO2017089890A1 ADC49	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC49 linker	[282]
ADC Info	WO2017089890A1 ADC50	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC50 linker	[282]
ADC Info	WO2017089890A1 ADC51	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC51 linker	[282]
ADC Info	WO2017089890A1 ADC52	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC52 linker	[282]
ADC Info	WO2017089890A1 ADC53	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC53 linker	[282]
ADC Info	WO2017089890A1 ADC54	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC54 linker	[282]
ADC Info	WO2017089890A1 ADC55	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC55 linker	[282]
ADC Info	WO2017089890A1 ADC76	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC76 linker	[282]
ADC Info	WO2017089890A1 ADC88	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC88 linker	[282]
ADC Info	WO2017089890A1 ADC89	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC89 linker	[282]
ADC Info	WO2017089890A1 ADC90	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC90 linker	[282]
ADC Info	WO2017089890A1 ADC91	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC91 linker	[282]
ADC Info	WO2017089890A1 ADC60	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC60 linker	[282]
ADC Info	WO2017089890A1 ADC61	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC61 linker	[282]
ADC Info	WO2017089890A1 ADC62	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC62 linker	[282]
ADC Info	WO2017089890A1 ADC63	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	WO2017089890A1_ADC63 linker	[282]
ADC Info	WO2017089890A1 ADC77	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	WO2017089890A1_ADC77 linker	[282]
ADC Info	WO2017089890A1 ADC64	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC64 linker	[282]
ADC Info	WO2017089890A1 ADC65	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	WO2017089890A1_ADC65 linker	[282]
ADC Info	WO2017089890A1 ADC66	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC66 linker	[282]
ADC Info	WO2017089890A1 ADC67	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089890A1_ADC67 linker	[282]
ADC Info	WO2017089890A1 ADC68	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin E	WO2017089890A1_ADC68 linker	[282]
ADC Info	WO2017089890A1 ADC69	Anti-CD19 mAb DI-B4	B-lymphocyte antigen CD19 (CD19)	Monomethyl auristatin F	WO2017089890A1_ADC69 linker	[282]
ADC Info	WO2017089890A1 ADC70	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089890A1_ADC70 linker	[282]
ADC Info	WO2017089890A1 ADC71	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	WO2017089890A1_ADC71 linker	[282]
ADC Info	WO2017089890A1 ADC72	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin F	WO2017089890A1_ADC72 linker	[282]
ADC Info	WO2017089890A1 ADC73	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC73 linker	[282]
ADC Info	WO2017089890A1 ADC74	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	WO2017089890A1_ADC74 linker	[282]
ADC Info	WO2017089890A1 ADC75	Depatuxizumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	WO2017089890A1_ADC75 linker	[282]
ADC Info	Anti-BCMA 15B2GL-mcMMAF	Anti-BCMA antibody 15B2GL	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA 15B2WT-mcMMAF	Anti-BCMA antibody 15B2WT	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA I09-mcMMAF	Anti-BCMA antibody I09	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA L15-mcMMAF	Anti-BCMA antibody L15	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA M02-mcMMAF	Anti-BCMA antibody M02	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA N22-mcMMAF	Anti-BCMA antibody N22	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA P10-mcMMAF	Anti-BCMA antibody P10	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	Anti-BCMA J6M0-mcMMAF	Anti-BCMA antibody J6M0	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin F	Maleimido-caproyl	[283]
ADC Info	2C3 WT-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 WT	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	2C3 A114N-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 A114N	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	2C3 Y436S-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 Y436S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	2C3 S440N-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 S440N	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	2C3 S442N-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 S442N	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	2C3 NGT-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 NGT	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	2C3 S298N Y300S-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 2C3 S298N Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	TEM1 Clone 187 WT-Mc-Val-Cit-PABC-MMAE	Anti-TEM1 mAb Clone 187 WT	Endosialin (CD248)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	TEM1 Clone 187 A114N-Mc-Val-Cit-PABC-MMAE	Anti-TEM1 mAb Clone 187 A114N	Endosialin (CD248)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	HER2 WT-Mc-Val-Cit-PABC-MMAE	Anti-HER2 mAb WT	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	A114N-Mc-Val-Cit-PABC-MMAE	Anti-HER2 mAb A114N	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	NNAS-Mc-Val-Cit-PABC-MMAE	Anti-HER2 mAb NNAS	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	A114N NNAS-Mc-Val-Cit-PABC-MMAE	Anti-HER2 mAb A114N NNAS	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	HER2 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-HER2 mAb S298N/T299A/Y300S	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	H66-Mc-Val-Cit-PABC-MMAE	Anti-TRAC mAb H66	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	H66 S298N/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-TRAC mAb H66 S298N/Y300S	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	H66 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-TRAC mAb H66 S298N/T299A/Y300S	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	H66 N297Q/S298N/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-TRAC mAb H66 N297Q/S298N/Y300S	T cell receptor alpha chain constant (TRAC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	12G6 WT-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 12G6 WT	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	12G6 S298N/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 12G6 S298N/Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	12G6 S298N/T299A/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 12G6 S298N/T299A/Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	12G6 N297Q/S298N/Y300S-Mc-Val-Cit-PABC-MMAE	Anti-CD52 mAb 12G6 N297Q/S298N/Y300S	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[284]
ADC Info	Anti-HER-AO-Cys-MC-VC-PABC-MMAE	Anti-HER2 mAb WT	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER-AO-Cys-MC-VC-PABC-MMAE linker	[284]
ADC Info	Anti-FAP B11-MC-VC-PABC-MMAE	Anti-FAP mAb B11	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	Anti-FAP B11-MC-VC-PABC-MMAE linker	[284]
ADC Info	Anti-FAP B11-AO-Cys-MC-VC-PABC-MMAE	Anti-FAP mAb B11	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	Anti-FAP B11-AO-Cys-MC-VC-PABC-MMAE linker	[284]
ADC Info	huPr1-vcMMAE	Anti-TMEFF2 mAb huPr1	Tomoregulin-2 (TMEFF2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[285]
ADC Info	WO2015177360A1 ADC-wt-vcMMAE	Anti-PSMA mAb wt	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[286]
ADC Info	WO2015177360A1 ADC-HC41-vcMMAE	Anti-PSMA mAb wt HC S41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[286]
ADC Info	WO2015177360A1 ADC-LC40-vcMMAE	Anti-PSMA mAb wt LC P40C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[286]
ADC Info	WO2015177360A1 ADC-LC41-vcMMAE	Anti-PSMA mAb wt LC G41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[286]
ADC Info	WO2015177360A1 ADC-H8-HC40-vcMMAE	Anti-5T4 mAb H8 S40C	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[286]
ADC Info	WO2015177360A1 ADC-wt-mcMMAF	Anti-PSMA mAb wt	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	[286]
ADC Info	WO2015177360A1 ADC-HC41-mcMMAF	Anti-PSMA mAb wt HC S41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	[286]
ADC Info	WO2015177360A1 ADC-LC40-mcMMAF	Anti-PSMA mAb wt LC P40C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	[286]
ADC Info	WO2015177360A1 ADC-LC41-mcMMAF	Anti-PSMA mAb wt LC G41C	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Maleimido-caproyl	[286]
ADC Info	WO2015177360A1 ADC-H8-wt-mcMMAF	Anti-5T4 mAb H8 wt	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	[286]
ADC Info	WO2015177360A1 ADC-H8-HC40-mcMMAF	Anti-5T4 mAb H8 S40C	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin F	Maleimido-caproyl	[286]
ADC Info	h3G10.A57-h3G10 vcMMAD	h3G10.A57-h3G10	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.A57-h3G10 vc0101	h3G10.A57-h3G10	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.A57-h3G10.2.72 vcMMAD	h3G10.A57-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.A57-h3G10.2.72 vc0101	h3G10.A57-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.1.91-h3G10.2.72 vcMMAD	h3G10.1.91-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.1.91-h3G10.2.72 vc0101	h3G10.1.91-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.2.37-h3G10.2.72 vcMMAD	h3G10.2.37-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	h3G10.2.37-h3G10.2.72 vc0101	h3G10.2.37-h3G10.2.72	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	3G10-TG6-vcMMAD	3G10-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	6B6-TG6-vcMMAD	6B6-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	12A11-TG6-vcMMAD	12A11-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Monomethyl auristatin D	Mc-Val-Cit-PABC	[21]
ADC Info	3G10-TG6-vc0101	3G10-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	6B6-TG6-vc0101	6B6-TG6	C-X-C chemokine receptor type 4 (CXCR4)	Auristatin 0101	Mc-Val-Cit-PABC	[21]
ADC Info	Trastuzumab-Compound 9	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Trastuzumab-Compound 9 linker	[287]
ADC Info	Pertuzumab-Compound 9	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Pertuzumab-Compound 9 linker	[287]
ADC Info	Rituximab-Compound 9	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Rituximab-Compound 9 linker	[287]
ADC Info	Alemtuzumab-Compound 9	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM1	Alemtuzumab-Compound 9 linker	[287]
ADC Info	Bevacizumab-Compound 9	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM1	Bevacizumab-Compound 9 linker	[287]
ADC Info	Adalimumab-Compound 9	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Adalimumab-Compound 9 linker	[287]
ADC Info	Cetuximab-Compound 9	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Cetuximab-Compound 9 linker	[287]
ADC Info	Amatuximab-Compound 9	Amatuximab	Mesothelin (MSLN)	Mertansine DM1	Amatuximab-Compound 9 linker	[287]
ADC Info	Blinatumomab-Compound 9	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Mertansine DM1	Blinatumomab-Compound 9 linker	[287]
ADC Info	Brentuximab-Compound 9	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Brentuximab-Compound 9 linker	[287]
ADC Info	Sacituzumab-Compound 9	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Sacituzumab-Compound 9 linker	[287]
ADC Info	Panitumumab-Compound 9	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Panitumumab-Compound 9 linker	[287]
ADC Info	Nimotuzumab-Compound 9	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Nimotuzumab-Compound 9 linker	[287]
ADC Info	Gemtuzumab-Compound 9	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM1	Gemtuzumab-Compound 9 linker	[287]
ADC Info	Golimumab-Compound 9	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Golimumab-Compound 9 linker	[287]
ADC Info	Ibritumomab-Compound 9	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ibritumomab-Compound 9 linker	[287]
ADC Info	Infliximab-Compound 9	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM1	Infliximab-Compound 9 linker	[287]
ADC Info	Ipilimumab-Compound 9	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Ipilimumab-Compound 9 linker	[287]
ADC Info	Ofatumumab-Compound 9	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ofatumumab-Compound 9 linker	[287]
ADC Info	Tositumomab-Compound 9	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Tositumomab-Compound 9 linker	[287]
ADC Info	Trastuzumab-Compound 17	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Trastuzumab-Compound 17 linker	[287]
ADC Info	Pertuzumab-Compound 17	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Pertuzumab-Compound 17 linker	[287]
ADC Info	Rituximab-Compound 17	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Rituximab-Compound 17 linker	[287]
ADC Info	Alemtuzumab-Compound 17	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM4	Alemtuzumab-Compound 17 linker	[287]
ADC Info	Bevacizumab-Compound 17	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM4	Bevacizumab-Compound 17 linker	[287]
ADC Info	Adalimumab-Compound 17	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Adalimumab-Compound 17 linker	[287]
ADC Info	Cetuximab-Compound 17	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Cetuximab-Compound 17 linker	[287]
ADC Info	Amatuximab-Compound 17	Amatuximab	Mesothelin (MSLN)	Mertansine DM4	Amatuximab-Compound 17 linker	[287]
ADC Info	Blinatumomab-Compound 17	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Mertansine DM4	Blinatumomab-Compound 17 linker	[287]
ADC Info	Brentuximab-Compound 17	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM4	Brentuximab-Compound 17 linker	[287]
ADC Info	Sacituzumab-Compound 17	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM4	Sacituzumab-Compound 17 linker	[287]
ADC Info	Panitumumab-Compound 17	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Panitumumab-Compound 17 linker	[287]
ADC Info	Nimotuzumab-Compound 17	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Nimotuzumab-Compound 17 linker	[287]
ADC Info	Gemtuzumab-Compound 17	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM4	Gemtuzumab-Compound 17 linker	[287]
ADC Info	Golimumab-Compound 17	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Golimumab-Compound 17 linker	[287]
ADC Info	Ibritumomab-Compound 17	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ibritumomab-Compound 17 linker	[287]
ADC Info	Infliximab-Compound 17	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM4	Infliximab-Compound 17 linker	[287]
ADC Info	Ipilimumab-Compound 17	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM4	Ipilimumab-Compound 17 linker	[287]
ADC Info	Ofatumumab-Compound 17	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ofatumumab-Compound 17 linker	[287]
ADC Info	Tositumomab-Compound 17	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Tositumomab-Compound 17 linker	[287]
ADC Info	Trastuzumab-Compound 25	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Trastuzumab-Compound 25 linker	[287]
ADC Info	Pertuzumab-Compound 25	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pertuzumab-Compound 25 linker	[287]
ADC Info	Rituximab-Compound 25	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 25 linker	[287]
ADC Info	Alemtuzumab-Compound 25	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 25 linker	[287]
ADC Info	Bevacizumab-Compound 25	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 25 linker	[287]
ADC Info	Adalimumab-Compound 25	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 25 linker	[287]
ADC Info	Cetuximab-Compound 25	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 25 linker	[287]
ADC Info	Amatuximab-Compound 25	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 25 linker	[287]
ADC Info	Blinatumomab-Compound 25	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Monomethyl auristatin E	Blinatumomab-Compound 25 linker	[287]
ADC Info	Brentuximab-Compound 25	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 25 linker	[287]
ADC Info	Sacituzumab-Compound 25	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 25 linker	[287]
ADC Info	Panitumumab-Compound 25	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 25 linker	[287]
ADC Info	Nimotuzumab-Compound 25	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 25 linker	[287]
ADC Info	Gemtuzumab-Compound 25	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 25 linker	[287]
ADC Info	Golimumab-Compound 25	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 25 linker	[287]
ADC Info	Ibritumomab-Compound 25	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 25 linker	[287]
ADC Info	Infliximab-Compound 25	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 25 linker	[287]
ADC Info	Ipilimumab-Compound 25	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 25 linker	[287]
ADC Info	Ofatumumab-Compound 25	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 25 linker	[287]
ADC Info	Tositumomab-Compound 25	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 25 linker	[287]
ADC Info	Trastuzumab-Compound 31	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Trastuzumab-Compound 31 linker	[287]
ADC Info	Pertuzumab-Compound 31	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Pertuzumab-Compound 31 linker	[287]
ADC Info	Rituximab-Compound 31	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Rituximab-Compound 31 linker	[287]
ADC Info	Alemtuzumab-Compound 31	Alemtuzumab	CAMPATH-1 antigen (CD52)	Auristatin 0101	Alemtuzumab-Compound 31 linker	[287]
ADC Info	Bevacizumab-Compound 31	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Auristatin 0101	Bevacizumab-Compound 31 linker	[287]
ADC Info	Adalimumab-Compound 31	Adalimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Adalimumab-Compound 31 linker	[287]
ADC Info	Cetuximab-Compound 31	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Cetuximab-Compound 31 linker	[287]
ADC Info	Amatuximab-Compound 31	Amatuximab	Mesothelin (MSLN)	Auristatin 0101	Amatuximab-Compound 31 linker	[287]
ADC Info	Blinatumomab-Compound 31	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Auristatin 0101	Blinatumomab-Compound 31 linker	[287]
ADC Info	Brentuximab-Compound 31	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin 0101	Brentuximab-Compound 31 linker	[287]
ADC Info	Sacituzumab-Compound 31	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	Sacituzumab-Compound 31 linker	[287]
ADC Info	Panitumumab-Compound 31	Panitumumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Panitumumab-Compound 31 linker	[287]
ADC Info	Nimotuzumab-Compound 31	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Nimotuzumab-Compound 31 linker	[287]
ADC Info	Gemtuzumab-Compound 31	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Auristatin 0101	Gemtuzumab-Compound 31 linker	[287]
ADC Info	Golimumab-Compound 31	Golimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Golimumab-Compound 31 linker	[287]
ADC Info	Ibritumomab-Compound 31	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ibritumomab-Compound 31 linker	[287]
ADC Info	Infliximab-Compound 31	Infliximab	Tumor necrosis factor (TNF)	Auristatin 0101	Infliximab-Compound 31 linker	[287]
ADC Info	Ipilimumab-Compound 31	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Auristatin 0101	Ipilimumab-Compound 31 linker	[287]
ADC Info	Ofatumumab-Compound 31	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ofatumumab-Compound 31 linker	[287]
ADC Info	Tositumomab-Compound 31	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Tositumomab-Compound 31 linker	[287]
ADC Info	Trastuzumab-Compound 36	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Trastuzumab-Compound 36 linker	[287]
ADC Info	Pertuzumab-Compound 36	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pertuzumab-Compound 36 linker	[287]
ADC Info	Rituximab-Compound 36	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 36 linker	[287]
ADC Info	Alemtuzumab-Compound 36	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 36 linker	[287]
ADC Info	Bevacizumab-Compound 36	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 36 linker	[287]
ADC Info	Adalimumab-Compound 36	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 36 linker	[287]
ADC Info	Cetuximab-Compound 36	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 36 linker	[287]
ADC Info	Amatuximab-Compound 36	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 36 linker	[287]
ADC Info	Blinatumomab-Compound 36	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Monomethyl auristatin E	Blinatumomab-Compound 36 linker	[287]
ADC Info	Brentuximab-Compound 36	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 36 linker	[287]
ADC Info	Sacituzumab-Compound 36	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 36 linker	[287]
ADC Info	Panitumumab-Compound 36	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 36 linker	[287]
ADC Info	Nimotuzumab-Compound 36	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 36 linker	[287]
ADC Info	Gemtuzumab-Compound 36	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 36 linker	[287]
ADC Info	Golimumab-Compound 36	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 36 linker	[287]
ADC Info	Ibritumomab-Compound 36	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 36 linker	[287]
ADC Info	Infliximab-Compound 36	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 36 linker	[287]
ADC Info	Ipilimumab-Compound 36	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 36 linker	[287]
ADC Info	Ofatumumab-Compound 36	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 36 linker	[287]
ADC Info	Tositumomab-Compound 36	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 36 linker	[287]
ADC Info	Trastuzumab-Compound 55	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Trastuzumab-Compound 55 linker	[287]
ADC Info	Pertuzumab-Compound 55	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Pertuzumab-Compound 55 linker	[287]
ADC Info	Rituximab-Compound 55	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Rituximab-Compound 55 linker	[287]
ADC Info	Alemtuzumab-Compound 55	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM1	Alemtuzumab-Compound 55 linker	[287]
ADC Info	Bevacizumab-Compound 55	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM1	Bevacizumab-Compound 55 linker	[287]
ADC Info	Adalimumab-Compound 55	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Adalimumab-Compound 55 linker	[287]
ADC Info	Cetuximab-Compound 55	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Cetuximab-Compound 55 linker	[287]
ADC Info	Amatuximab-Compound 55	Amatuximab	Mesothelin (MSLN)	Mertansine DM1	Amatuximab-Compound 55 linker	[287]
ADC Info	Blinatumomab-Compound 55	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Mertansine DM1	Blinatumomab-Compound 55 linker	[287]
ADC Info	Brentuximab-Compound 55	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Brentuximab-Compound 55 linker	[287]
ADC Info	Sacituzumab-Compound 55	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Sacituzumab-Compound 55 linker	[287]
ADC Info	Panitumumab-Compound 55	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Panitumumab-Compound 55 linker	[287]
ADC Info	Nimotuzumab-Compound 55	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Nimotuzumab-Compound 55 linker	[287]
ADC Info	Gemtuzumab-Compound 55	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM1	Gemtuzumab-Compound 55 linker	[287]
ADC Info	Golimumab-Compound 55	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Golimumab-Compound 55 linker	[287]
ADC Info	Ibritumomab-Compound 55	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ibritumomab-Compound 55 linker	[287]
ADC Info	Infliximab-Compound 55	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM1	Infliximab-Compound 55 linker	[287]
ADC Info	Ipilimumab-Compound 55	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Ipilimumab-Compound 55 linker	[287]
ADC Info	Ofatumumab-Compound 55	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ofatumumab-Compound 55 linker	[287]
ADC Info	Tositumomab-Compound 55	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Tositumomab-Compound 55 linker	[287]
ADC Info	Trastuzumab-Compound 59	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Trastuzumab-Compound 59 linker	[287]
ADC Info	Pertuzumab-Compound 59	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Pertuzumab-Compound 59 linker	[287]
ADC Info	Rituximab-Compound 59	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Rituximab-Compound 59 linker	[287]
ADC Info	Alemtuzumab-Compound 59	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM4	Alemtuzumab-Compound 59 linker	[287]
ADC Info	Bevacizumab-Compound 59	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM4	Bevacizumab-Compound 59 linker	[287]
ADC Info	Adalimumab-Compound 59	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Adalimumab-Compound 59 linker	[287]
ADC Info	Cetuximab-Compound 59	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Cetuximab-Compound 59 linker	[287]
ADC Info	Amatuximab-Compound 59	Amatuximab	Mesothelin (MSLN)	Mertansine DM4	Amatuximab-Compound 59 linker	[287]
ADC Info	Blinatumomab-Compound 59	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Mertansine DM4	Blinatumomab-Compound 59 linker	[287]
ADC Info	Brentuximab-Compound 59	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM4	Brentuximab-Compound 59 linker	[287]
ADC Info	Sacituzumab-Compound 59	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM4	Sacituzumab-Compound 59 linker	[287]
ADC Info	Panitumumab-Compound 59	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Panitumumab-Compound 59 linker	[287]
ADC Info	Nimotuzumab-Compound 59	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Nimotuzumab-Compound 59 linker	[287]
ADC Info	Gemtuzumab-Compound 59	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM4	Gemtuzumab-Compound 59 linker	[287]
ADC Info	Golimumab-Compound 59	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Golimumab-Compound 59 linker	[287]
ADC Info	Ibritumomab-Compound 59	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ibritumomab-Compound 59 linker	[287]
ADC Info	Infliximab-Compound 59	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM4	Infliximab-Compound 59 linker	[287]
ADC Info	Ipilimumab-Compound 59	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM4	Ipilimumab-Compound 59 linker	[287]
ADC Info	Ofatumumab-Compound 59	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ofatumumab-Compound 59 linker	[287]
ADC Info	Tositumomab-Compound 59	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Tositumomab-Compound 59 linker	[287]
ADC Info	Trastuzumab-Compound 64	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Trastuzumab-Compound 64 linker	[287]
ADC Info	Pertuzumab-Compound 64	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pertuzumab-Compound 64 linker	[287]
ADC Info	Rituximab-Compound 64	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 64 linker	[287]
ADC Info	Alemtuzumab-Compound 64	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 64 linker	[287]
ADC Info	Bevacizumab-Compound 64	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 64 linker	[287]
ADC Info	Adalimumab-Compound 64	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 64 linker	[287]
ADC Info	Cetuximab-Compound 64	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 64 linker	[287]
ADC Info	Amatuximab-Compound 64	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 64 linker	[287]
ADC Info	Blinatumomab-Compound 64	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Monomethyl auristatin E	Blinatumomab-Compound 64 linker	[287]
ADC Info	Brentuximab-Compound 64	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 64 linker	[287]
ADC Info	Sacituzumab-Compound 64	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 64 linker	[287]
ADC Info	Panitumumab-Compound 64	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 64 linker	[287]
ADC Info	Nimotuzumab-Compound 64	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 64 linker	[287]
ADC Info	Gemtuzumab-Compound 64	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 64 linker	[287]
ADC Info	Golimumab-Compound 64	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 64 linker	[287]
ADC Info	Ibritumomab-Compound 64	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 64 linker	[287]
ADC Info	Infliximab-Compound 64	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 64 linker	[287]
ADC Info	Ipilimumab-Compound 64	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 64 linker	[287]
ADC Info	Ofatumumab-Compound 64	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 64 linker	[287]
ADC Info	Tositumomab-Compound 64	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 64 linker	[287]
ADC Info	Trastuzumab-Compound 69	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Trastuzumab-Compound 69 linker	[287]
ADC Info	Pertuzumab-Compound 69	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pertuzumab-Compound 69 linker	[287]
ADC Info	Rituximab-Compound 69	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 69 linker	[287]
ADC Info	Alemtuzumab-Compound 69	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 69 linker	[287]
ADC Info	Bevacizumab-Compound 69	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 69 linker	[287]
ADC Info	Adalimumab-Compound 69	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 69 linker	[287]
ADC Info	Cetuximab-Compound 69	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 69 linker	[287]
ADC Info	Amatuximab-Compound 69	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 69 linker	[287]
ADC Info	Blinatumomab-Compound 69	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Monomethyl auristatin E	Blinatumomab-Compound 69 linker	[287]
ADC Info	Brentuximab-Compound 69	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 69 linker	[287]
ADC Info	Sacituzumab-Compound 69	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 69 linker	[287]
ADC Info	Panitumumab-Compound 69	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 69 linker	[287]
ADC Info	Nimotuzumab-Compound 69	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 69 linker	[287]
ADC Info	Gemtuzumab-Compound 69	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 69 linker	[287]
ADC Info	Golimumab-Compound 69	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 69 linker	[287]
ADC Info	Ibritumomab-Compound 69	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 69 linker	[287]
ADC Info	Infliximab-Compound 69	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 69 linker	[287]
ADC Info	Ipilimumab-Compound 69	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 69 linker	[287]
ADC Info	Ofatumumab-Compound 69	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 69 linker	[287]
ADC Info	Tositumomab-Compound 69	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 69 linker	[287]
ADC Info	Trastuzumab-Compound 75	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Trastuzumab-Compound 75 linker	[287]
ADC Info	Pertuzumab-Compound 75	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pertuzumab-Compound 75 linker	[287]
ADC Info	Rituximab-Compound 75	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 75 linker	[287]
ADC Info	Alemtuzumab-Compound 75	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 75 linker	[287]
ADC Info	Bevacizumab-Compound 75	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 75 linker	[287]
ADC Info	Adalimumab-Compound 75	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 75 linker	[287]
ADC Info	Cetuximab-Compound 75	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 75 linker	[287]
ADC Info	Amatuximab-Compound 75	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 75 linker	[287]
ADC Info	Blinatumomab-Compound 75	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Monomethyl auristatin E	Blinatumomab-Compound 75 linker	[287]
ADC Info	Brentuximab-Compound 75	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 75 linker	[287]
ADC Info	Sacituzumab-Compound 75	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 75 linker	[287]
ADC Info	Panitumumab-Compound 75	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 75 linker	[287]
ADC Info	Nimotuzumab-Compound 75	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 75 linker	[287]
ADC Info	Gemtuzumab-Compound 75	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 75 linker	[287]
ADC Info	Golimumab-Compound 75	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 75 linker	[287]
ADC Info	Ibritumomab-Compound 75	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 75 linker	[287]
ADC Info	Infliximab-Compound 75	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 75 linker	[287]
ADC Info	Ipilimumab-Compound 75	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 75 linker	[287]
ADC Info	Ofatumumab-Compound 75	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 75 linker	[287]
ADC Info	Tositumomab-Compound 75	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 75 linker	[287]
ADC Info	Trastuzumab-Compound 76	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Trastuzumab-Compound 76 linker	[287]
ADC Info	Pertuzumab-Compound 76	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Pertuzumab-Compound 76 linker	[287]
ADC Info	Rituximab-Compound 76	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Rituximab-Compound 76 linker	[287]
ADC Info	Alemtuzumab-Compound 76	Alemtuzumab	CAMPATH-1 antigen (CD52)	Monomethyl auristatin E	Alemtuzumab-Compound 76 linker	[287]
ADC Info	Bevacizumab-Compound 76	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Monomethyl auristatin E	Bevacizumab-Compound 76 linker	[287]
ADC Info	Adalimumab-Compound 76	Adalimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Adalimumab-Compound 76 linker	[287]
ADC Info	Cetuximab-Compound 76	Cetuximab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Cetuximab-Compound 76 linker	[287]
ADC Info	Amatuximab-Compound 76	Amatuximab	Mesothelin (MSLN)	Monomethyl auristatin E	Amatuximab-Compound 76 linker	[287]
ADC Info	Blinatumomab-Compound 76	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Monomethyl auristatin E	Blinatumomab-Compound 76 linker	[287]
ADC Info	Brentuximab-Compound 76	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Brentuximab-Compound 76 linker	[287]
ADC Info	Sacituzumab-Compound 76	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Sacituzumab-Compound 76 linker	[287]
ADC Info	Panitumumab-Compound 76	Panitumumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Panitumumab-Compound 76 linker	[287]
ADC Info	Nimotuzumab-Compound 76	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Nimotuzumab-Compound 76 linker	[287]
ADC Info	Gemtuzumab-Compound 76	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Monomethyl auristatin E	Gemtuzumab-Compound 76 linker	[287]
ADC Info	Golimumab-Compound 76	Golimumab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Golimumab-Compound 76 linker	[287]
ADC Info	Ibritumomab-Compound 76	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ibritumomab-Compound 76 linker	[287]
ADC Info	Infliximab-Compound 76	Infliximab	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Infliximab-Compound 76 linker	[287]
ADC Info	Ipilimumab-Compound 76	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Monomethyl auristatin E	Ipilimumab-Compound 76 linker	[287]
ADC Info	Ofatumumab-Compound 76	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Ofatumumab-Compound 76 linker	[287]
ADC Info	Tositumomab-Compound 76	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Tositumomab-Compound 76 linker	[287]
ADC Info	Trastuzumab-Compound 77	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Trastuzumab-Compound 77 linker	[287]
ADC Info	Pertuzumab-Compound 77	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Pertuzumab-Compound 77 linker	[287]
ADC Info	Rituximab-Compound 77	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Rituximab-Compound 77 linker	[287]
ADC Info	Alemtuzumab-Compound 77	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM1	Alemtuzumab-Compound 77 linker	[287]
ADC Info	Bevacizumab-Compound 77	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM1	Bevacizumab-Compound 77 linker	[287]
ADC Info	Adalimumab-Compound 77	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Adalimumab-Compound 77 linker	[287]
ADC Info	Cetuximab-Compound 77	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Cetuximab-Compound 77 linker	[287]
ADC Info	Amatuximab-Compound 77	Amatuximab	Mesothelin (MSLN)	Mertansine DM1	Amatuximab-Compound 77 linker	[287]
ADC Info	Blinatumomab-Compound 77	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Mertansine DM1	Blinatumomab-Compound 77 linker	[287]
ADC Info	Brentuximab-Compound 77	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM1	Brentuximab-Compound 77 linker	[287]
ADC Info	Sacituzumab-Compound 77	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM1	Sacituzumab-Compound 77 linker	[287]
ADC Info	Panitumumab-Compound 77	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Panitumumab-Compound 77 linker	[287]
ADC Info	Nimotuzumab-Compound 77	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Nimotuzumab-Compound 77 linker	[287]
ADC Info	Gemtuzumab-Compound 77	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM1	Gemtuzumab-Compound 77 linker	[287]
ADC Info	Golimumab-Compound 77	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM1	Golimumab-Compound 77 linker	[287]
ADC Info	Ibritumomab-Compound 77	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ibritumomab-Compound 77 linker	[287]
ADC Info	Infliximab-Compound 77	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM1	Infliximab-Compound 77 linker	[287]
ADC Info	Ipilimumab-Compound 77	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM1	Ipilimumab-Compound 77 linker	[287]
ADC Info	Ofatumumab-Compound 77	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Ofatumumab-Compound 77 linker	[287]
ADC Info	Tositumomab-Compound 77	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM1	Tositumomab-Compound 77 linker	[287]
ADC Info	Trastuzumab-Compound 78	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Trastuzumab-Compound 78 linker	[287]
ADC Info	Pertuzumab-Compound 78	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Pertuzumab-Compound 78 linker	[287]
ADC Info	Rituximab-Compound 78	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Rituximab-Compound 78 linker	[287]
ADC Info	Alemtuzumab-Compound 78	Alemtuzumab	CAMPATH-1 antigen (CD52)	Auristatin 0101	Alemtuzumab-Compound 78 linker	[287]
ADC Info	Bevacizumab-Compound 78	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Auristatin 0101	Bevacizumab-Compound 78 linker	[287]
ADC Info	Adalimumab-Compound 78	Adalimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Adalimumab-Compound 78 linker	[287]
ADC Info	Cetuximab-Compound 78	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Cetuximab-Compound 78 linker	[287]
ADC Info	Amatuximab-Compound 78	Amatuximab	Mesothelin (MSLN)	Auristatin 0101	Amatuximab-Compound 78 linker	[287]
ADC Info	Blinatumomab-Compound 78	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Auristatin 0101	Blinatumomab-Compound 78 linker	[287]
ADC Info	Brentuximab-Compound 78	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin 0101	Brentuximab-Compound 78 linker	[287]
ADC Info	Sacituzumab-Compound 78	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	Sacituzumab-Compound 78 linker	[287]
ADC Info	Panitumumab-Compound 78	Panitumumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Panitumumab-Compound 78 linker	[287]
ADC Info	Nimotuzumab-Compound 78	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Nimotuzumab-Compound 78 linker	[287]
ADC Info	Gemtuzumab-Compound 78	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Auristatin 0101	Gemtuzumab-Compound 78 linker	[287]
ADC Info	Golimumab-Compound 78	Golimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Golimumab-Compound 78 linker	[287]
ADC Info	Ibritumomab-Compound 78	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ibritumomab-Compound 78 linker	[287]
ADC Info	Infliximab-Compound 78	Infliximab	Tumor necrosis factor (TNF)	Auristatin 0101	Infliximab-Compound 78 linker	[287]
ADC Info	Ipilimumab-Compound 78	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Auristatin 0101	Ipilimumab-Compound 78 linker	[287]
ADC Info	Ofatumumab-Compound 78	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ofatumumab-Compound 78 linker	[287]
ADC Info	Tositumomab-Compound 78	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Tositumomab-Compound 78 linker	[287]
ADC Info	Trastuzumab-Compound 79	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Trastuzumab-Compound 79 linker	[287]
ADC Info	Pertuzumab-Compound 79	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Pertuzumab-Compound 79 linker	[287]
ADC Info	Rituximab-Compound 79	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Rituximab-Compound 79 linker	[287]
ADC Info	Alemtuzumab-Compound 79	Alemtuzumab	CAMPATH-1 antigen (CD52)	Auristatin 0101	Alemtuzumab-Compound 79 linker	[287]
ADC Info	Bevacizumab-Compound 79	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Auristatin 0101	Bevacizumab-Compound 79 linker	[287]
ADC Info	Adalimumab-Compound 79	Adalimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Adalimumab-Compound 79 linker	[287]
ADC Info	Cetuximab-Compound 79	Cetuximab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Cetuximab-Compound 79 linker	[287]
ADC Info	Amatuximab-Compound 79	Amatuximab	Mesothelin (MSLN)	Auristatin 0101	Amatuximab-Compound 79 linker	[287]
ADC Info	Blinatumomab-Compound 79	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Auristatin 0101	Blinatumomab-Compound 79 linker	[287]
ADC Info	Brentuximab-Compound 79	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Auristatin 0101	Brentuximab-Compound 79 linker	[287]
ADC Info	Sacituzumab-Compound 79	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Auristatin 0101	Sacituzumab-Compound 79 linker	[287]
ADC Info	Panitumumab-Compound 79	Panitumumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Panitumumab-Compound 79 linker	[287]
ADC Info	Nimotuzumab-Compound 79	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Auristatin 0101	Nimotuzumab-Compound 79 linker	[287]
ADC Info	Gemtuzumab-Compound 79	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Auristatin 0101	Gemtuzumab-Compound 79 linker	[287]
ADC Info	Golimumab-Compound 79	Golimumab	Tumor necrosis factor (TNF)	Auristatin 0101	Golimumab-Compound 79 linker	[287]
ADC Info	Ibritumomab-Compound 79	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ibritumomab-Compound 79 linker	[287]
ADC Info	Infliximab-Compound 79	Infliximab	Tumor necrosis factor (TNF)	Auristatin 0101	Infliximab-Compound 79 linker	[287]
ADC Info	Ipilimumab-Compound 79	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Auristatin 0101	Ipilimumab-Compound 79 linker	[287]
ADC Info	Ofatumumab-Compound 79	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Ofatumumab-Compound 79 linker	[287]
ADC Info	Tositumomab-Compound 79	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Auristatin 0101	Tositumomab-Compound 79 linker	[287]
ADC Info	Trastuzumab-Compound 80	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Trastuzumab-Compound 80 linker	[287]
ADC Info	Pertuzumab-Compound 80	Pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Pertuzumab-Compound 80 linker	[287]
ADC Info	Rituximab-Compound 80	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Rituximab-Compound 80 linker	[287]
ADC Info	Alemtuzumab-Compound 80	Alemtuzumab	CAMPATH-1 antigen (CD52)	Mertansine DM4	Alemtuzumab-Compound 80 linker	[287]
ADC Info	Bevacizumab-Compound 80	Bevacizumab	Vascular endothelial growth factor A (VEGFA)	Mertansine DM4	Bevacizumab-Compound 80 linker	[287]
ADC Info	Adalimumab-Compound 80	Adalimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Adalimumab-Compound 80 linker	[287]
ADC Info	Cetuximab-Compound 80	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Cetuximab-Compound 80 linker	[287]
ADC Info	Amatuximab-Compound 80	Amatuximab	Mesothelin (MSLN)	Mertansine DM4	Amatuximab-Compound 80 linker	[287]
ADC Info	Blinatumomab-Compound 80	Blinatumomab	B-lymphocyte antigen CD19 (CD19); T-cell surface glycoprotein CD3 delta chain (CD3;TPBG)	Mertansine DM4	Blinatumomab-Compound 80 linker	[287]
ADC Info	Brentuximab-Compound 80	Brentuximab	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Mertansine DM4	Brentuximab-Compound 80 linker	[287]
ADC Info	Sacituzumab-Compound 80	Sacituzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Mertansine DM4	Sacituzumab-Compound 80 linker	[287]
ADC Info	Panitumumab-Compound 80	Panitumumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Panitumumab-Compound 80 linker	[287]
ADC Info	Nimotuzumab-Compound 80	Nimotuzumab	Epidermal growth factor receptor (EGFR)	Mertansine DM4	Nimotuzumab-Compound 80 linker	[287]
ADC Info	Gemtuzumab-Compound 80	Gemtuzumab	Myeloid cell surface antigen CD33 (CD33)	Mertansine DM4	Gemtuzumab-Compound 80 linker	[287]
ADC Info	Golimumab-Compound 80	Golimumab	Tumor necrosis factor (TNF)	Mertansine DM4	Golimumab-Compound 80 linker	[287]
ADC Info	Ibritumomab-Compound 80	Ibritumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ibritumomab-Compound 80 linker	[287]
ADC Info	Infliximab-Compound 80	Infliximab	Tumor necrosis factor (TNF)	Mertansine DM4	Infliximab-Compound 80 linker	[287]
ADC Info	Ipilimumab-Compound 80	Ipilimumab	Cytotoxic T-lymphocyte protein 4 (CTLA4)	Mertansine DM4	Ipilimumab-Compound 80 linker	[287]
ADC Info	Ofatumumab-Compound 80	Ofatumumab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Ofatumumab-Compound 80 linker	[287]
ADC Info	Tositumomab-Compound 80	Tositumomab	B-lymphocyte antigen CD20 (MS4A1)	Mertansine DM4	Tositumomab-Compound 80 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 9	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM1	Anti-MSL1 mAb-Compound 9 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 9	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM1	Anti-CD59 mAb-Compound 9 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 9	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Anti-HER2 mAb-Compound 9 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 17	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM4	Anti-MSL1 mAb-Compound 17 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 17	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM4	Anti-CD59 mAb-Compound 17 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 17	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Anti-HER2 mAb-Compound 17 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 25	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 25 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 25	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 25 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 25	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 25 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 31	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Auristatin 0101	Anti-MSL1 mAb-Compound 31 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 31	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Auristatin 0101	Anti-CD59 mAb-Compound 31 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 31	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Anti-HER2 mAb-Compound 31 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 36	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 36 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 36	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 36 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 36	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 36 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 55	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM1	Anti-MSL1 mAb-Compound 55 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 55	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM1	Anti-CD59 mAb-Compound 55 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 55	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Anti-HER2 mAb-Compound 55 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 59	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM4	Anti-MSL1 mAb-Compound 59 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 59	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM4	Anti-CD59 mAb-Compound 59 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 59	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Anti-HER2 mAb-Compound 59 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 64	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 64 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 64	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 64 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 64	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 64 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 69	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 69 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 69	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 69 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 69	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 69 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 75	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 75 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 75	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 75 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 75	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 75 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 76	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Monomethyl auristatin E	Anti-MSL1 mAb-Compound 76 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 76	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Monomethyl auristatin E	Anti-CD59 mAb-Compound 76 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 76	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Anti-HER2 mAb-Compound 76 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 77	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM1	Anti-MSL1 mAb-Compound 77 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 77	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM1	Anti-CD59 mAb-Compound 77 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 77	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Anti-HER2 mAb-Compound 77 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 78	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Auristatin 0101	Anti-MSL1 mAb-Compound 78 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 78	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Auristatin 0101	Anti-CD59 mAb-Compound 78 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 78	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Anti-HER2 mAb-Compound 78 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 79	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Auristatin 0101	Anti-MSL1 mAb-Compound 79 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 79	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Auristatin 0101	Anti-CD59 mAb-Compound 79 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 79	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Auristatin 0101	Anti-HER2 mAb-Compound 79 linker	[287]
ADC Info	Anti-MSL1 mAb-Compound 80	Anti-MSL1 mAb	Male-specific lethal 1 homolog (MSL1)	Mertansine DM4	Anti-MSL1 mAb-Compound 80 linker	[287]
ADC Info	Anti-CD59 mAb-Compound 80	Anti-CD59 mAb	CD59 glycoprotein (CD59)	Mertansine DM4	Anti-CD59 mAb-Compound 80 linker	[287]
ADC Info	Anti-HER2 mAb-Compound 80	Anti-HER2 mAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM4	Anti-HER2 mAb-Compound 80 linker	[287]
ADC Info	Anti-KIT 9P3-SMCC-DM1	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT NEG024-SMCC-DM1	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT NEG026-SMCC-DM1	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT NEG027-SMCC-DM1	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT NEG085-SMCC-DM1	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT NEG086-SMCC-DM1	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT NEG087-SMCC-DM1	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT 20376-SMCC-DM1	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[288]
ADC Info	Anti-KIT 9P3-SPDB-DM4	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT NEG024-SPDB-DM4	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT NEG026-SPDB-DM4	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT NEG027-SPDB-DM4	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT NEG085-SPDB-DM4	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT NEG086-SPDB-DM4	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT NEG087-SPDB-DM4	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT 20376-SPDB-DM4	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[288]
ADC Info	Anti-KIT 9P3-CX1-1-DM1	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT NEG024-CX1-1-DM1	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT NEG026-CX1-1-DM1	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT NEG027-CX1-1-DM1	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT NEG085-CX1-1-DM1	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT NEG086-CX1-1-DM1	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT NEG087-CX1-1-DM1	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT 20376-CX1-1-DM1	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[288]
ADC Info	Anti-KIT 9P3-SSNPP-DM3	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT NEG024-SSNPP-DM3	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT NEG026-SSNPP-DM3	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT NEG027-SSNPP-DM3	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT NEG085-SSNPP-DM3	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT NEG086-SSNPP-DM3	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT NEG087-SSNPP-DM3	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT 20376-SSNPP-DM3	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[288]
ADC Info	Anti-KIT 9P3-SPP-DM1	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT NEG024-SPP-DM1	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT NEG026-SPP-DM1	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT NEG027-SPP-DM1	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT NEG085-SPP-DM1	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT NEG086-SPP-DM1	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT NEG087-SPP-DM1	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT 20376-SPP-DM1	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[288]
ADC Info	Anti-KIT 9P3-SPDP-DM1	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT NEG024-SPDP-DM1	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT NEG026-SPDP-DM1	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT NEG027-SPDP-DM1	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT NEG085-SPDP-DM1	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT NEG086-SPDP-DM1	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT NEG087-SPDP-DM1	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT 20376-SPDP-DM1	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[288]
ADC Info	Anti-KIT 9P3 Sulfo-SPDB-DM4	Anti-KIT mAb 9P3	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT NEG024 Sulfo-SPDB-DM4	Anti-KIT mAb NEG024	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT NEG026 Sulfo-SPDB-DM4	Anti-KIT mAb NEG026	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT NEG027 Sulfo-SPDB-DM4	Anti-KIT mAb NEG027	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT NEG085 Sulfo-SPDB-DM4	Anti-KIT mAb NEG085	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT NEG086 Sulfo-SPDB-DM4	Anti-KIT mAb NEG086	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT NEG087 Sulfo-SPDB-DM4	Anti-KIT mAb NEG087	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-KIT 20376 Sulfo-SPDB-DM4	Anti-KIT mAb 20376	Mast/stem cell growth factor receptor Kit (KIT)	Mertansine DM4	Sulfo-SPDB	[288]
ADC Info	Anti-FGFR2/4 mAb-12425 SMCC-DM1	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 SMCC-DM1	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 SMCC-DM1	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 SMCC-DM1	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 SMCC-DM1	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 SMCC-DM1	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-10164 SMCC-DM1	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-10220 SMCC-DM1	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-10846 SMCC-DM1	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 SMCC-DM1	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 SMCC-DM1	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 SMCC-DM1	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-11723 SMCC-DM1	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-11725 SMCC-DM1	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-12433 SMCC-DM1	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-12931 SMCC-DM1	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-12944 SMCC-DM1	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2 mAb-12947 SMCC-DM1	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 SMCC-DM1	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 SMCC-DM1	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 SMCC-DM1	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 SMCC-DM1	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 SMCC-DM1	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 SMCC-DM1	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[289]
ADC Info	Anti-FGFR2/4 mAb-12425 SPDB-DM4	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 SPDB-DM4	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 SPDB-DM4	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 SPDB-DM4	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 SPDB-DM4	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 SPDB-DM4	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-10164 SPDB-DM4	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-10220 SPDB-DM4	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-10846 SPDB-DM4	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 SPDB-DM4	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 SPDB-DM4	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 SPDB-DM4	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-11723 SPDB-DM4	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-11725 SPDB-DM4	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-12433 SPDB-DM4	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-12931 SPDB-DM4	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-12944 SPDB-DM4	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2 mAb-12947 SPDB-DM4	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 SPDB-DM4	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 SPDB-DM4	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 SPDB-DM4	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 SPDB-DM4	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 SPDB-DM4	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 SPDB-DM4	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)	[289]
ADC Info	Anti-FGFR2/4 mAb-12425 CX1-1-DM1	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 CX1-1-DM1	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 CX1-1-DM1	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 CX1-1-DM1	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 CX1-1-DM1	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 CX1-1-DM1	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-10164 CX1-1-DM1	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-10220 CX1-1-DM1	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-10846 CX1-1-DM1	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 CX1-1-DM1	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 CX1-1-DM1	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 CX1-1-DM1	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-11723 CX1-1-DM1	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-11725 CX1-1-DM1	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-12433 CX1-1-DM1	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-12931 CX1-1-DM1	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-12944 CX1-1-DM1	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2 mAb-12947 CX1-1-DM1	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 CX1-1-DM1	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 CX1-1-DM1	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 CX1-1-DM1	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 CX1-1-DM1	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 CX1-1-DM1	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 CX1-1-DM1	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)	[289]
ADC Info	Anti-FGFR2/4 mAb-12425 SSNPP-DM3	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 SSNPP-DM3	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 SSNPP-DM3	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 SSNPP-DM3	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 SSNPP-DM3	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 SSNPP-DM3	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-10164 SSNPP-DM3	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-10220 SSNPP-DM3	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-10846 SSNPP-DM3	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 SSNPP-DM3	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 SSNPP-DM3	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 SSNPP-DM3	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-11723 SSNPP-DM3	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-11725 SSNPP-DM3	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-12433 SSNPP-DM3	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-12931 SSNPP-DM3	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-12944 SSNPP-DM3	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2 mAb-12947 SSNPP-DM3	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 SSNPP-DM3	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 SSNPP-DM3	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 SSNPP-DM3	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 SSNPP-DM3	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 SSNPP-DM3	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 SSNPP-DM3	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Maytansinoid DM3	Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12425 SPP-DM1	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 SPP-DM1	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 SPP-DM1	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 SPP-DM1	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 SPP-DM1	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 SPP-DM1	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-10164 SPP-DM1	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-10220 SPP-DM1	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-10846 SPP-DM1	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 SPP-DM1	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 SPP-DM1	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 SPP-DM1	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-11723 SPP-DM1	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-11725 SPP-DM1	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-12433 SPP-DM1	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-12931 SPP-DM1	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-12944 SPP-DM1	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2 mAb-12947 SPP-DM1	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 SPP-DM1	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 SPP-DM1	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 SPP-DM1	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 SPP-DM1	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 SPP-DM1	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 SPP-DM1	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12425 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-10164 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-10220 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-10846 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-11723 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-11725 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-12433 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-12931 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-12944 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2 mAb-12947 Sulfo-SPDB-DM4	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 Sulfo-SPDB-DM4	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM4	Sulfo-SPDB	[289]
ADC Info	Anti-FGFR2/4 mAb-12425 SPDP-DM1	Anti-FGFR2/4 mAb 12425	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-14629 SPDP-DM1	Anti-FGFR2/4 mAb 14629	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-20562 SPDP-DM1	Anti-FGFR2/4 mAb 20562	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-20811 SPDP-DM1	Anti-FGFR2/4 mAb 20811	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12422 SPDP-DM1	Anti-FGFR2/4 mAb 12422	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12439 SPDP-DM1	Anti-FGFR2/4 mAb 12439	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-10164 SPDP-DM1	Anti-FGFR2 mAb 10164	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-10220 SPDP-DM1	Anti-FGFR2 mAb 10220	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-10846 SPDP-DM1	Anti-FGFR2 mAb 10846	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10918 SPDP-DM1	Anti-FGFR2/4 mAb 10918	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10923 SPDP-DM1	Anti-FGFR2/4 mAb 10923	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-11722 SPDP-DM1	Anti-FGFR2/4 mAb 11722	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-11723 SPDP-DM1	Anti-FGFR2 mAb 11723	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-11725 SPDP-DM1	Anti-FGFR2 mAb 11725	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-12433 SPDP-DM1	Anti-FGFR2 mAb 12433	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-12931 SPDP-DM1	Anti-FGFR2 mAb 12931	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-12944 SPDP-DM1	Anti-FGFR2 mAb 12944	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2 mAb-12947 SPDP-DM1	Anti-FGFR2 mAb 12947	Fibroblast growth factor receptor 2 (FGFR2)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10553 SPDP-DM1	Anti-FGFR2/4 mAb 10553	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10554 SPDP-DM1	Anti-FGFR2/4 mAb 10554	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10925 SPDP-DM1	Anti-FGFR2/4 mAb 10925	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-10729 SPDP-DM1	Anti-FGFR2/4 mAb 10729	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12435 SPDP-DM1	Anti-FGFR2/4 mAb 12435	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Anti-FGFR2/4 mAb-12438 SPDP-DM1	Anti-FGFR2/4 mAb 12438	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)	[289]
ADC Info	Ab1-mcMMAF	Anti-EGFR Ab1	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Maleimido-caproyl	[14]
ADC Info	Ab3-mcMMAF	Anti-EGFR Ab3	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin F	Maleimido-caproyl	[14]
ADC Info	AbA-mcMMAE	Anti-EGFR AbA	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Maleimido-caproyl	[14]

Terminated

Click To Hide/Show 12 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	Alpha-CD70-Mc-MMAF	Chimeric Anti-CD70 Anti-ody	CD70 antigen (CD70)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[290]
ADC Info	CD30-BTG-ADC	Anti-CD30 mAb cAC10Q	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	PEG3-benzotriazole-PEG-Val-Cit-PABC	[291]
ADC Info	Anti-TenB2 antibody drug conjugate	Anti-TENB2 monoclonal Anti-ody (mAb)	Tomoregulin-2 (TMEFF2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[292]
ADC Info	Alpha-CD30-Val-Cit-MMAE	Anti-CD30 alphaCD30-vcMMAE mAb	Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[293]
ADC Info	B-1453	Undisclosed	Tumor necrosis factor ligand superfamily member 10 (TNFSF10)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[294]
ADC Info	B-1452	Undisclosed	B-lymphocyte antigen CD20 (MS4A1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[294]
ADC Info	EGFRvIII/MMAE antibody drug conjugate	Undisclosed	Epidermal growth factor receptor variant III (EGFRvIII)	Monomethyl auristatin E	Undisclosed	[295]
ADC Info	C-met monoclonal antibody-drug conjugate	STI-D0606	Hepatocyte growth factor receptor (MET)	Mertansine DM1	Undisclosed	[296]
ADC Info	Cetuximab based antibody-drug conjugate	Cetuximab	Epidermal growth factor receptor (EGFR)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[297]
ADC Info	FGFR2/FGFR4 dual targeting antibody-drug conjugate	Undisclosed	Fibroblast growth factor receptor 2 (FGFR2); Fibroblast growth factor receptor 4 (FGFR4)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[298]
ADC Info	Trastuzumab-dTSPEG-MMAF	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	dTSPEG	[299]
ADC Info	Fluorescent Antibody-Drug Conjugate	Anti-CEA mAb MIC0101	Pregnancy-specific beta-1-glycoprotein 2 (PSG2)	Paclitaxel	Undisclosed	[300]

Investigative

Click To Hide/Show 457 ADC Related to This Stage

ADC Info	ADC Name	Antibody	Antigen	Payload	Linker	Ref
ADC Info	RC88-Mc-Val-Cit-PAB-MMAE	RC88	Mesothelin (MSLN)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[301]
ADC Info	RC88-Py-MAA-Val-Cit-PAB-MMAE	RC88	Mesothelin (MSLN)	Monomethyl auristatin E	PY-MAA-Val-Cit-PABC	[301]
ADC Info	Trastuzumab botidotin	Trastuzumab	HER2	Duostatin 5	K-lock-Val-Cit-PABC	[302]
ADC Info	CBP-1008	Undisclosed	Folate receptor alpha (FOLR1); Transient receptor potential cation channel subfamily V member 6 (TRPV6)	Monomethyl auristatin E	Undisclosed	[303]
ADC Info	DXC004	Nimotuzumab derivative	EGFR	Tubulysin B analog	Undisclosed	[304]
ADC Info	ADC2122	Pertuzumab	HER2	Duostatin 5	Pip-Val-Cit linker	[305]
ADC Info	CPO-102	Undisclosed	Claudin-18.2 (CLDN18.2)	Monomethyl auristatin E	Undisclosed	[306]
ADC Info	16A5-MCC-DM1	MBH-1309	Lymphocyte antigen 75 (LY75)	Mertansine DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)	[307]
ADC Info	RG-7600	Humanized IgG1 Anti-MSLN mAb h7D9.v3	Mesothelin (MSLN)	Monomethyl auristatin E	Protease-labile valine-citrulline linker	[308]
ADC Info	HS630	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Mertansine DM1	Undisclosed	[309]
ADC Info	CD276 mAb-MMAF	Hu276 mAb	CD276 antigen (CD276)	Monomethyl auristatin F	DBM linker	[310]
ADC Info	37146146 IC1-MMAF	Chimeric ICAM1 Antibody (clone #R6.5)	Intercellular adhesion molecule 1 (ICAM-1)	Monomethyl auristatin F	Undisclosed	[311]
ADC Info	Anti-CD276 mAb-MMAF	Anti-CD276 mAb	CD276 antigen (CD276)	Monomethyl auristatin F	Undisclosed	[312]
ADC Info	aCSPG4 (scFv)-SNAP-AURIF	aCSPG4 (scFv)-SNAP	Chondroitin sulfate proteoglycan 4 (CSPG4)	Monomethyl auristatin F	Undisclosed	[313]
ADC Info	40410803 16B10-MMAF	16B10	Transforming growth factor alpha (TGFA)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[314]
ADC Info	40410803 5F1-MMAF	5F1	Transforming growth factor alpha (TGFA)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[314]
ADC Info	Anti-CD64 (scFv)-SNAP-Auristatin F	H22 (scFv)-SNAP	High affinity immunoglobulin gamma Fc receptor I (Fcgr1)	Monomethyl auristatin F	Undisclosed	[315]
ADC Info	39870768 20D9h3-MMAF	20D9h3	Receptor-type tyrosine-protein kinase FLT3 (FLT3)	Monomethyl auristatin F	Undisclosed	[316]
ADC Info	huB12-MMAF	huB12	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[317]
ADC Info	38501590 Anti-HER2 ARC-FDC (1)	Trastuzumab-Fab-cd38	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	2'-Cl-araNAD linker	[318]
ADC Info	38501590 Anti-HER2 ARC-FDC (2)	Trastuzumab-Fab-cd38	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	2'-Cl-araNAD linker	[318]
ADC Info	PF-08046032	A detuned-affinity anti-CD25 mAb	CD25	MMAE	Mc-Val-Cit-PABC	[319]
ADC Info	YB-800 MMAF	YB-800	Neuronal pentraxin receptor (NPTXR)	Monomethyl auristatin F	Undisclosed	[320]
ADC Info	TGW101	Anti-TAG-72 antibody	TAG-72	MMAE	A cleavable linker	[321]
ADC Info	PLB-002	PLB-002-ab7	CLDN6	Eribulin	A cleavable linker	[322]
ADC Info	PF-08046031	HL49	CD228	MMAE	Mc-Val-Cit-PABC	[323]
ADC Info	BR111	Anti-ROR1 mAb	ROR1	Eribulin	Undisclosed	[324]
ADC Info	KY-0301	EGFR/c-Met bispecific nanobody	EGFR; c-Met	MMAE	A cleavable linker
ADC Info	CN119343152A 1C1-Example 1	1C1	Ephrin type-A receptor 2 (EPHA2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example1 Linker	[325]
ADC Info	CN119343152A 1C1-Example 2	1C1	Ephrin type-A receptor 2 (EPHA2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example2 Linker	[325]
ADC Info	Trastuzumab-Example 1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example1 Linker	[325]
ADC Info	Trastuzumab-Example 2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example2 Linker	[325]
ADC Info	NOV169N31Q-Example 1	NOV169N31Q	Cadherin-3 (CDH3)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example1 Linker	[325]
ADC Info	NOV169N31Q-Example 2	NOV169N31Q	Cadherin-3 (CDH3)	CN119343152A 1C1-Example1 Payload	CN119343152A 1C1-Example2 Linker	[325]
ADC Info	Trastuzumab-Example 5	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	CN119343152A Trastuzumab-Example5 Payload	CN119343152A 1C1-Example1 Linker	[325]
ADC Info	CN110997009BADC#42	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	CN110997009B ADC#42 Payload	CN110997009B ADC#42 Linker	[326]
ADC Info	CN110997009BADC#43	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	CN110997009B ADC#43 Payload	CN110997009B ADC#42 Linker	[326]
ADC Info	CN110997009BADC#44	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duo5	CN110997009B ADC#40 Linker	[326]
ADC Info	CN110997009BADC#45	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duo5	CN110997009B ADC#45 Linker	[326]
ADC Info	CN110997009BADC#46	C38A2/C38D8	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)	Duo5	CN110997009B ADC#46 Linker	[326]
ADC Info	MORAb-003 ADC13	MORAb-003	Folate receptor alpha (FOLR1)	Dolicatatin 5	Asn-Ala linker	[327]
ADC Info	MORAb-003 ADC33	MORAb-003	Folate receptor alpha (FOLR1)	Dolicatatin 5	PEG-pAB linker	[328]
ADC Info	EP4461318A2 anti-PSMA ADC2	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Undisclosed	[329]
ADC Info	EP4461318A2 anti-PSMA ADC3	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	CLeavable (Val-Citruline-PEG1) linker	[329]
ADC Info	EP4461318A2 anti-PSMA ADC4	Humanized Anti-PSMA Antibody Variant 1	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Short Cleavable (Valine-Citruline-Acetyl)	[329]
ADC Info	EP4461318A2 anti-PSMA ADC7	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Undisclosed	[329]
ADC Info	EP4461318A2 anti-PSMA ADC8	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	CLeavable (Val-Citruline-PEG1) linker	[329]
ADC Info	EP4461318A2 anti-PSMA ADC9	Humanized Anti-PSMA Antibody Variant 2	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Short Cleavable (Valine-Citruline-Acetyl)	[329]
ADC Info	EP4461318A2 anti-PSMA ADC12	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Undisclosed	[329]
ADC Info	EP4461318A2 anti-PSMA ADC13	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	CLeavable (Val-Citruline-PEG1) linker	[329]
ADC Info	EP4461318A2 anti-PSMA ADC14	Chimeric Anti-PSMA Antibody	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin F	Short Cleavable (Valine-Citruline-Acetyl)	[329]
ADC Info	CAT-10-106	undisclosed	Tumor-associated calcium signal transducer 2 (TACSTD2)	Maytansine	Undisclosed	[330]
ADC Info	CAB-Axl-ADCf	BA3011	Tyrosine-protein kinase receptor UFO (AXL)	Monomethyl auristatin F	Undisclosed	[331]
ADC Info	ICAM1-MMAF 4.09	undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[332]
ADC Info	US20230109312A1 ADC with 4 MMAF	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	US20230109312A1 ADC with 4 MMAF Linker	[333]
ADC Info	HuMab-CD74-005-mcMMAF	HuMab-CD74-005	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin F	Undisclosed	[334]
ADC Info	HuMab-CD74-006-mcMMAF	HuMab-CD74-006	HLA class II histocompatibility antigen gamma chain (CD74)	Monomethyl auristatin F	Undisclosed	[334]
ADC Info	Trastuzumab N221 (WT)-MMAF #1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[335]
ADC Info	Trastuzumab N221 (WT)-MMAF #2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[335]
ADC Info	Trastuzumab N221 (GDLN)-MMAF	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[335]
ADC Info	Tras-LN-MMAF	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[335]
ADC Info	Tras.D221N-MMAF (HEK GDLN)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[335]
ADC Info	Tras.D221N-MMAF (HEK WT)	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[335]
ADC Info	MER-M6	M6	Tyrosine-protein kinase Mer (MERTK)	Monomethyl auristatin F	Undisclosed	[336]
ADC Info	Anti-Trop2- (Q295-mcValCitPABC-A6)- (mcMMAF)	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Her2- (Q295-mcValCitPABC-A6)- (mcMMAF)	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Trop2- (Q295-mcA6)- (mcMMMAF)	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Her2- (0295-mcA6)- (mcMMAF)	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Trop2- (Q295-mcMMAF)- (mcValCitPABC-A6)	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Her2- (0295-mcMMAF)- (mcValCitPABC-A6)	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Trop2- (0295-mcMMAF)- (mc-A6)	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Anti-Her2- (0295-mcMMAF)- (mc-A6)	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Trop2-Saci- (mc-MMAF)- (McAsnAsn-A6)	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Trop2-Saci- (mc-MMAF)- (mc-A6)	Trastuzumab	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Her2-Saci- (mc-MMAF)- (McAsnAsn-A6)	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	Her2-Saci- (mc-MMAF)- (mc-A6)	Sacituzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Undisclosed	[337]
ADC Info	WO2024193682A1 8H10-ADC	8H10	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	[338]
ADC Info	WO2024193682A1 8D9-ADC	8D9	Trophoblast glycoprotein (TPBG)	Monomethyl auristatin E	Undisclosed	[338]
ADC Info	FM2b-S-D2	FM2b-S	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[339]
ADC Info	FM2b-F-D2	FM2b-F	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[339]
ADC Info	FM2b-K-D2	FM2b-K	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[339]
ADC Info	FM2b-Y-D2	FM2b-Y	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[339]
ADC Info	BB02E-MMAE	BB02E	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[340]
ADC Info	BB03E-MMAE	BB03E	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[340]
ADC Info	BB03E-A-MMAE	BB03E-A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[340]
ADC Info	BB04E-MMAE	BB04E	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[340]
ADC Info	BB05E-MMAE	BB05E	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[340]
ADC Info	Degly-ISOmAb-1-mc-vc-PAB-MMAE	degly-ISOmAb	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[341]
ADC Info	Degly-mAb1-1-mc-vc-PAB-MMAE	degly-mAb1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[341]
ADC Info	mAb1-mc-vc-PAB-MMAE	mAb1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[341]
ADC Info	IN202317039249 ACD6-ADC	undisclosed	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[342]
ADC Info	mIgG-ADC	undisclosed	T-cell differentiation antigen CD6 (CD6)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[342]
ADC Info	W3195-1.53.1-p1-ulgG11-MMAE	W3195-1.53.1-p1-ulgG11	Cadherin-3 (CDH3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[343]
ADC Info	TWI852077B-J1	Anti-cKIT Fab'1	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J2	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J3	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J4	Anti-cKIT Fab'4	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J5	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J6	Anti-Her2Fab'	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J9	Anti-cKIT F (ab'4)<sub>2</sub>	Mast/stem cell growth factor receptor Kit (KIT)	TWI852077B-C4-payload	TWI852077B-C4-linker	[344]
ADC Info	TWI852077B-J11	Anti-cKIT Fab3	Mast/stem cell growth factor receptor Kit (KIT)	TWI852077B-C4-payload	TWI852077B-C4-linker	[344]
ADC Info	TWI852077B-J12	Anti-cKIT F (ab')<sub>2</sub>	Mast/stem cell growth factor receptor Kit (KIT)	TWI852077B-C4-payload	TWI852077B-C4-linker	[344]
ADC Info	TWI852077B-J14	Anti-cKIT Fab'1	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[344]
ADC Info	TWI852077B-J16	Anti-cKIT Fab'1	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J17	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[344]
ADC Info	TWI852077B-J19	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J20	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[344]
ADC Info	TWI852077B-J22	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J23	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J24	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852077B-J25	Anti-cKIT Fab'5	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[344]
ADC Info	TWI852077B-JW	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852078B-JX	Anti-cKIT Fab'2	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[344]
ADC Info	TWI852079B-JY	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin E	TWI852077B-C1-linker	[344]
ADC Info	TWI852080B-JZ	Anti-cKIT Fab'3	Mast/stem cell growth factor receptor Kit (KIT)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[344]
ADC Info	P015004-vc-PAB-MMAE	P015004	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[345]
ADC Info	P015042-vc-PAB-MMAE	P015042	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[345]
ADC Info	P015043-vc-PAB-MMAE	P015043	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[345]
ADC Info	P015044-vc-PAB-MMAE	P015044	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[345]
ADC Info	UC961-vc-PAB-MMAE	UC961	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[345]
ADC Info	LC0HC0-VC-MMAE	LC0HC0	C-type mannose receptor 2 (MRC2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[346]
ADC Info	LC4HC3-VC-MMAE	LC4HC3	C-type mannose receptor 2 (MRC2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[346]
ADC Info	RKAAR-PABC-MMAE	RKAAR	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[347]
ADC Info	RRKAY-PABC-MMAE	RRKAY	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[347]
ADC Info	RRK-PABC-MMAE	RRK	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[347]
ADC Info	ARKRA-PABC-MMAE	ARKRA	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[347]
ADC Info	RKAA-PABC-MMAE	RKAA	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[347]
ADC Info	KAR-PABC-MMAE	KAR	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[347]
ADC Info	EP3838893B1-ADC-I	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C3-Val-Ala-PAB	[348]
ADC Info	EP3838893B1-ADC-II	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-Val-Ala-PAB	[348]
ADC Info	EP3838893B1-ADC-III	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-Val-Cit-PAB	[348]
ADC Info	EP3838893B1-ADC-A	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-PEG4-Val-Ala-PAB	[348]
ADC Info	EP3838893B1-ADC-B	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-PEG8-Val-Ala-PAB	[348]
ADC Info	EP3838893B1-ADC-C	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-PEG8'-Val-Ala-PAB	[348]
ADC Info	Su-C6-Val-Cit-PAB	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[348]
ADC Info	Maa-C6-Val-Ala-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maa-C6-Val-Ala-PAB	[348]
ADC Info	Maa-C6-Val-Cit-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Maa-C6-Val-Cit-PAB	[348]
ADC Info	Mf-C6-Val-Ala-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-Val-Ala-PAB	[348]
ADC Info	Mf-C3-Val-Ala-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C3-Val-Ala-PAB	[348]
ADC Info	Mf-C6-Val-Cit-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mf-C6-Val-Cit-PAB	[348]
ADC Info	Mm-C6-Val-Ala-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-Val-Ala-PAB	[348]
ADC Info	Mm-C3-Val-Ala-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C3-Val-Ala-PAB	[348]
ADC Info	Mm-C6-Val-Cit-PAB-MMAE	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-Val-Cit-PAB	[348]
ADC Info	Mm-C6-PEG4-Val-Ala-PAB-MMAE	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-PEG4-Val-Ala-PAB	[348]
ADC Info	Mm-C6-PEG8-Val-Ala-PAB-MMAE	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-PEG8-Val-Ala-PAB	[348]
ADC Info	Mm-C6-PEG8'-Val-Ala-PAB-MMAE	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mm-C6-PEG8'-Val-Ala-PAB	[348]
ADC Info	Su-C3-VA	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	PEG2-Val-Cit-PABC	[348]
ADC Info	Su-C6-VC	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[348]
ADC Info	Su-C6-VA	mil40	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Ala-PABC	[348]
ADC Info	WO2024140927A1-ADC-A (DAR4)	mAb-A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2024140927A1-ADC-B (DAR4)	mAb-B	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2024140927A1-ADC-C (DAR2)	mAb-C	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2024140927A1-ADC-C (DAR4)	mAb-C	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2024140927A1-ADC-C (DAR7)	mAb-C	Tumor necrosis factor (TNF)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2024140927A1-ADC-A (DAR6)	mAb-A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2024140927A1-ADC-A (DAR2)	mAb-A	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[349]
ADC Info	WO2023047090A1-MMAE ADC	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[350]
ADC Info	AU2022395626A1 ADC-H1-P1	Trastuzumab-K249	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	[351]
ADC Info	AU2022395626A1 ADC-H1-P2	Trastuzumab-K249	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H2-P1	Trastuzumab-K251	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	[351]
ADC Info	AU2022395626A1 ADC-H3-P1	Trastuzumab-K291	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	[351]
ADC Info	AU2022395626A1 ADC-H4-P1	Trastuzumab-K320	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	[351]
ADC Info	AU2022395626A1 ADC-H4-P2	Trastuzumab-K320	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H5-P1	Trastuzumab-K343	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-PEG9-Val-Ala-PAB	[351]
ADC Info	AU2022395626A1 ADC-H6-P2	Trastuzumab-P41	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H7-P2	Trastuzumab-G42	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-L1-P2	Trastuzumab-A51	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-L2-P2	Trastuzumab-A111	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-L3-P2	Trastuzumab-K169	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-L4-P2	Trastuzumab-G41	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-L5-P2	Trastuzumab-P59	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H1H4-P2	Trastuzumab-K249&K320	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H1H5-P2	Trastuzumab-K249&K343	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H1L3-P2	Trastuzumab-K249&K169	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H1L4-P2	Trastuzumab-K249&G41	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H4L3-P2	Trastuzumab-K320&K169	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H4L4-P2	Trastuzumab-K320&G41	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	AU2022395626A1 ADC-H6L4-P2	Trastuzumab-P41&G41	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	GlyADC-H1-P2	Trastuzumab-K249	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	GlyADC-H4-P2	Trastuzumab-K320	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	H-Tet-Glucuronide	[351]
ADC Info	LN474-63	STI-1260	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin E	CN118079014A-linker-1	[352]
ADC Info	LN437-99	BY016	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	CN118079014A-linker-2	[352]
ADC Info	LN474-64	STI-1260	Tumor necrosis factor receptor superfamily member 17 (TNFRSF17)	Monomethyl auristatin E	CN118079014A-linker-3	[352]
ADC Info	Hu001-2-MMAE	Hu001-2	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[353]
ADC Info	Hu001-3-MMAE	Hu001-3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[353]
ADC Info	Hu005-44-MMAE	Hu005-44	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[353]
ADC Info	Hu005-46-MMAE	Hu005-46	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[353]
ADC Info	UC961-MMAE	UC961	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[353]
ADC Info	mAb001c-vc-MMAE	mAb001c	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[353]
ADC Info	WO2024092067A1 2E7-vedotin	20000000	CD70 antigen (CD70)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[354]
ADC Info	hz26A12C1H4L3-MMAE	hz26A12C1H4L3	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[355]
ADC Info	hz46F1D5H4L3-MMAE	hz46F1D5H4L3	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[355]
ADC Info	hz49E10H1H5L6-MMAE	hz49E10H1H5L6	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[355]
ADC Info	hz49E10H1H5L7-MMAE	hz49E10H1H5L7	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[355]
ADC Info	hz103E9B3H5L5-MMAE	hz103E9B3H5L5	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[355]
ADC Info	hz103E9B3H6L5-MMAE	hz103E9B3H6L5	Neural cell adhesion molecule L1 (L1CAM)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[355]
ADC Info	IN202417103159A D04-Yl80/F404-LP11	undisclosed	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	DBCO-SO3-PEG4-Val-Cit-PABC	[356]
ADC Info	IN202417078684A+ADC6	IN202417078684A+Ab4	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[357]
ADC Info	IN202417078684A+ADC9	IN202417078684A+Ab4	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	[357]
ADC Info	Abl-Linker-MMAF	Ab1	Nectin-4 (NECTIN4)	Monomethyl auristatin F	Undisclosed	[358]
ADC Info	WO2024107014A1 Ab3-Linker-MMAF	Ab3	Nectin-4 (NECTIN4)	Monomethyl auristatin F	Undisclosed	[358]
ADC Info	HG4K IgG4-Linker-MMAF (3)	HG4K IgG4	Basal cell adhesion molecule (BCAM)	Monomethyl auristatin F	Undisclosed	[358]
ADC Info	CO20240013452A2 ADC1	B62-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[359]
ADC Info	CO20240013452A2 ADC1 (2)	B31-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[359]
ADC Info	CO20240013452A2 99961-MMAE	99961.1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[359]
ADC Info	EP4495597A2 1F-MMAE	1F	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 25A-MMAE	25A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 25A3-MMAE	25A3	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 25G1-MMAE	25G1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 29E-MMAE	29E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 39A-MMAE	39A	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 43B1-MMAE	43B1	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 43D7-MMAE	43D7	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 43Ea-MMAE	43Ea	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	EP4495597A2 54E-MMAE	54E	Tissue factor (F3)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[360]
ADC Info	anti-EGFR Ab No.1 (L328C)-vcMMAE	EGFR No.1 (L328C)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	anti-HER2 Ab (L328C)-vcMMAE	HER2 (L328C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	anti-TROP2 Ab (L328C)-vcMMAE	TROP2 (L328C)	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	anti-EGFR Ab No.1 (L234A, L235A, L328C)-vcMMAE	EGFR No.1 (L234A, L235A, L328C)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	anti-EGFR Ab No.3 (L234A, L235A, L328C)-vcMMAE	EGFR No.3 (L234A, L235A, L328C)	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	LOL1-anti-HER2 Ab (L234A, L235A, L328C)	LOL1-HER2 (L234A, L235A, L328C)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	anti-TROP2 Ab (L234A, L235A, L328C)-vcMMAE	TROP2 Ab (L234A, L235A, L328C)	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[361]
ADC Info	EP4470568A1 ADC-3	hAb017-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[362]
ADC Info	EP4470568A1 ADC-5	hAb015-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[362]
ADC Info	EP4470568A1 ADC-6	hAb015-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[362]
ADC Info	EP4470568A1 ADC-7	hAb015-10	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[362]
ADC Info	EP4470568A1 ADC-8	SN8	B-cell antigen receptor complex-associated protein beta chain (CD79B)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[362]
ADC Info	WO2024110905A1 ADC1-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-2	[363]
ADC Info	WO2024110905A1 ADC1-4	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-4	[363]
ADC Info	WO2024110905A1 ADC1-11	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-11	[363]
ADC Info	WO2024110905A1 ADC2-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-2	[363]
ADC Info	WO2024110905A1 ADC2-4	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-4	[363]
ADC Info	WO2024110905A1 ADC2-9-1	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-9-1	[363]
ADC Info	WO2024110905A1 ADC2-9-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-9-1	[363]
ADC Info	WO2024110905A1 ADC2-11	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC1-11	[363]
ADC Info	WO2024110905A1 ADC2-36-1	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-36-1	[363]
ADC Info	WO2024110905A1 ADC2-36-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-36-1	[363]
ADC Info	WO2024110905A1 ADC2-43	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	Linker of ADC2-43	[363]
ADC Info	WO2024110905A1 ADC2-62-1	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-62-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-62-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-62-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-63-1	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-63-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-63-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-63-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-64-1	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-64-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-64-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-64-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-65-1	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-62-1 Linker	[363]
ADC Info	WO2024110905A1 ADC2-65-2	undisclosed	Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)	Monomethyl auristatin E	ADC2-64-1 Linker	[363]
ADC Info	YC1605	J591	Glutamate carboxypeptidase 2 (FOLH1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[364]
ADC Info	WO2024105206A1 33i-5657 2	TPP-5657	Undisclosed	Monomethyl auristatin E	22i-5657 Linker	[365]
ADC Info	WO2024105206A1 34p-Avelu 2	TPP-Avelumab	Programmed cell death 1 ligand 1 (PD-L1)	Monomethyl auristatin E	22i-5657 Linker	[365]
ADC Info	anti-TRBC1-MMAE	undisclosed	T-cell receptor beta constant region (TRBC)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[366]
ADC Info	AU2023281032A1 ADC-1	undisclosed	Undisclosed	Monomethyl auristatin E	AU2023281032A1 ADC-1 linker	[367]
ADC Info	AU2023281032A1 ADC-5	anti-TROP2 antibody	Tumor-associated calcium signal transducer 2 (TACSTD2)	Monomethyl auristatin E	AU2023281032A1 ADC-1 linker	[367]
ADC Info	C1.18 DBM- (C6)-MMAF	C1.18	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 146C: DBM- (C6)-MMAF	146C:	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 164A: DBM- (C6)-MMAF	164A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 208A: DBM- (C6)-MMAF	208A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 215A: DBM- (C6)-MMAF	215A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 230A: DBM- (C6)-MMAF	230A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 259A: DBM- (C6)-MMAF	259A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 305A: DBM- (C6)-MMAF	305A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 353A: DBM- (C6)-MMAF	353A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 53A: DBM- (C6)-MMAF	53A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 5B: DBM- (C6)-MMAF	5B	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 175A: DBM- (C6)-MMAF	175A	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	CN114230664B 76E1: DBM- (C6)-MMAF	760	V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR)	Monomethyl auristatin F	DBM linker	[368]
ADC Info	mAb1-MMAE	mAb1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb2-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb3-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb4-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb5-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb6-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb7-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb8-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb9-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb10-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb11-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb12-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb13-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb14-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb15-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb16-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb17-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb18-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[369]
ADC Info	mAb1-MMAF	mAb1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[369]
ADC Info	mAb2-MMAF	Undisclosed	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	[369]
ADC Info	mAb3-MMAF	Undisclosed	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	[369]
ADC Info	mAb17-MMAF	Undisclosed	Undisclosed	Monomethyl auristatin F	Mc-Val-Cit-PABC	[369]
ADC Info	uS11903948B2 I-1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Dolicatatin 5	Undisclosed	[370]
ADC Info	cD44-VCMMAE	Undisclosed	CD44 antigen (CD44)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[371]
ADC Info	cD44-MMAE	Undisclosed	CD44 antigen (CD44)	Monomethyl auristatin E	CN117362435A+SCD44-MMAE+Linker	[371]
ADC Info	cANO01-MC-MMAF	CANO01	Undisclosed	Monomethyl auristatin F	Maleimidocaproyl (me) linker	[372]
ADC Info	lR004-VC-MMAE	LR004	Undisclosed	Monomethyl auristatin E	Mc-Val-Cit-PABC	[373]
ADC Info	cN112638426B ADC1	mil40	Undisclosed	Tubulin inhibitor B	CN112638426B +ADC1+Linker	[374]
ADC Info	cN112638426B ADC2	mil40	Undisclosed	Tubulin inhibitor B	CN112638426B +ADC2+Linker	[374]
ADC Info	uS11661457B2 Ab-E-12	IGF-1R	Undisclosed	US11661457B2+Ab-E-12+payload	Mc-Val-Cit-PABC	[375]
ADC Info	uS11661457B2 Ab-G-12	IGF-1R	Undisclosed	US11661457B2+Ab-E-12+payload	6-Maleimidocaproic acid	[375]
ADC Info	wO2024099368A1 Tra-CAST-MMAE	undisclosed	Undisclosed	Monomethyl auristatin E	WO2024099368A1+Tra-CAST-MMAE+Linker	[376]
ADC Info	dBCO-vc-MMAE	HuSS1	Undisclosed	Monomethyl auristatin E	EP4161582A4+DBCO-vc-MMAE+Linker	[377]
ADC Info	bCN-PEG3-VC-PAB-MMAE	HuSS1	Undisclosed	Monomethyl auristatin E	EP4161582A4+BCN-PEG3-VC-PAB-MMAE+Linker	[377]
ADC Info	dBCO-PEG3-2 (PEG3-VC-PAB-MMAE)	HuSS1	Undisclosed	Monomethyl auristatin E	EP4161582A4+DBCO-PEG3-2 (PEG3-VC-PAB-MMAE)+Linker	[377]
ADC Info	igG2a-Val-Cit-Pab-MMAE	Undisclosed	Undisclosed	Monomethyl auristatin E	WO2024102603A1+lgG2a-Val-Cit-Pab-MMAE+Linker	[378]
ADC Info	igG2a-PEG8-MMAE	Undisclosed	Transmembrane 4 L6 family member 1 (TM4SF1)	Monomethyl auristatin E	WO2024102603A1+lgG2a-PEG8-MMAE+Linker	[378]
ADC Info	cN114106088A ADC1	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	[379]
ADC Info	cN114106088A ADC2	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	[379]
ADC Info	cN114106088A ADC3	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	[379]
ADC Info	cN114106088A ADC4	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	[379]
ADC Info	cN114106088A ADC5	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	[379]
ADC Info	cN114106088A ADC6	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	[379]
ADC Info	cN114106088A ADC7	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	[379]
ADC Info	cN114106088A ADC8	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	[379]
ADC Info	cN114106088A ADC9	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	[379]
ADC Info	cN114106088A ADC10	Undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	[379]
ADC Info	lN401-20-1	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	[379]
ADC Info	lN401-20-2	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	[379]
ADC Info	lN401-89-5	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	[379]
ADC Info	lN401-89-6	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	[379]
ADC Info	lN401-88-5	Undisclosed	Peripheral myelin protein 22 (Pmp22)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	[379]
ADC Info	lN401-31-1	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC1+Linker	[379]
ADC Info	lN401-31-2	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC2+Linker	[379]
ADC Info	lN401-90-5	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC3+Linker	[379]
ADC Info	lN401-90-6	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC4+Linker	[379]
ADC Info	lN401-90-4	undisclosed	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Tubulin inhibitor B	CN114106088A+ADC5+Linker	[379]
ADC Info	kR1020250008730A ADC1	B62-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[380]
ADC Info	kR1020250008730A ADC2	B31-H3L3	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[380]
ADC Info	kR1020250008730A 99961.1-MMAE	99961.1	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[380]
ADC Info	uS20240091372A1 3H9-KGDEVD-MMAE	3H9	Prion-like protein doppel (PRND)	Monomethyl auristatin E	KGDEVD linker	[381]
ADC Info	uS20240091372A1 3D1-KGDEVD-MMAE	3D1	Interleukin-3 receptor subunit alpha (IL3RA)	Monomethyl auristatin E	KGDEVD linker	[381]
ADC Info	uS20240091372A1 3D5-KGDEVD-MMAE	3D5	Prion-like protein doppel (PRND)	Monomethyl auristatin E	KGDEVD linker	[381]
ADC Info	uS20240091372A1 4D1-KGDEVD-MMAE	4D1	Prion-like protein doppel (PRND)	Monomethyl auristatin E	KGDEVD linker	[381]
ADC Info	uS20240091372A1 3H9-vc-MMAE	3H9	Prion-like protein doppel (PRND)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[381]
ADC Info	uS20240091372A1 3D1-vc-MMAE	3D1	Interleukin-3 receptor subunit alpha (IL3RA)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[381]
ADC Info	uS20240091372A1 3D5-vc-MMAE	3D5	Prion-like protein doppel (PRND)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[381]
ADC Info	uS20240091372A1 4D1-vc-MMAE	4D1	Prion-like protein doppel (PRND)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[381]
ADC Info	uS20240091372A1 3H9-DEVD-MMAE	3H9	Prion-like protein doppel (PRND)	Monomethyl auristatin E	DEVD linker	[381]
ADC Info	f314-MC-VC-PAB-MMAE	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[382]
ADC Info	f314-C4-VC-PAB-MMAE	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C4-VC-PAB	[382]
ADC Info	f314-C5-VC-PAB-MMAE-0.8	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	[382]
ADC Info	f314-C5-VC-PAB-MMAE-1.8	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	[382]
ADC Info	f314-C5-VC-PAB-MMAE-2.3	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	[382]
ADC Info	f314-C5-VC-PAB-MMAE-3.0	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C5-VC-PAB	[382]
ADC Info	f314-C6-VC-PAB-MMAE	F314	Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	Monomethyl auristatin E	C6-VC-PAB	[382]
ADC Info	wO2023232144A1ADC-1	anti-HER2 antibody mAb-1	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	WO2023232144A1, ADC-1, Payload	WO2023232144A1, ADC-1, linker	[383]
ADC Info	wO2023232144A1ADC-4	anti-TROP2 antibody mAb-2	Tumor-associated calcium signal transducer 2 (TACSTD2)	WO2023232144A1, ADC-1, Payload	WO2023232144A1, ADC-1, linker	[383]
ADC Info	wO2025019776A2ADC 22-2	A22	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Monomethyl auristatin E	WO2025019776A2, ADC 22-2, Linker	[384]
ADC Info	wO2025019776A2ADC 33-2	A33	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Monomethyl auristatin E	WO2025019776A2, ADC 22-2, Linker	[384]
ADC Info	wO2025019776A2ADC 52-2	A52	Interleukin-13 receptor subunit alpha-2 (IL13RA2)	Monomethyl auristatin E	WO2025019776A2, ADC 22-2, Linker	[384]
ADC Info	aU2023279443A1 Example 2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-031	AU2023279443A1, Example 3, Linker	[385]
ADC Info	aU2023279443A1 Example 4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-031	AU2023279443A1, Example 4, Linker	[385]
ADC Info	aU2023279443A1 Example 5	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-031	AU2023279443A1, Example 5, Linker	[385]
ADC Info	aU2023279443A1 Example A1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Undisclosed	[385]
ADC Info	aU2023279443A1 Example A3	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-031	AU2023279443A1, Example A3, Linker	[385]
ADC Info	aU2023279443A1 Example A3b	Rituximab	B-lymphocyte antigen CD20 (MS4A1)	U-031	AU2023279443A1, Example A3, Linker	[385]
ADC Info	aU2023279443A1 Example A3c	Cetuximab	Epidermal growth factor receptor (EGFR)	U-031	AU2023279443A1, Example A3, Linker	[385]
ADC Info	aU2023279443A1 Example A4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-003	Undisclosed	[385]
ADC Info	aU2023279443A1 Example A5	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-029	Undisclosed	[385]
ADC Info	aU2023279443A1 Example A6	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	AU2023279443A1, Example A6, Linker	[385]
ADC Info	aU2023279443A1 Example A7	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	AU2023279443A1, Example A7, Linker	[385]
ADC Info	aU2023279443A1 Example A8	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	RU20241285-9-linker	[385]
ADC Info	aU2023279443A1 Example A9	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-036	RU20241285-9-linker	[385]
ADC Info	aU2023279443A1 Example A12	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-035	AU2023279443A1, Example A12, Linker	[385]
ADC Info	aU2023279443A1Example A15	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-031	AU2023279443A1, Example A15, Linker	[385]
ADC Info	aU2023279443A1 Example A19	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	U-031	AU2023279443A1, Example A19, Linker	[385]
ADC Info	aU2023279443A1 Comparative Control Compound-1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[385]
ADC Info	wO2024181570A1 ADC3	Antibody 1	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC4	Antibody 1	Syndecan-1 (SDC1)	Monomethyl auristatin F	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC8	Antibody 3	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC9	Antibody 4	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC10	Antibody 5	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC11	Antibody 6	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC12	Antibody 10	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC13	Antibody 11	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2024181570A1 ADC14	Antibody 12	Syndecan-1 (SDC1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[386]
ADC Info	wO2020252015A1 ADCLP-11	mAb42	Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)	Monomethyl auristatin E	DBCO-SO3-PEG4-Val-Cit-PABC	[387]
ADC Info	anti-HER-MC-VC-FABC-MMAE	Anti-Her2 WT	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Aminooxy-Cys linker	[388]
ADC Info	antiHER-AO-Cys-MC-VC-FABC-MMAE	Anti-Her2 WT	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Aminooxy-Cys linker	[388]
ADC Info	anti FAF BI1-MC-VC-FABC-MMAE	Anti-FAF B11	Fibroblast growth factor (FGF)	Monomethyl auristatin E	Aminooxy-Cys linker	[388]
ADC Info	anti FAF B11-AO-Cys-MC-VC-FABC-MMAE	Anti-FAF B11	Fibroblast growth factor (FGF)	Monomethyl auristatin E	Aminooxy-Cys linker	[388]
ADC Info	sWY2110-VC-MMAE ADC	SWY2110	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[389]
ADC Info	vH4Vk3-MC-VCP-MMAE ADC	VH4Vk3	Ephrin type-A receptor 5 (EPHA5)	Monomethyl auristatin E	MC-VCP linker	[390]
ADC Info	vH4Vk3-ThioBridge-VCP-MMAE ADC	VH4Vk3	Ephrin type-A receptor 5 (EPHA5)	Monomethyl auristatin E	ThioBridge®-VCP linker	[390]
ADC Info	abT-EXP9	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP9-linker	[391]
ADC Info	abT-EXP10	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP10-linker	[391]
ADC Info	abT-EXP11	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP11-linker	[391]
ADC Info	abT-EXP12	AbT	Bacterial transglutaminase (BTG)	Monomethyl auristatin E	CN116137818A-AbT-EXP12-linker	[391]
ADC Info	mAb-P5 (PEG12)- VC-PAB-MMAE	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG12)- VC-PAB linker	[392]
ADC Info	mAb-P5 (PEG24)- VC-PAB-MMAE	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG24)- VC-PAB linker	[392]
ADC Info	mAb-P5 (PEG2)- VC-PAB-MMAE	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG2)- VC-PAB linker	[392]
ADC Info	mAb-P5 (PEG12)-VA-PAB-MMAE	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG12)-VA-PAB linker	[392]
ADC Info	mAb-P5 (PEG2)-VA-PAB-MMAE	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG2)-VA-PAB linker	[392]
ADC Info	mAb-P5 (PEG24)-VA-PAB-MMAE	AV-25	N-myc downstream-regulated gene 2B (NDRG2B)	Monomethyl auristatin E	P5 (PEG24)-VA-PAB linker	[392]
ADC Info	igG-MMAE 1-10	undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[393]
ADC Info	iCAM1-MMAE 1-10	undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[393]
ADC Info	igG-MMAF	undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	6-Maleimidocaproic acid	[393]
ADC Info	iCAM1-MMAF 1-10	undisclosed	Intercellular adhesion molecule 1 (ICAM1)	Monomethyl auristatin F	6-Maleimidocaproic acid	[393]
ADC Info	zHER2-Gly3-VC-PAB-MMAF	ZHER2	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin F	Gly3-VC-PAB	[394]
ADC Info	zHER2-Gly3-VC-PAB-MMAE	ZHER2	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Gly3-VC-PAB	[394]
ADC Info	huM25-vcMMAE ADCs	huM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin E	Mc-Val-Cit-PABC	[395]
ADC Info	anti-huLRRC15 ADCs	huM25	Leucine-rich repeat-containing protein 15 (LRRC15)	Monomethyl auristatin F	6-Maleimidocaproic acid	[395]
ADC Info	cN114306633A A-1	pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	CN114306633A-A-1-linker	[396]
ADC Info	cN114306633A C-3	pertuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	CN114306633A-C-3-linker	[396]
ADC Info	cN110974975B C-00	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	CN110974975B-C-00-linker	[397]
ADC Info	sCT-200-M-1	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-M-1-linker	[398]
ADC Info	sCT-200-M-2	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-M-2-linker	[398]
ADC Info	sCT-200-M-3	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-M-3-linker	[398]
ADC Info	sCT-200-C-1	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-1-linker	[398]
ADC Info	sCT-200-C-2	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-2-linker	[398]
ADC Info	sCT-200-C-3	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-3-linker	[398]
ADC Info	sCT-200-C-4	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-4-linker	[398]
ADC Info	sCT-200-C-5	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-C-5-linker	[398]
ADC Info	sCT-200-R-1	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-R-1-linker	[398]
ADC Info	sCT-200-R-2	SCT-200	Epidermal growth factor receptor (EGFR)	Monomethyl auristatin E	CN112604004B-SCT-200-R-2-linker	[398]
ADC Info	(RC48-vc-MMAE)	RC48	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Mc-Val-Ala-PABC	[399]
ADC Info	pCAD-mab2-L4-P1	PCAD-mab2	Cadherin-3 (CDH3)	L4P1 payload	L4-P1 linker	[400]
ADC Info	pCAD-mab2-L6-P1	PCAD-mab2	Cadherin-3 (CDH3)	L4P1 payload	L6-P1 linker	[400]
ADC Info	igG-L4-P1	undisclosed	P-Cadherin (pCAD)	L4P1 payload	L4-P1 linker	[400]
ADC Info	igG-L6-P1	undisclosed	P-Cadherin (pCAD)	L4P1 payload	L6-P1 linker	[400]
ADC Info	tW202506738A C-332	undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-327-LINKER	[401]
ADC Info	tW202506738A C-333	undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-333-LINKER	[401]
ADC Info	tW202506738A C-334	undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-333-LINKER	[401]
ADC Info	tW202506738A C-335	undisclosed	Undisclosed	TW202506738A-C-332-PAYLOAD	TW202506738A-C-335-LINKER	[401]
ADC Info	cN113874046B ADC-1	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	CN113874046B-ADC-1-LINKER	[402]
ADC Info	cN113874046B ADC-4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	CN113874046B-ADC-4-LINKER	[402]
ADC Info	cN113874046B ADC-7	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	CN113874046B-ADC-7-LINKER	[402]
ADC Info	aZO-ADC-0	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Solubilizing group-PEG0-Hypoxia sensitive linker-Azobenzene	[403]
ADC Info	aZO-ADC-2	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Solubilizing group-PEG2-Hypoxia sensitive linker-Azobenzene	[403]
ADC Info	aZO-ADC-4	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Solubilizing group-PEG4-Hypoxia sensitive linker-Azobenzene	[403]
ADC Info	aZO-ADC-6	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Solubilizing group-PEG6-Hypoxia sensitive linker-Azobenzene	[403]
ADC Info	aZO-ADC-8	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	Solubilizing group-PEG8-Hypoxia sensitive linker-Azobenzene	[403]
ADC Info	igG (8)-m- (b-PEG12)-VC-MMAE	Trastuzumab	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	IgG (8)-m- (b-PEG12)-VC-MMAE	[404]
ADC Info	mb (4)-m- (b-PEG12)-VC-MMAE	Minibody (4 cys)	Receptor tyrosine-protein kinase erbB-2 (ERBB2)	Monomethyl auristatin E	IgG (8)-m- (b-PEG12)-VC-MMAE	[404]
ADC Info	nAPC-ADC	sibrotuzumab	Prolyl endopeptidase FAP (FAP)	Monomethyl auristatin E	MC-Radiation-responsive linker	[405]
ADC Info	aLE.P02	Anti-CLDN1 antibody	CLDN1	MMAE	Mc-Val-Cit-PABC
ADC Info	sYS6005	Anti-ROR1 Fc-silenced mAb	ROR1	MMAE	A cleavable linker
ADC Info	dXC-008	Anti-PSMA/STEAP1 dual-target antibody	PSMA; STEAP1	Tubulysin B analog	A cleavable linker
ADC Info	debio 1562M	Naratuximab	CD37	DM1	Multilink? Cleavable Linker
ADC Info	hY0001a	HY0001	CDCP1	MMAE	A cleavable linker
ADC Info	hDM2005	Anti-ROR1 antibody	ROR1	MMAE	Mc-Val-Cit-PABC
ADC Info	mRG004A	MAB804	tissue factor	MMAE	BCN-Val-Cit linker
ADC Info	laventatug tivedotin	Laventatug	LIV-1	MMAE	BrAc-Val-Cit-PABC
ADC Info	vBC101-F11	Anti-EGFR/c-Met bsAb	EGFR; c-Met	MMAE	Undisclosed
ADC Info	pF-08046054	undisclosed	Programmed cell death ligand 1 (PDL1)	Monomethyl auristatin E	Mc-Val-Cit-PABC
ADC Info	wEF-001	undisclosed	Undisclosed	Monomethyl auristatin E	Undisclosed
ADC Info	pF-08052667	Anti-ITGB6 mAb	ITGB6	MMAE	Mal PEG12 based β-glucuronide linker
ADC Info	bL-M24D1	undisclosed	Undisclosed	WA-00	Undisclosed
ADC Info	hX111	Anti-OX40 antibody	OX40	MMAE	Mc-Val-Cit-PABC
ADC Info	sacituzumab vedotin	Sacituzumab	TROP2	MMAE	Mc-Val-Cit-PABC
ADC Info	sG2918	Anti-LILRB4 mAb	LILRB4	MMAE	A cleavable linker
ADC Info	cKD-703	Anti-c-Met antibody	c-Met	MMAE	Undisclosed
ADC Info	aRX305	Anti-CD70 mAb	CD70	Amberstatin 269 (AS269)	Oxime-PEG3
ADC Info	jNJ-95298177	Anti-PSMA IgG1k mAb	PSMA	Amberstatin 269 (AS269)	Oxime-PEG3
ADC Info	aVID100	MAB100	EGFR	DM1	Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Info	aGS-16M8F	Anti-ENPP3 antibody	ENPP3	MMAF	Maleimido-caproyl
ADC Info	mBRC-101	Anti-EphA5 mAb	EphA5	MMAE	ThioBridge bis-sulfone Val-Cit linker
ADC Info	nC18	Trastuzumab	HER2	AF-HEA	PHF polymer linker
ADC Info	mHB118C	Anti-IGF-1R antibody	IGF-1R	Undisclosed	Undisclosed
ADC Info	lY203725	KS1/4	Undisclosed	4-desacetylvinblastine (DAVLB)	A cleavable linker
ADC Info	lY256787	KS1/4	Undisclosed	4-desacetylvinblastine (DAVLB)	A cleavable linker

References

Ref 1	Introduction to basic information on ADC drug trastuzumab vedotin.
Ref 2	Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers
Ref 3	Immunoconjugates targeting cd138 and uses thereof; 2009-07-02.
Ref 4	Tisotumab Vedotin: First Approval
Ref 5	Belantamab Mafodotin: First Approval
Ref 6	FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Ref 7	Mirvetuximab Soravtansine: First Approval
Ref 8	FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas
Ref 9	Trastuzumab emtansine: first global approval
Ref 10	[Relation between goiter endemia and iodine content of the drinking water in some zones of Piedmont and Sardinia]
Ref 11	89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Ref 12	Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors. J Nucl Med. 2018 Mar;59(3):494-501. doi: 10.2967/jnumed.117.196279. Epub 2017 Nov 16.
Ref 13	Aryl Sulfate is a Useful Motif for Conjugating and Releasing Phenolic Molecules: Sulfur Fluorine Exchange Click Chemistry Enables Discovery of Ortho-Hydroxy-Protected Aryl Sulfate Linker. Bioconjug Chem. 2019 Jul 17;30(7):1957-1968. doi: 10.1021/acs.bioconjchem.9b00340. Epub 2019 Jun 28.
Ref 14	Anti-egfr antibodies and antibody drug conjugates.
Ref 15	AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage. Acta Pharmacol Sin. 2023 Jun;44(6):1290-1303. doi: 10.1038/s41401-022-01047-6. Epub 2023 Jan 17.
Ref 16	Discovery of BCG033, a novel anti-PTK7 x TROP2 bispecific antibody-drug conjugate with promising efficacy against triple-negative breast cancer. Cancer Res (2023) 83 (8_Supplement): LB216.
Ref 17	Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016 Dec 1;126(12):4640-4653. doi: 10.1172/JCI85856. Epub 2016 Nov 14.
Ref 18	MAbs. 2023 Jan-Dec;15(1):2149057. doi: 10.1080/19420862.2022.2149057.
Ref 19	Anti-integrin immunoconjugates, methods and uses; 2008-01-17.
Ref 20	Tridentate connexon and use thereof.
Ref 21	Anti-cxcr4 antibodies and antibody-drug conjugates.
Ref 22	Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766.
Ref 23	Anti-mesothelin antibody and antibody-drug conjugate thereof; 2019-11-28.
Ref 24	Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors. Blood (2013) 122 (21): 1637.
Ref 25	IMGN853, a Folate Receptor- (FR)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FR-Expressing Tumors. Mol Cancer Ther. 2015 Jul;14(7):1605-13.
Ref 26	Introduction to basic information on ADC drug anti-FR (clone M9346A)-SPDB-DM4.
Ref 27	Treating Tissue Factor-Positive Cancers with Antibody-Drug Conjugates That Do Not Affect Blood Clotting. Mol Cancer Ther. 2018 Nov;17(11):2412-2426.
Ref 28	Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade. Mol Cancer Ther. 2022 Sep 6;21(9):1462-1472.
Ref 29	Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models. Front Oncol. 2022 May 4;12:856424.
Ref 30	High-throughput membrane-anchored proteome screening reveals PIEZO1 as a promising antibody-drug target for human esophageal squamous cell carcinoma. Cancer Med. 2022 Oct;11(19):3700-3713.
Ref 31	Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer. Int J Mol Sci. 2022 Feb 18;23(4):2264.
Ref 32	Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model. Cancer Cell Int. 2022 Dec 27;22(1):417.
Ref 33	Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer. Neoplasia. 2023 Jan;35:100853.
Ref 34	Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target. RSC Chem Biol. 2021 May 31;2(4):1206-1220.
Ref 35	An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer. Eur J Med Chem. 2022 Nov 5;241:114617.
Ref 36	Enzymatic glycan remodeling-metal free click (GlycoConnect) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering. MAbs. 2022 Jan-Dec;14(1):2078466.
Ref 37	Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res. 2008 Nov 15;68(22):9280-90.
Ref 38	Biological Evaluation of Maytansinoid-Based Site-Specific Antibody-Drug Conjugate Produced by Fully Chemical Conjugation Approach: AJICAP. Front Biosci (Landmark Ed). 2022 Aug 5;27(8):234.
Ref 39	Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics. 2021 Nov 3;13(11):1847.
Ref 40	Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker. Mol Cancer Ther. 2016 Jun;15(6):1301-10.
Ref 41	Development of ASG-15ME, a Novel Antibody-Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker. Mol Cancer Ther. 2016 Jun;15(6):1301-10. doi: 10.1158/1535-7163.MCT-15-0570. Epub 2016 Mar 4.
Ref 42	A glypican-1-targeted antibody-drug conjugate exhibits potent tumorgrowth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma. Neoplasia. 2021 Sep;23(9):939-950.
Ref 43	Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma. Mol Cancer Ther. 2021 Sep;20(9):1713-1722. doi: 10.1158/1535-7163.MCT-21-0015. Epub 2021 Jun 17.
Ref 44	Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer. Mil Med Res. 2021 Dec 9;8(1):63.
Ref 45	A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors. Mol Oncol. 2022 Mar;16(6):1290-1308.
Ref 46	Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers. Cancer Discov. 2017 Sep;7(9):1030-1045.
Ref 47	Novel peptide linkers for highly potent antibody-auristatin conjugate. Bioconjug Chem. 2008 Oct;19(10):1960-3. doi: 10.1021/bc800289a. Epub 2008 Sep 20.
Ref 48	Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation. Mol Cancer Ther. 2017 May;16(5):879-892.
Ref 49	Protease-activated drug development. Theranostics. 2012;2(2):156-78.
Ref 50	The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo. Clin Cancer Res. 2009 Jun 15;15(12):4028-37.
Ref 51	Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells. Blood. 2004 Dec 1;104(12):3688-96.
Ref 52	AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage. Acta Pharmacol Sin. 2023 Jun;44(6):1290-1303.
Ref 53	Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. Nat Med. 2018 Feb;24(2):203-212.
Ref 54	Targeting and pharmacology of an anti-IL13R2 antibody and antibody-drug conjugate in a melanoma xenograft model. MAbs. 2021 Jan-Dec;13(1):1958662.
Ref 55	Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nat Commun. 2021 Jun 10;12(1):3528.
Ref 56	Compact hydrophilic electrophiles enable highly efficacious high DAR ADCs with excellent in vivo PK profile. Chem Sci. 2023 Jan 3;14(9):2259-2266. doi: 10.1039/d2sc05678j. eCollection 2023 Mar 1.
Ref 57	A new immunochemical strategy for triple-negative breast cancer therapy. Sci Rep. 2021 Jul 21;11(1):14875.
Ref 58	Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation. Bioorg Chem. 2021 Nov;116:105366.
Ref 59	Cyclopentadiene as a Multifunctional Reagent for Normal- and Inverse-Electron Demand Diels-Alder Bioconjugation. Bioconjug Chem. 2022 Sep 21;33(9):1609-1619.
Ref 60	Synthesis and Evaluation of Three Azide-Modified Disaccharide Oxazolines as Enzyme Substrates for Single-Step Fc Glycan-Mediated Antibody-Drug Conjugation. Bioconjug Chem. 2022 Jun 15;33(6):1179-1191.
Ref 61	General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates. ACS Chem Biol. 2021 Nov 19;16(11):2502-2514.
Ref 62	Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation. Bioconjug Chem. 2022 Jun 15;33(6):1192-1200.
Ref 63	EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing. Biol Chem. 2021 Sep 20;403(5-6):525-534.
Ref 64	A FZD7-specific Antibody-Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models. Mol Cancer Ther. 2022 Jan;21(1):113-124.
Ref 65	Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies. Mol Pharm. 2022 May 2;19(5):1422-1433.
Ref 66	Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity. Biomed Pharmacother. 2023 Jan;157:114047.
Ref 67	An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs. Cancer Lett. 2023 Feb 1;554:216024.
Ref 68	Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release. Bioconjug Chem. 2022 Aug 17;33(8):1474-1484.
Ref 69	The HB22.7 Anti-CD22 Monoclonal Antibody Is an Effective Platform for CD22-Targeted Antibody Drug Conjugates for Treatment of Lymphoma and Acute Lymphoblastic Leukemia. Blood. 2012 ;120(21):-. doi: 10.1182/blood.V120.21.1653.1653.
Ref 70	Anti-tumor efficacy of GMF-1A3, an MMAE-based antibody drug conjugate targeting cell surface cleaved Amphiregulin in breast cancer. Cancer Res (2023) 83 (7_Supplement): 562.
Ref 71	Introduction to basic information on ADC drug IN30705.
Ref 72	Izeltabart tapatansine by MacroGenics for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval; 30 May 2023.
Ref 73	Discovery of A Novel EGFR-Targeting Antibody-Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies. Mol Cancer Ther. 2019 Jun;18(6):1104-1114. doi: 10.1158/1535-7163.MCT-18-0854.
Ref 74	Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies. Blood. 2019 ;134():-. doi: 10.1182/blood-2019-132062.
Ref 75	Preclinical Development of a Bcma Targeting Antibody-Drug Conjugate with Novel Payload for Multiple Myeloma Therapy. Blood. 2019 ;134():-. doi: 10.1182/blood-2019-132080.
Ref 76	Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989.
Ref 77	RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models. Mol Cancer Ther. 2016 Nov;15(11):2698-2708. doi: 10.1158/1535-7163.MCT-16-0431. Epub 2016 Aug 31.
Ref 78	RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models. Oncotarget. 2018 Sep 11;9(71):33446-33458. doi: 10.18632/oncotarget.26002. eCollection 2018 Sep 11.
Ref 79	NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells. Cell Rep Med. 2021 May 18;2(5):100279. doi: 10.1016/j.xcrm.2021.100279. eCollection 2021 May 18.
Ref 80	Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer. Sci Rep. 2019 Jun 10;9(1):8420. doi: 10.1038/s41598-019-44874-0.
Ref 81	Mediapharma product pipeline
Ref 82	FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther. 2012 Oct;11(10):2222-32. doi: 10.1158/1535-7163.MCT-12-0087. Epub 2012 Jul 17.
Ref 83	Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates. Chem Sci. 2017 Jan 1;8(1):366-370. doi: 10.1039/c6sc01831a. Epub 2016 Aug 22.
Ref 84	Evaluation of endoglin/CD105 as a tumor vasculature target with antibody drug conjugates. Cancer Res (2018) 78 (13_Supplement): 2900.
Ref 85	Introduction to basic information on ADC drug IMB-101 and IMB-102.
Ref 86	Cybrexa therapeutics product pipeline
Ref 87	Introduction to basic information on ADC drug Oberotatug ravtansine.
Ref 88	Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy. Mol Ther Oncolytics. 2021 Apr 29;21:329-339. doi: 10.1016/j.omto.2021.04.013. eCollection 2021 Jun 25.
Ref 89	Spirea secures more capital to develop nextgeneration ADC cancer therapeutics; 2020
Ref 90	Develop highly specific cell engager constructs with improved function and safety by understanding target-effector cell avidity.
Ref 91	Adcitmer , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. Br J Dermatol. 2022 Feb;186(2):295-306. doi: 10.1111/bjd.20770.
Ref 92	Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer. Bioconjug Chem. 2022 Feb 16;33(2):418-426. doi: 10.1021/acs.bioconjchem.2c00015. Epub 2022 Feb 1.
Ref 93	Divinylpyrimidine reagents generate antibody-drug conjugates with excellent in vivo efficacy and tolerability. Chem Commun (Camb). 2022 Feb 8;58(12):1962-1965. doi: 10.1039/d1cc06766d.
Ref 94	Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer. Cancer Chemother Pharmacol. 2019 Jul;84(1):61-72. doi: 10.1007/s00280-019-03848-9. Epub 2019 Apr 29.
Ref 95	MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy. J Exp Clin Cancer Res. 2020 Sep 22;39(1):198. doi: 10.1186/s13046-020-01711-x.
Ref 96	Old target, but new approach: Targeting cancer-associated MUC1 with ADC and Car-T. Cancer Res (2020) 80 (16_Supplement): 6530.
Ref 97	Preclinical characterization of a novel SSEA-4-targeting antibody drug conjugate, OBI-998. Cancer Res (2021) 81 (13_Supplement): 955.
Ref 98	ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. Blood Adv. 2020 Oct 27;4(20):5203-5214. doi: 10.1182/bloodadvances.2020002395.
Ref 99	Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release. J Clin Invest. 2018 Jul 2;128(7):2927-2943. doi: 10.1172/JCI120481. Epub 2018 Jun 4.
Ref 100	Introduction to basic information on ADC drug IMAB362-VCMMAE.
Ref 101	Preclinical characterization of the safety and antitumor activity of IMAB027-vcMMAE, an anticlaudin 6 antibody-drug conjugate. Cancer Res (2018) 78 (13_Supplement): 1778.
Ref 102	Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody libraries. Sci Rep. 2021 Jul 29;11(1):15430. doi: 10.1038/s41598-021-94902-1.
Ref 103	Introduction to basic information on ADC drug Bstrongximab ADC (CureMeta).
Ref 104	The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells. Mol Med. 2021 May 7;27(1):46. doi: 10.1186/s10020-021-00306-2.
Ref 105	An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells. Leuk Res. 2021 Sep;108:106626. doi: 10.1016/j.leukres.2021.106626.
Ref 106	Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy. J Immunother Cancer. 2019 Sep 13;7(1):250. doi: 10.1186/s40425-019-0732-8.
Ref 107	Introduction to basic information on ADC drug GB-7008-01-vcMMAE.
Ref 108	Development of Cirmtuzumab Antibody-Drug Conjugates (ADCs) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1). Blood. 2018 ;132():-. doi: 10.1182/blood-2018-99-119447.
Ref 109	Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy. Nat Commun. 2022 Jul 5;13(1):3869. doi: 10.1038/s41467-022-31601-z.
Ref 110	Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model. Bioconjug Chem. 2021 Mar 17;32(3):595-606. doi: 10.1021/acs.bioconjchem.1c00058. Epub 2021 Feb 25.
Ref 111	Avibodie are engineered, bivalent antibody fragments, precisely loaded with imaging or cytotoxic payloads
Ref 112	Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau. Oncotarget. 2018 May 1;9(33):23289-23305. doi: 10.18632/oncotarget.25289. eCollection 2018 May 1.
Ref 113	FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther. 2012 Oct;11(10):2222-32. doi: 10.1158/1535-7163.MCT-12-0087. Epub 2012 Jul 17.
Ref 114	Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates. Mol Cancer Ther. 2016 May;15(5):938-45. doi: 10.1158/1535-7163.MCT-16-0038. Epub 2016 Mar 4.
Ref 115	Immunoregulation by IL-7R-targeting antibody-drug conjugates: overcoming steroid-resistance in cancer and autoimmune disease. Sci Rep. 2017 Sep 6;7(1):10735. doi: 10.1038/s41598-017-11255-4.
Ref 116	A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models. Signal Transduct Target Ther. 2021 Sep 3;6(1):320. doi: 10.1038/s41392-021-00666-5.
Ref 117	Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible Antigen. Clin Cancer Res. 2021 Jun 1;27(11):3224-3233. doi: 10.1158/1078-0432.CCR-20-1725.
Ref 118	Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Ann Oncol. 2017 Apr 1;28(4):769-776. doi: 10.1093/annonc/mdw678.
Ref 119	Introduction to basic information on ADC drug ST1.
Ref 120	A novel pegylated bispecific antibody-drug conjugate (P-BsADCpb-adc) targeting cancers co-expressing PD-L1 and CD47. Cancer Res (2023) 83 (7_Supplement): 6307.
Ref 121	Antibody-Drug Conjugates Used in Breast Cancers. J Oncol. 2021 Jun 24;2021:9927433. doi: 10.1155/2021/9927433. eCollection 2021.
Ref 122	LCB97, an antibody drug conjugate (ADC) targeting a novel tumor antigen for the treatment of multiple solid tumors. Cancer Res (2023) 83 (7_Supplement): 5653.
Ref 123	Legochem biosciences biopharmaceutical company product pipeline
Ref 124	Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies. Mol Cancer Ther. 2015 Sep;14(9):2081-9. doi: 10.1158/1535-7163.MCT-15-0312. Epub 2015 Jul 16.
Ref 125	Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol. 2018 Apr 1;29(4):917-923.
Ref 126	Introduction to basic information on ADC drug DM003.
Ref 127	Anti-MSLN ADC against cancer; institute of pharmaceutics development center for biotechnology; 2020
Ref 128	A first-in-class anti-HER2/TROP2 bispecific antibody-drug conjugate (YH012) exhibits potent anti-tumor efficacy. Cancer Res (2023) 83 (7_Supplement): 2977.
Ref 129	YH013, a novel EGFR x MET bispecific antibody-drug conjugate, exhibits potent antitumor efficacy. Cancer Res (2023) 83 (7_Supplement): 2978.
Ref 130	Identification of DM004, a first-in-class anti-5T4/MET bispecific antibody-drug conjugate. Cancer Res (2023) 83 (8_Supplement): LB213.
Ref 131	A novel EGFR x MUC1 bispecific antibody-drug conjugate, BSA01, targets MUC1 transmembrane cleavage products and improves tumor selectivity. Cancer Res (2023) 83 (7_Supplement): 6325.
Ref 132	BCG022: A novel bispecific antibody-drug conjugate targeting HER3 and MET. Cancer Res (2023) 83 (8_Supplement): LB212.
Ref 133	NextGen conditionally active biologic (CAB) anti-Nectin-4-ADC with improved stability and safety. Cancer Res (2023) 83 (7_Supplement): 1541.
Ref 134	Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors. Cancer Res (2020) 80 (16_Supplement): 4560.
Ref 135	A CD79b Targeting ADC with Superior Anti-Tumor Activity and Safety Resulting in Significantly Improved Therapeutic Index (TI): Safe and Efficacious CD79b ADC. Blood. 2022 ;140():11568-11569. doi: 10.1182/blood-2022-160056.
Ref 136	A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers. Cancer Res (2014) 74 (19_Supplement): 4494.
Ref 137	Anwita biosciences product pipeline
Ref 138	Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers. Mol Cancer Ther. 2017 Jul;16(7):1299-1311. doi: 10.1158/1535-7163.MCT-16-0839. Epub 2017 Apr 4.
Ref 139	A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells. mBio. 2022 Feb 22;13(1):e0338421. doi: 10.1128/mbio.03384-21. Epub 2022 Jan 18.
Ref 140	Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody-Drug Conjugate LR-DM1 for Pancreatic Cancer. J Med Chem. 2022 May 26;65(10):7141-7153. doi: 10.1021/acs.jmedchem.1c01920. Epub 2022 May 6.
Ref 141	Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis. Neoplasia. 2017 Sep;19(9):716-733. doi: 10.1016/j.neo.2017.07.001. Epub 2017 Aug 19.
Ref 142	EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma. Cancers (Basel). 2018 Dec 17;10(12):519. doi: 10.3390/cancers10120519.
Ref 143	Antibody-drug conjugates targeting CD248(+) myofibroblasts effectively alleviate renal fibrosis in mice. FASEB J. 2022 Feb;36(2):e22102. doi: 10.1096/fj.202101441R.
Ref 144	A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer. Adv Sci (Weinh). 2020 Nov 3;7(24):2002852. doi: 10.1002/advs.202002852.
Ref 145	A ca6 antigen-specific cytotoxic conjugate and methods of using the same; 2005-02-03
Ref 146	Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy. Clin Cancer Res. 2014 Dec 1;20(23):6045-58. doi: 10.1158/1078-0432.CCR-14-0898. Epub 2014 Oct 7.
Ref 147	Antibody-Drug Conjugate to Treat Meningiomas. Pharmaceuticals (Basel). 2021 May 2;14(5):427. doi: 10.3390/ph14050427.
Ref 148	A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer. Breast Cancer. 2022 Nov;29(6):1121-1132. doi: 10.1007/s12282-022-01393-7. Epub 2022 Aug 18.
Ref 149	Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft. Oncotarget. 2019 Feb 1;10(10):1031-1044. doi: 10.18632/oncotarget.26613. eCollection 2019 Feb 1.
Ref 150	Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy. Eng Life Sci. 2020 Oct 7;21(1-2):37-44. doi: 10.1002/elsc.202000027. eCollection 2021 Jan.
Ref 151	Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines (Basel). 2021 Aug 10;9(8):882. doi: 10.3390/vaccines9080882.
Ref 152	Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer. Anticancer Res. 2022 Jul;42(7):3453-3461. doi: 10.21873/anticanres.15832.
Ref 153	Bispecific HER2 ADC: Making more potent HER2 ADC by improving target internalization; Cancer Res (2019) 79 (13_Supplement): 233..
Ref 154	Post translational modification therapeutics product pipeline
Ref 155	Antibody drug conjugate using CTAT linker technology shows superior efficacy in xenograft trial; 2015
Ref 156	Introduction to basic information on humanized anti-HER2 mab-maytansine conjugate(Anhui Anke Biotechnology/Wuxi Pharmatech).
Ref 157	Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C-Lock linker. Cancer Med. 2019 Apr;8(4):1793-1805. doi: 10.1002/cam4.2066. Epub 2019 Mar 7.
Ref 158	CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Am J Obstet Gynecol. 2021 Feb;224(2):197.e1-197.e23. doi: 10.1016/j.ajog.2020.08.028. Epub 2020 Aug 19.
Ref 159	N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability. MAbs. 2021 Jan-Dec;13(1):1914885. doi: 10.1080/19420862.2021.1914885.
Ref 160	Antibody targeting of B-cell maturation antigen on malignant plasma cells. Mol Cancer Ther. 2007 Nov;6(11):3009-18. doi: 10.1158/1535-7163.MCT-07-0464.
Ref 161	An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers. Adv Sci (Weinh). 2021 Dec;8(23):e2102414. doi: 10.1002/advs.202102414. Epub 2021 Oct 18.
Ref 162	Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy. J Control Release. 2021 Aug 10;336:433-442. doi: 10.1016/j.jconrel.2021.06.041. Epub 2021 Jun 29.
Ref 163	EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma. J Control Release. 2018 May 10;277:48-56. doi: 10.1016/j.jconrel.2018.03.016. Epub 2018 Mar 14.
Ref 164	MP-EV20-ADC: humanized anti-HER3 antibody drug conjugate
Ref 165	AVIPEP Therapeutics product pipeline
Ref 166	Preclinical evaluation of NC-6201, an antibody/drug-conjugated micelle incorporating novel hemiasterlin analogue E7974.
Ref 167	Utilization of the Angiopep platform to enable brain penetration of therapeutic mAbs or Antibody-Drug Conjugates for treatment of brain tumors. Cancer Res (2014) 74 (19_Supplement): 2657.
Ref 168	Aphios biotechnology company product pipeline
Ref 169	Compounds, linker-drugs and ligand-drug conjugates; 2020-06-16
Ref 170	Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry. Bioconjug Chem. 2015 Nov 18;26(11):2249-60. doi: 10.1021/acs.bioconjchem.5b00359.
Ref 171	Dantari biotechnology company product pipeline
Ref 172	Stable and Potent Selenomab-Drug Conjugates. Cell Chem Biol. 2017 Apr 20;24(4):433-442.e6. doi: 10.1016/j.chembiol.2017.02.012.
Ref 173	Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance. J Immunother. 2016 Apr;39(3):117-26. doi: 10.1097/CJI.0000000000000115.
Ref 174	Introduction to basic information on eribulin ADC (Jiangsu hengrui)
Ref 175	Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate. Mol Cancer Ther. 2021 Jun;20(6):1121-1132.
Ref 176	Coare biopharmaceutical company product pipeline
Ref 177	MI130004, a Novel Antibody-Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors. Mol Cancer Ther. 2018 Apr;17(4):786-794. doi: 10.1158/1535-7163.MCT-17-0795. Epub 2018 Feb 13.
Ref 178	CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110. J Hematol Oncol. 2020 Apr 7;13(1):32. doi: 10.1186/s13045-020-00865-7.
Ref 179	Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice. Br J Cancer. 1994 Feb;69(2):279-85. doi: 10.1038/bjc.1994.52.
Ref 180	Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. Blood. 1995 Apr 15;85(8):2139-46.
Ref 181	Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development. PLoS One. 2021 Jan 27;16(1):e0246197. doi: 10.1371/journal.pone.0246197. eCollection 2021.
Ref 182	Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Br J Cancer. 2001 Feb;84(4):571-8. doi: 10.1054/bjoc.2000.1633.
Ref 183	Application of a Biocatalytic Strategy for the Preparation of Tiancimycin-Based Antibody-Drug Conjugates Revealing Key Insights into Structure-Activity Relationships. J Med Chem. 2023 Jan 26;66(2):1562-1573. doi: 10.1021/acs.jmedchem.2c01771.
Ref 184	A novel molecule with profound tumor killing activity. Cancer Res (2019) 79 (13_Supplement): 353.
Ref 185	Bliss Biopharmaceutical company product pipeline
Ref 186	Novel peptide linker-based nectin-4 targeting ADC shows improved tolerability with long-lasting anti-tumor efficacy at low doses. Cancer Res (2023) 83 (8_Supplement): LB221.
Ref 187	Mediapharma product pipeline
Ref 188	The antibody-drug conjugate GENA-111 conjugated to auristatin F shows therapeutic potency in BCAM positive epithelial cancer. 2022.
Ref 189	Novel antibody drug conjugate to inhibit mesothelioma tumor growth. Cancer Res (2019) 79 (13_Supplement): 210.
Ref 190	Novel antibody conjugates and uses thereof; 2014-08-28.
Ref 191	Anti-huLRRC15 antibody drug conjugates and methods for their use. 2017-06-08
Ref 192	A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Sci Adv. 2023 May 5;9(18):eabq7866. doi: 10.1126/sciadv.abq7866. Epub 2023 May 5.
Ref 193	Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology. Bioconjug Chem. 2023 Mar 15;34(3):538-548. doi: 10.1021/acs.bioconjchem.2c00611. Epub 2023 Mar 1.
Ref 194	Human antibodies targeting ENPP1 as candidate therapeutics for cancers. Front Immunol. 2023 Jan 25;14:1070492. doi: 10.3389/fimmu.2023.1070492. eCollection 2023.
Ref 195	AB-3A4: A novel KAAG1-targeting antibody-drug conjugate is active in models of ovarian carcinoma, triple-negative breast cancer and castration-resistant prostate cancer. Cancer Res (2014) 74 (19_Supplement): 666.
Ref 196	Introduction to basic information on ADC drug IGN-786
Ref 197	ADC review AVID-300
Ref 198	Click Chemistry-Generated Auristatin F-Linker-Benzylguanine for a SNAP-Tag-Based Recombinant Antibody-Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells. ACS Omega. 2023 Jan 17;8(4):4026-4037. doi: 10.1021/acsomega.2c06844. eCollection 2023 Jan 31.
Ref 199	Old Drug, New Delivery Strategy: MMAE Repackaged. Int J Mol Sci. 2023 May 10;24(10):8543. doi: 10.3390/ijms24108543.
Ref 200	Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell Biosci. 2023 Apr 11;13(1):72. doi: 10.1186/s13578-023-01015-5.
Ref 201	Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma. Mol Oncol. 2023 Aug;17(8):1460-1473. doi: 10.1002/1878-0261.13453. Epub 2023 Jun 7.
Ref 202	Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs. J Control Release. 2023 Mar;355:515-527. doi: 10.1016/j.jconrel.2023.02.005. Epub 2023 Feb 14.
Ref 203	Development of a new minimally invasive phototherapy for lung cancer using antibody-toxin conjugate. Thorac Cancer. 2023 Mar;14(7):645-653. doi: 10.1111/1759-7714.14776. Epub 2023 Jan 19.
Ref 204	Discovery of novel antibody-drug conjugates bearing tissue protease specific linker with both anti-angiogenic and strong cytotoxic effects. Bioorg Chem. 2023 Aug;137:106575. doi: 10.1016/j.bioorg.2023.106575. Epub 2023 Apr 26.
Ref 205	DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis. Front Immunol. 2023 Jan 26;14:1051506. doi: 10.3389/fimmu.2023.1051506. eCollection 2023.
Ref 206	Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of Sarcoma. Mol Cancer Ther. 2023 Feb 1;22(2):240-253. doi: 10.1158/1535-7163.MCT-22-0312.
Ref 207	An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer. J Immunother Cancer. 2023 Mar;11(3):e006274. doi: 10.1136/jitc-2022-006274.
Ref 208	Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids. Bioorg Med Chem. 2020 Dec 1;28(23):115785. doi: 10.1016/j.bmc.2020.115785. Epub 2020 Oct 11.
Ref 209	Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. Cancers (Basel). 2020 Mar 21;12(3):744. doi: 10.3390/cancers12030744.
Ref 210	Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model. Monoclon Antib Immunodiagn Immunother. 2020 Apr;39(2):37-44. doi: 10.1089/mab.2020.0001. Epub 2020 Mar 17.
Ref 211	Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. Br J Cancer. 2020 Apr;122(9):1333-1341. doi: 10.1038/s41416-020-0781-2. Epub 2020 Mar 10.
Ref 212	Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer. Theranostics. 2020 Jan 12;10(5):2095-2114. doi: 10.7150/thno.30736. eCollection 2020.
Ref 213	Chemical Artificial Internalizing Receptors for Primary T Cells. Adv Sci (Weinh). 2020 Jul 26;7(18):2001395. doi: 10.1002/advs.202001395. eCollection 2020 Sep.
Ref 214	Antibody-Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome-Disruptive Peptide. ACS Omega. 2019 Jul 31;4(7):12955-12968. doi: 10.1021/acsomega.9b01585. eCollection 2019 Jul 31.
Ref 215	Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. Antibodies (Basel). 2019 Nov 5;8(4):54. doi: 10.3390/antib8040054.
Ref 216	Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models. MAbs. 2019 Jan;11(1):153-165. doi: 10.1080/19420862.2018.1541370. Epub 2018 Nov 8.
Ref 217	Antibody-Mediated Endocytosis of Polysialic Acid Enables Intracellular Delivery and Cytotoxicity of a Glycan-Directed Antibody-Drug Conjugate. Cancer Res. 2019 Apr 15;79(8):1810-1821. doi: 10.1158/0008-5472.CAN-18-3119. Epub 2019 Feb 26.
Ref 218	Anti-tumor activity of antibody drug conjugate targeting aspartate--hydroxylase in pancreatic ductal adenocarcinoma. Cancer Lett. 2019 May 1;449:87-98. doi: 10.1016/j.canlet.2019.02.006. Epub 2019 Feb 12.
Ref 219	APOMAB Antibody-Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo. Mol Cancer Ther. 2019 Feb;18(2):335-345. doi: 10.1158/1535-7163.MCT-18-0842. Epub 2018 Nov 9.
Ref 220	Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase. Mol Pharm. 2018 Aug 6;15(8):3260-3271. doi: 10.1021/acs.molpharmaceut.8b00298. Epub 2018 Jun 26.
Ref 221	Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. J Drug Target. 2018 Dec;26(10):905-912. doi: 10.1080/1061186X.2018.1450413. Epub 2018 Apr 13.
Ref 222	Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids. Bioorg Med Chem. 2018 May 15;26(9):2271-2279. doi: 10.1016/j.bmc.2018.02.025. Epub 2018 Feb 21.
Ref 223	Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor?2-positive gastric cancer. Oncol Rep. 2018 Mar;39(3):1396-1404. doi: 10.3892/or.2018.6201. Epub 2018 Jan 9.
Ref 224	Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer. Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.
Ref 225	Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3). Anticancer Drugs. 2020 Jun;31(5):463-472. doi: 10.1097/CAD.0000000000000878.
Ref 226	A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation. Mol Pharm. 2019 Sep 3;16(9):3926-3937. doi: 10.1021/acs.molpharmaceut.9b00529. Epub 2019 Jul 31.
Ref 227	A coiled-coil masking domain for selective activation of therapeutic antibodies. Nat Biotechnol. 2019 Jul;37(7):761-765. doi: 10.1038/s41587-019-0135-x. Epub 2019 May 27.
Ref 228	A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer. Biochem Biophys Res Commun. 2019 Jun 11;513(4):1083-1091. doi: 10.1016/j.bbrc.2019.04.046. Epub 2019 Apr 19.
Ref 229	Novel b7-h3 binding molecules, antibody drug conjugates thereof and methods of use thereof; 2017-10-19.
Ref 230	Antibody molecules and conjugates; 2023-05-19.
Ref 231	CA6 antigen-specific cytotoxic conjugate and methods of using the same; 2017-11-21.
Ref 232	Folate receptor 1 antibodies and immunoconjugates and uses thereof; 2011-09-01.
Ref 233	Introduction to basic information on ADC drug 1C1-mcMMAF
Ref 234	Compositions and methods related to anti-cd19 antibody drug conjugates; 2017-03-30.
Ref 235	Compositions and methods related to anti-egfr antibody drug conjugates; 2017-03-30.
Ref 236	Antibody-drug conjugate; 2016-08-25.
Ref 237	Tissue factor-targeted antibody-drug conjugate; 2018-03-01.
Ref 238	Anti-claudin 18.2 antibody and antibody-drug conjugate thereof; 2022-11-17.
Ref 239	Antibody-drug conjugates comprising branched linkers and methods related thereto; 2017-06-01.
Ref 240	Antibody-drug conjugate comprising antibody against human ror1, and use for the same; 2021-04-01.
Ref 241	Beta-glucuronide-linker drug conjugates; 2007-10-25.
Ref 242	Methylene carbamate linkers for use with targeted-drug conjugates; 2015-06-25.
Ref 243	Anti-c-met antibody-drug conjugate and applications thereof; 2022-03-10.
Ref 244	Hydrophilic antibody-drug conjugates; 2015-08-20.
Ref 245	Anti-cd228 antibodies and antibody-drug conjugates; 2022-02-10.
Ref 246	A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma. Front Oncol. 2019 Apr 10;9:258. doi: 10.3389/fonc.2019.00258. eCollection 2019.
Ref 247	A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors. Theranostics. 2019 Jul 13;9(18):5412-5423. doi: 10.7150/thno.33598. eCollection 2019.
Ref 248	Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate. PLoS One. 2018 Apr 19;13(4):e0195823. doi: 10.1371/journal.pone.0195823. eCollection 2018.
Ref 249	Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers. PLoS One. 2018 Feb 8;13(2):e0192194. doi: 10.1371/journal.pone.0192194. eCollection 2018.
Ref 250	Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR(+) and Heterogeneous Tumor Models. Mol Cancer Ther. 2018 Aug;17(8):1752-1760. doi: 10.1158/1535-7163.MCT-18-0073. Epub 2018 Jun 4.
Ref 251	Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice. Nat Commun. 2018 Jun 28;9(1):2512. doi: 10.1038/s41467-018-04982-3.
Ref 252	Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility. Antibodies (Basel). 2018 Mar 22;7(2):15. doi: 10.3390/antib7020015.
Ref 253	Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer. Sci Rep. 2019 Oct 17;9(1):14934. doi: 10.1038/s41598-019-51453-w.
Ref 254	Integrin 10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival. Cancers (Basel). 2019 Apr 25;11(4):587. doi: 10.3390/cancers11040587.
Ref 255	Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy. Cancers (Basel). 2019 Jul 8;11(7):957. doi: 10.3390/cancers11070957.
Ref 256	Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates. Sci Rep. 2019 Feb 21;9(1):2443. doi: 10.1038/s41598-019-38745-x.
Ref 257	Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases. Theranostics. 2019 Feb 7;9(4):1154-1169. doi: 10.7150/thno.29146. eCollection 2019.
Ref 258	An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. Int J Cancer. 2019 Oct 1;145(7):1838-1851. doi: 10.1002/ijc.32273. Epub 2019 Apr 1.
Ref 259	Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer. J Immunother Cancer. 2019 Oct 29;7(1):280. doi: 10.1186/s40425-019-0765-z.
Ref 260	Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates. Org Biomol Chem. 2018 Mar 14;16(11):1882-1889. doi: 10.1039/c7ob02780j.
Ref 261	Peroxide-cleavable linkers for antibody-drug conjugates. Chem Commun (Camb). 2023 Feb 9;59(13):1841-1844. doi: 10.1039/d2cc06677g.
Ref 262	Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) c-MET Antibodies and Antibody-Drug Conjugates. J Biol Chem. 2016 Nov 25;291(48):25106-25119. doi: 10.1074/jbc.M116.753491. Epub 2016 Sep 30.
Ref 263	ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen. Cancer Res. 2020 Oct 15;80(20):4552-4564. doi: 10.1158/0008-5472.CAN-20-1418. Epub 2020 Aug 31.
Ref 264	MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FR Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17(12):2665-2675. doi: 10.1158/1535-7163.MCT-17-1215. Epub 2018 Sep 27.
Ref 265	Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance. Front Pharmacol. 2022 Jun 17;13:764540. doi: 10.3389/fphar.2022.764540. eCollection 2022.
Ref 266	Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors. J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646.
Ref 267	A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and Selectivity. Bioconjug Chem. 2022 Oct 19;33(10):1860-1866. doi: 10.1021/acs.bioconjchem.2c00314. Epub 2022 Sep 15.
Ref 268	One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling. Bioconjug Chem. 2021 Aug 18;32(8):1888-1897. doi: 10.1021/acs.bioconjchem.1c00314. Epub 2021 Aug 5.
Ref 269	Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. Blood. 2022 Apr 21;139(16):2471-2482. doi: 10.1182/blood.2021015161.
Ref 270	Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766. doi: 10.1080/10717544.2022.2039807.
Ref 271	Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation. Org Lett. 2020 Nov 6;22(21):8419-8423. doi: 10.1021/acs.orglett.0c03049. Epub 2020 Oct 19.
Ref 272	Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. Int J Mol Sci. 2020 Sep 19;21(18):6882. doi: 10.3390/ijms21186882.
Ref 273	Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models. Am J Cancer Res. 2020 Aug 1;10(8):2387-2408. eCollection 2020.
Ref 274	Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer. Br J Cancer. 2020 Nov;123(10):1502-1512. doi: 10.1038/s41416-020-01046-6. Epub 2020 Sep 11.
Ref 275	Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells. PLoS One. 2020 Sep 28;15(9):e0239813. doi: 10.1371/journal.pone.0239813. eCollection 2020.
Ref 276	Divinylsulfonamides enable the construction of homogeneous antibody-drug conjugates. Bioorg Med Chem. 2020 Dec 1;28(23):115793. doi: 10.1016/j.bmc.2020.115793. Epub 2020 Oct 6.
Ref 277	Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect. Bioeng Transl Med. 2022 Aug 21;7(3):e10388. doi: 10.1002/btm2.10388. eCollection 2022 Sep.
Ref 278	Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminase. RSC Adv. 2022 Nov 22;12(52):33510-33515. doi: 10.1039/d2ra05630e. eCollection 2022 Nov 22.
Ref 279	Hiding Payload Inside the IgG Fc Cavity Significantly Enhances the Therapeutic Index of Antibody-Drug Conjugates. J Med Chem. 2023 Jan 12;66(1):1011-1026. doi: 10.1021/acs.jmedchem.2c01812. Epub 2022 Dec 30.
Ref 280	Anti-cdh6 antibody and anti-cdh6 antibody-drug conjugate.
Ref 281	Cysteine engineered antibodies and conjugates.
Ref 282	Conjugates comprising self-immolative groups and methods related thereto.
Ref 283	Bcma monoclonal antibody-drug conjugate.
Ref 284	Site-specific antibody-drug conjugation through glycoengineering.
Ref 285	An overview of huPr1-vcMMAE.
Ref 286	Site-specific conjugation of linker drugs to antibodies and resulting adcs.
Ref 287	Covalent linkers in antibody-drug conjugates and methods of making and using the same.
Ref 288	Antibody drug conjugates.
Ref 289	Antibody drug conjugates.
Ref 290	Introduction to basic information on ADC drug Alpha-CD70-Mc-MMAF
Ref 291	Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models. Mol Pharm. 2015 Jun 1;12(6):1863-71. doi: 10.1021/mp500666j. Epub 2015 Feb 9.
Ref 292	Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer. Oncotarget. 2019 Oct 22;10(58):6234-6244. doi: 10.18632/oncotarget.27263. eCollection 2019 Oct 22.
Ref 293	Recombinant anti-cd30 antibodies and uses thereof; 2006-02-02
Ref 294	Tasly pharma announcement; 2020
Ref 295	Introduction to basic information on EGFRvIII/MMAE antibody drug conjugate(Abgenix, Inc.).
Ref 296	Introduction to basic information on ADC drug C-met monoclonal antibody-drug conjugate
Ref 297	Introduction to basic information on ADC drug ADC-W-2589.
Ref 298	In vitro and in vivo activity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugate. Cancer Res (2015) 75 (15_Supplement): 1680.
Ref 299	Antibody-drug conjugates and related compounds, compositions, and methods.
Ref 300	Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer. PLoS One. 2016 Jun 23;11(6):e0157762. doi: 10.1371/journal.pone.0157762. eCollection 2016.
Ref 301	Anti-mesothelin antibody and antibody drug conjugate thereof
Ref 302	Introduction to basic information on ADC drug trastuzumab botidotin.
Ref 303	A phase Ia/Ib study of CBP-1008, a bispecific ligand drug conjugate, in patients with advanced solid tumors. Journal of Clinical Oncology 2022 40:16_suppl, 3000-3000.
Ref 304	DAC biotechnology company product pipeline
Ref 305	Introduction to basic information on ADC drug ZV203; 6 Jan 2020.
Ref 306	Conjupro biotherapeutics product pipeline
Ref 307	MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors. Mol Cancer Ther. 2019 Sep;18(9):1533-1543. doi: 10.1158/1535-7163.MCT-18-0624. Epub 2019 Jun 21.
Ref 308	Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer. Mol Cancer Ther. 2016 Mar;15(3):439-47. doi: 10.1158/1535-7163.MCT-15-0693.
Ref 309	Novel development strategies and challenges for anti-Her2 antibody-drug conjugates. Antib Ther. 2022 Jan 27;5(1):18-29. doi: 10.1093/abt/tbac001.
Ref 310	A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer
Ref 311	A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo
Ref 312	A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)
Ref 313	CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate
Ref 314	An antibody-drug conjugate targeting soluble and membrane-bound TGFα is effective against pancreatic tumors
Ref 315	Anti-CD64(scFv)-SNAP-Auristatin F: An in vitro proof of concept study for a recombinant antibody conjugate targeting CD64(+) acute monocytic leukemia
Ref 316	Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates
Ref 317	Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein
Ref 318	Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases
Ref 319	PF-08046032: A Novel, Investigational CD25-Directed Antibody-Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
Ref 320	PCO25-210: Design of Novel Antibody Drug Conjugates Using a Fully Humanized Monoclonal Antibody Targeting the Human Neuronal Pentraxin Receptor (YB800-ADCs) for Therapeutic Intervention in Oncology
Ref 321	Preclinical development of TGW101, a first in class click-cleavable ADC with MMAE against non-internalizing pan-carcinoma marker TAG72
Ref 322	PLB-002 is a novel Claudin 6 antibody-drug conjugate for ovarian cancer and testicular germ cell cancer
Ref 323	PF-08046031: A promising first-in-class antibody-drug conjugate for targeting novel tumor antigen in melanoma
Ref 324	Translational medicine studies of BR111, a biparatopic anti-ROR1 antibody drug conjugate for hematological and solid tumor treatment
Ref 325	Antibody-drug conjugates
Ref 326	CD38 antibody-drug conjugates
Ref 327	Antibody-drug conjugates based on eribulin and methods of use
Ref 328	Fan bracket
Ref 329	Novel anti-prostate-specific membrane antigen (PSMA) antibody drug conjugates
Ref 330	Methods of using antibody-drug conjugates
Ref 331	Methods for treating AXL-expressing cancer with anti-AXL antibodies, antibody fragments and their immune conjugates
Ref 332	Intercellular adhesion molecule 1 (ICAM1) antibody drug conjugate and uses thereof
Ref 333	Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
Ref 334	Antibodies, expression vectors, recombinant prokaryotic host cells, pharmaceutical compositions, and uses of the antibody
Ref 335	Glyco-engineered antibody-drug conjugates comprising an oxime linker
Ref 336	Anti-MERTK agonistic antibodies and uses thereof
Ref 337	Targeted delivery of dual payloads of MMAF or MMAE and TLR7 agonists for the treatment of cancer
Ref 338	Anti-TPBG/MET antibodies and uses thereof
Ref 339	Antibody-drug conjugate comprising modified antibody
Ref 340	Tetravalent antibody-drug conjugates and uses thereof
Ref 341	Selenium antibody conjugates
Ref 342	Anti-CD6 antibody conjugates for treating t-cell and b-cell mediated disorders, and t-cell and b-cell cancers
Ref 343	Antibody conjugate comprising anti-P-cadherin antibody and uses thereof
Ref 344	Antibody-drug conjugates for removing hematopoietic stem cells
Ref 345	Anti-ror1 antibodies and their uses
Ref 346	Antibody-drug conjugates targeting uPARAP comprising irinotecan derivatives
Ref 347	Methods for producing antibody-linker conjugates
Ref 348	Linker, antibody-drug conjugate including same, and uses thereof
Ref 349	Use of hydroxypropyl-β-cyclodextrin in stabilizing antibody-drug conjugate formulations
Ref 350	Antibody-drug conjugates
Ref 351	Improved antibody-payload conjugates (APCs) prepared by site-specific conjugation utilizing genetic code expansion
Ref 352	Antibody-drug conjugate intermediate SET0562, and its preparation and uses
Ref 353	Antibodies specifically binding ROR1, their drug conjugates, preparation methods and uses
Ref 354	CD70 antibody drug conjugates and methods of using the same
Ref 355	Humanized L1CAM antibody-drug conjugate
Ref 356	Anti-ROR1 antibodies and antibody conjugates, compositions comprising Anti-ROR1 antibodies or antibody conjugates, and methods of making and using Anti-ROR1 antibodies and antibody conjugates
Ref 357	Ph-dependent Anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate
Ref 358	Anti-basal cell adhesion molecule antibody-drug conjugate
Ref 359	Binding molecule directed to ror1 and its use
Ref 360	Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
Ref 361	Antibody compositions comprising Fc mutations and site-specific conjugation properties for use in treating cancer, immunological disorders, and methods thereof
Ref 362	Pharmaceutical composition comprising anti-CD79b antibody-drug conjugate and use thereof
Ref 363	Anti-CEA antibody drug conjugates and methods of use
Ref 364	Anti-PSMA antibody-drug conjugates and their preparation methods and applications
Ref 365	Antibody-drug conjugates cleavable in a tumor microenvironment
Ref 366	TRBC targeting antibody-drug conjugates
Ref 367	Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
Ref 368	Anti-C10orf54 antibodies and uses thereof
Ref 369	Antibody-drug conjugates and production thereof
Ref 370	Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof
Ref 371	CD44-specific antibodies and their antibody-drug conjugates
Ref 372	Preparation and use of anti-FSHR antibody and antibody-drug conjugate thereof
Ref 373	Application of ALK inhibitors together with EGFR-targeted antibody-drug conjugates in the preparation of medicines for treating lung cancer
Ref 374	Nitroaryl-based linkers, antibody-drug conjugates comprising the linkers and uses thereof
Ref 375	IGF-1R antibody-drug conjugate and its use for the treatment of cancer
Ref 376	Peptide tags, compositions and methods for site-specific protein conjugation
Ref 377	Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof
Ref 378	Bisecting-glycan bridged conjugation for producing glycoprotein conjugates
Ref 379	Bromomethylpyrazine-based drug conjugates and ADCs
Ref 380	Ror1-targeted binding molecules and their Applications
Ref 381	Anti-doppel antibody drug conjugates
Ref 382	Anti-CD39 antibody-drug conjugate and use thereof
Ref 383	Oligosaccharide linkers, linker-payloads comprising the linkers, and glycan chain-remodeled antibody-drug conjugates, preparation methods and uses thereof
Ref 384	Interleukin-13 receptor subunit alpha-2 antibody-drug conjugates and uses thereof
Ref 385	Antibody-multidrug conjugate
Ref 386	Antibody-drug complexes containing anti-CD138 antibodies
Ref 387	Immunomodulator antibody drug conjugates and uses thereof
Ref 388	Site-specific antibody-drug conjugation through glycoengineering
Ref 389	Uses of an antibody-drug conjugate
Ref 390	Antibody-drug conjugates targeting receptor tyrosine kinase EphA5
Ref 391	p-Aminobenzyl linkers, preparation methods and uses in conjugates
Ref 392	Novel antibody drug conjugates with novel NaPi2b antibodies, therapeutic methods and uses thereof
Ref 393	Intercellular adhesion molecule 1 (ICAM1) antibody-drug conjugates and uses thereof
Ref 394	Methods for preparing protein-small-molecule drug conjugates and applications thereof
Ref 395	Anti-huLRRC15 antibody drug conjugates and methods for their use
Ref 396	Preparation method for doubly substituted bridge-linked antibody-drug conjugates
Ref 397	Rapid-release antibody-drug conjugates
Ref 398	Anti-human EGFR antibody-drug conjugates and their preparation methods and applications
Ref 399	Pharmaceutical compositions of anti-HER2 antibody-drug conjugate
Ref 400	Antibody drug conjugates having linkers comprising hydrophilic groups
Ref 401	Site-specific conjugation of antibodies
Ref 402	Peptide linkers containing glycosides for antibody-drug conjugates
Ref 403	Azobenzene-Based Linker Strategy for Selective Activation of Antibody-Drug Conjugates
Ref 404	Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer
Ref 405	Radiotherapy activates picolinium prodrugs in tumours

Target Information

Citation

Visitor Map

Correspondence

Prof. Feng ZHU (zhufeng@zju.edu.cn)

Prof. Xiaowu DONG (dongxw@zju.edu.cn)

Prof. Luo FANG (fangluo@zjcc.org.cn)